0,1,2,3
ABBV,5 DAYS AGO,"Collaboration Between AbbVie, Biogen and Pfizer Creates World’s Largest Browsable Resource Linking Rare Protein-Coding Genetic Variants to Human Health and Disease",https://www.nasdaq.com/press-release/collaboration-between-abbvie-biogen-and-pfizer-creates-worlds-largest-browsable-0
ABC,"JUN 24, 2021",AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2021 Earnings Release,https://www.nasdaq.com/press-release/amerisourcebergen-announces-date-and-time-for-third-quarter-fiscal-2021-earnings
ABCL,1 DAY AGO,AbCellera Appoints Neil Berkley as Chief Business Officer,https://www.nasdaq.com/press-release/abcellera-appoints-neil-berkley-as-chief-business-officer-2021-07-13
ABCM,1 DAY AGO,"Abcam opens new US facility in Boston, MA",https://www.nasdaq.com/press-release/abcam-opens-new-us-facility-in-boston-ma-2021-07-13
ABEO,"JUL 7, 2021",Abeona Therapeutics Announces Updated EB-101 Phase 1/2a Clinical Results in Recessive Dystrophic Epidermolysis Bullosa at the Society for Pediatric Dermatology 46th Annual Meeting,https://www.nasdaq.com/press-release/abeona-therapeutics-announces-updated-eb-101-phase-1-2a-clinical-results-in-recessive
ABIO,1 DAY AGO,ARCA biopharma Provides Update on ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19,https://www.nasdaq.com/press-release/arca-biopharma-provides-update-on-aspen-covid-19-phase-2b-clinical-trial-evaluating
ABMD,"JUN 29, 2021",FDA Grants Highest Level of Approval to the Next Generation of Impella RP to Treat Right Heart Failure,https://www.nasdaq.com/press-release/fda-grants-highest-level-of-approval-to-the-next-generation-of-impella-rp-to-treat
ABT,"JUN 30, 2021",Abbott's XIENCE Stent Receives FDA Approval for Shortest Blood Thinner Course for High Bleeding Risk Patients,https://www.nasdaq.com/press-release/abbotts-xience-stent-receives-fda-approval-for-shortest-blood-thinner-course-for-high
ABUS,"JUL 7, 2021","Arbutus Receives Authorization to Proceed with an Investigational New Drug Application (IND) for AB-729, its Proprietary Subcutaneously-Delivered RNAi Agent",https://www.nasdaq.com/press-release/arbutus-receives-authorization-to-proceed-with-an-investigational-new-drug
ACAD,3 HOURS AGO,Acadia Pharmaceuticals to Present New Scientific Data on Pimavanserin in Neurodegenerative Diseases at the Alzheimer’s Association International Conference 2021 (AAIC),https://www.nasdaq.com/press-release/acadia-pharmaceuticals-to-present-new-scientific-data-on-pimavanserin-in-0
ACER,6 DAYS AGO,"50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021",https://www.nasdaq.com/press-release/50-companies-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-0
ACET,"JUN 28, 2021",Adicet Bio Added to the Russell 2000® Index,https://www.nasdaq.com/press-release/adicet-bio-added-to-the-russell-2000r-index-2021-06-28
ACHC,2 DAYS AGO,Acadia Healthcare Announces Date for Second Quarter 2021 Earnings Release,https://www.nasdaq.com/press-release/acadia-healthcare-announces-date-for-second-quarter-2021-earnings-release-2021-07-12
ACHV,"JUN 29, 2021",Achieve Announces Completion of Target Enrollment of 750 Subjects in Phase 3 ORCA-2 Smoking Cessation Trial of Cytisinicline,https://www.nasdaq.com/press-release/achieve-announces-completion-of-target-enrollment-of-750-subjects-in-phase-3-orca-2
ACIU,"JUN 25, 2021",AC Immune Holds its Annual General Meeting of Shareholders,https://www.nasdaq.com/press-release/ac-immune-holds-its-annual-general-meeting-of-shareholders-2021-06-25
ACOR,"JUN 16, 2021",Acorda Therapeutics Announces Repayment of Convertible Senior Notes,https://www.nasdaq.com/press-release/acorda-therapeutics-announces-repayment-of-convertible-senior-notes-2021-06-16
ACRS,6 DAYS AGO,Aclaris Therapeutics to Participate in the William Blair Biotech Focus Conference 2021,https://www.nasdaq.com/press-release/aclaris-therapeutics-to-participate-in-the-william-blair-biotech-focus-conference
ACRX,4 HOURS AGO,AcelRx Enters into Licensing Agreement for DZUVEO® in Europe and In-licensing Agreement for Two Products in the U.S.,https://www.nasdaq.com/press-release/acelrx-enters-into-licensing-agreement-for-dzuveor-in-europe-and-in-licensing
ACST,"JUN 22, 2021",Acasti Pharma Provides Fiscal 2021 Year-End Business Update,https://www.nasdaq.com/press-release/acasti-pharma-provides-fiscal-2021-year-end-business-update-2021-06-22
ADAP,"MAY 19, 2021",Two Complete Responses and Response Rate of 41% for People with Synovial Sarcoma Reported at ASCO in Adaptimmune’s Phase 2 SPEARHEAD-1 Trial,https://www.nasdaq.com/press-release/two-complete-responses-and-response-rate-of-41-for-people-with-synovial-sarcoma
ADCT,"JUN 22, 2021",ADC Therapeutics Announces Encouraging Interim Results from Pivotal Phase 2 Clinical Trial of Camidanlumab Tesirine (Cami) Presented at the 16th Annual International Conference on Malignant Lymphoma,https://www.nasdaq.com/press-release/adc-therapeutics-announces-encouraging-interim-results-from-pivotal-phase-2-clinical
ADIL,"JUL 7, 2021","Adial Announces $5,000,000 Above Market Private Placement at $3.00 Per Share",https://www.nasdaq.com/press-release/adial-announces-%245000000-above-market-private-placement-at-%243.00-per-share-2021-07-07
ADILW,,,
ADMA,"JUN 14, 2021",ADMA Biologics to Participate in the Raymond James Human Health Innovation Virtual Conference,https://www.nasdaq.com/press-release/adma-biologics-to-participate-in-the-raymond-james-human-health-innovation-virtual
ADMP,1 DAY AGO,"Adamis Urges Stockholders to Vote to Reelect the Company’s Board of Directors at Upcoming Annual Meeting on Friday, July 16th",https://www.nasdaq.com/press-release/adamis-urges-stockholders-to-vote-to-reelect-the-companys-board-of-directors-at
ADMS,4 DAYS AGO,Adamas Announces New Employment Inducement Grant,https://www.nasdaq.com/press-release/adamas-announces-new-employment-inducement-grant-2021-07-09
ADPT,1 DAY AGO,"Adaptive Biotechnologies to Report Second Quarter Financial Results on August 4, 2021",https://www.nasdaq.com/press-release/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021
ADTX,2 DAYS AGO,Aditxt Launches High-Sensitivity Neutralizing Antibody Test to Detect Individual Immune Response to COVID-19,https://www.nasdaq.com/press-release/aditxt-launches-high-sensitivity-neutralizing-antibody-test-to-detect-individual
ADUS,1 DAY AGO,Addus HomeCare Signs Definitive Agreement To Acquire Armada Skilled Home Health and Hospice in New Mexico,https://www.nasdaq.com/press-release/addus-homecare-signs-definitive-agreement-to-acquire-armada-skilled-home-health-and
ADVM,"JUL 1, 2021","Adverum Announces Appointment of Jon Williams, Ph.D., as Vice President, Clinical Affairs",https://www.nasdaq.com/press-release/adverum-announces-appointment-of-jon-williams-ph.d.-as-vice-president-clinical
ADXN,6 DAYS AGO,"50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021",https://www.nasdaq.com/press-release/50-companies-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-0
ADXS,"JUL 6, 2021",Advaxis and Biosight Announce Entry into Definitive Merger Agreement,https://www.nasdaq.com/press-release/advaxis-and-biosight-announce-entry-into-definitive-merger-agreement-2021-07-06
AEMD,"JUN 24, 2021",Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update,https://www.nasdaq.com/press-release/aethlon-medical-announces-fiscal-year-end-financial-results-and-provides-corporate-0
AERI,"JUN 21, 2021","Aerie Pharmaceuticals Announces Appointment of Frank Estrada, Ed.D., as Director, Salesforce Training",https://www.nasdaq.com/press-release/aerie-pharmaceuticals-announces-appointment-of-frank-estrada-ed.d.-as-director
AEZS,"JUN 7, 2021",Aeterna Zentaris Engages Dr. Michael Levy to Support Development of Autoimmune and Inflammatory CNS Disorders Programs,https://www.nasdaq.com/press-release/aeterna-zentaris-engages-dr.-michael-levy-to-support-development-of-autoimmune-and
AFIB,1 DAY AGO,"Acutus Medical, Inc. Announces Proposed Public Offering of Common Stock",https://www.nasdaq.com/press-release/acutus-medical-inc.-announces-proposed-public-offering-of-common-stock-2021-07-12
AFMD,"JUL 1, 2021",Affimed Reports First Quarter 2021 Financial Results and Highlights Operational Progress,https://www.nasdaq.com/press-release/affimed-reports-first-quarter-2021-financial-results-and-highlights-operational
AGE,"MAY 17, 2021",AgeX Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update,https://www.nasdaq.com/press-release/agex-therapeutics-reports-first-quarter-2021-financial-results-and-provides-business
AGEN,6 DAYS AGO,Agenus to Participate in Resistance-Focused Oncology Panel at the William Blair Biotech Focus Conference 2021,https://www.nasdaq.com/press-release/agenus-to-participate-in-resistance-focused-oncology-panel-at-the-william-blair
AGIO,"JUN 28, 2021",Agios Submits Marketing Authorisation Application to European Medicines Agency for Mitapivat for Treatment of Adults with Pyruvate Kinase Deficiency,https://www.nasdaq.com/press-release/agios-submits-marketing-authorisation-application-to-european-medicines-agency-for
AGLE,6 DAYS AGO,Aeglea BioTherapeutics Appoints Jonathan D. Alspaugh as Chief Financial Officer,https://www.nasdaq.com/press-release/aeglea-biotherapeutics-appoints-jonathan-d.-alspaugh-as-chief-financial-officer-2021
AGRX,6 DAYS AGO,"50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021",https://www.nasdaq.com/press-release/50-companies-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-0
AGTC,6 DAYS AGO,"AGTC to Host Virtual R&D Day on July 22, 2021",https://www.nasdaq.com/press-release/agtc-to-host-virtual-rd-day-on-july-22-2021-2021-07-08
AHCO,1 DAY AGO,AdaptHealth Corp. Schedules Second Quarter 2021 Financial Results and Conference Call,https://www.nasdaq.com/press-release/adapthealth-corp.-schedules-second-quarter-2021-financial-results-and-conference-call
AHPI,,,
AIH,"JUN 24, 2021",Aesthetic Medical International Holdings Group Limited Reports First Quarter 2021 Unaudited Financial Results,https://www.nasdaq.com/press-release/aesthetic-medical-international-holdings-group-limited-reports-first-quarter-2021
AIKI,1 DAY AGO,AIkido Pharma to Attend the Alzheimer's Association International Conference,https://www.nasdaq.com/press-release/aikido-pharma-to-attend-the-alzheimers-association-international-conference-2021-07
AIM,5 DAYS AGO,AIM ImmunoTech Announces Phase 2a Human Challenge Trial to Test its Drug Ampligen as an Intranasal Antiviral Prophylactic Therapy,https://www.nasdaq.com/press-release/aim-immunotech-announces-phase-2a-human-challenge-trial-to-test-its-drug-ampligen-as
AKBA,"JUL 1, 2021",Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/akebia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2021-5
AKER,,,
AKRO,4 HOURS AGO,"Akero Therapeutics Appoints Judy Chou, Ph.D., to its Board of Directors",https://www.nasdaq.com/press-release/akero-therapeutics-appoints-judy-chou-ph.d.-to-its-board-of-directors-2021-07-14
AKTX,"JUL 7, 2021",Akari Therapeutics Announces Private Placement,https://www.nasdaq.com/press-release/akari-therapeutics-announces-private-placement-2021-07-07
AKU,"JUN 25, 2021",Alliance Healthcare Services Announces Acquisition by and Integration With Akumin,https://www.nasdaq.com/press-release/alliance-healthcare-services-announces-acquisition-by-and-integration-with-akumin
AKUS,"MAY 13, 2021",Akouos Reports First Quarter 2021 Financial Results and Provides Business Updates,https://www.nasdaq.com/press-release/akouos-reports-first-quarter-2021-financial-results-and-provides-business-updates
ALBO,6 DAYS AGO,Albireo to Present at the William Blair Biotech Focus Conference 2021,https://www.nasdaq.com/press-release/albireo-to-present-at-the-william-blair-biotech-focus-conference-2021-2021-07-08
ALC,"JUN 28, 2021",Alcon Announces Executive Committee Changes,https://www.nasdaq.com/press-release/alcon-announces-executive-committee-changes-2021-06-28
ALDX,"JUL 1, 2021",Aldeyra Therapeutics Joins the Russell 2000® and Russell 3000® Indexes,https://www.nasdaq.com/press-release/aldeyra-therapeutics-joins-the-russell-2000r-and-russell-3000r-indexes-2021-07-01
ALEC,"JUL 2, 2021",Alector and GSK announce global collaboration in immuno-neurology for two clinical stage first-in-class monoclonal antibodies for neurodegenerative diseases,https://www.nasdaq.com/press-release/alector-and-gsk-announce-global-collaboration-in-immuno-neurology-for-two-clinical
ALGN,"JUL 1, 2021","Align Technology to Announce Second Quarter 2021 Results on July 28, 2021",https://www.nasdaq.com/press-release/align-technology-to-announce-second-quarter-2021-results-on-july-28-2021-2021-07-01
ALGS,"JUN 30, 2021",Aligos Therapeutics Announces Pricing of $83.6 Million Public Offering of Common Stock,https://www.nasdaq.com/press-release/aligos-therapeutics-announces-pricing-of-%2483.6-million-public-offering-of-common
ALIM,"MAY 27, 2021","35 of the Best Ideas Companies to Present at the Summer Solstice - Best Ideas from the Buy-Side Virtual Investor Conference on June 1-4, 2021",https://www.nasdaq.com/press-release/35-of-the-best-ideas-companies-to-present-at-the-summer-solstice-best-ideas-from-the
ALKS,1 DAY AGO,Alkermes Presented New Data Analysis on Healthcare Resource Use Among Veterans With Alcohol Dependence,https://www.nasdaq.com/press-release/alkermes-presented-new-data-analysis-on-healthcare-resource-use-among-veterans-with-0
ALLK,"JUN 7, 2021",Allakos Completes Patient Enrollment in Phase 3 Eosinophilic Gastritis and/or Eosinophilic Duodenitis and Phase 2/3 Eosinophilic Esophagitis Clinical Trials of Lirentelimab (AK002),https://www.nasdaq.com/press-release/allakos-completes-patient-enrollment-in-phase-3-eosinophilic-gastritis-and-or
ALLO,2 DAYS AGO,Allogene Therapeutics Announces Participation in Two Upcoming Virtual Investor Conferences,https://www.nasdaq.com/press-release/allogene-therapeutics-announces-participation-in-two-upcoming-virtual-investor-0
ALNA,13 HOURS AGO,Allena Pharmaceuticals Announces $28 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules,https://www.nasdaq.com/press-release/allena-pharmaceuticals-announces-%2428-million-registered-direct-offering-priced-at-the
ALNY,"JUN 30, 2021",Alnylam Initiates KARDIA-1 Phase 2 Study of Zilebesiran (ALN-AGT) in Patients with Mild-to-Moderate Hypertension,https://www.nasdaq.com/press-release/alnylam-initiates-kardia-1-phase-2-study-of-zilebesiran-aln-agt-in-patients-with-mild
ALPN,"JUN 30, 2021",Alpine Immune Sciences to Collaborate with Merck on Immuno-Oncology Study to Evaluate ALPN-202 in Combination with KEYTRUDA® (pembrolizumab),https://www.nasdaq.com/press-release/alpine-immune-sciences-to-collaborate-with-merck-on-immuno-oncology-study-to-evaluate
ALRN,6 DAYS AGO,Aileron Therapeutics to Participate in Fireside Chat at the William Blair Biotech Focus Conference 2021,https://www.nasdaq.com/press-release/aileron-therapeutics-to-participate-in-fireside-chat-at-the-william-blair-biotech
ALT,"JUN 29, 2021",Altimmune Announces Update on AdCOVID™ Phase 1 Clinical Trial,https://www.nasdaq.com/press-release/altimmune-announces-update-on-adcovidtm-phase-1-clinical-trial-2021-06-29
ALVR,"MAY 6, 2021",AlloVir Reports First Quarter 2021 Financial Results,https://www.nasdaq.com/press-release/allovir-reports-first-quarter-2021-financial-results-2021-05-06
ALXN,3 HOURS AGO,Accelerating Results for Patients,https://www.nasdaq.com/press-release/accelerating-results-for-patients-2021-07-14
ALXO,"JUL 3, 2021","ALX Oncology Announces New Data from ASPEN-01, the Phase 1b Study of ALX148, Showing Robust Objective Response in Patients with Gastric or Gastroesophageal Junction Cancer",https://www.nasdaq.com/press-release/alx-oncology-announces-new-data-from-aspen-01-the-phase-1b-study-of-alx148-showing-0
AMED,1 DAY AGO,Amedisys to Open Westchester County Home Health Care Center,https://www.nasdaq.com/press-release/amedisys-to-open-westchester-county-home-health-care-center-2021-07-13
AMGN,4 HOURS AGO,Amgen And The International Federation of Psoriasis Associations Launch UPLIFT Innovation Challenge,https://www.nasdaq.com/press-release/amgen-and-the-international-federation-of-psoriasis-associations-launch-uplift
AMPE,3 HOURS AGO,"Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 Second Quarter Financial Results and Provide Corporate Business Update",https://www.nasdaq.com/press-release/ampio-pharmaceuticals-inc.-to-report-fiscal-2021-second-quarter-financial-results-and
AMPH,"JUN 15, 2021",Amphastar Pharmaceuticals to Present at the Raymond James Human Health Innovation Conference,https://www.nasdaq.com/press-release/amphastar-pharmaceuticals-to-present-at-the-raymond-james-human-health-innovation
AMRN,"JUN 2, 2021",Further Insights into Mechanism of Action of Icosapent Ethyl and Its Unique Form of Eicosapentaenoic Acid (EPA) Presented at the European Atherosclerosis Society (EAS) Congress 2021,https://www.nasdaq.com/press-release/further-insights-into-mechanism-of-action-of-icosapent-ethyl-and-its-unique-form-of
AMRX,"JUN 17, 2021",Amneal Announces U.S. FDA Filing Acceptance of Biologics License Application (BLA) for Bevacizumab,https://www.nasdaq.com/press-release/amneal-announces-u.s.-fda-filing-acceptance-of-biologics-license-application-bla-for
AMS,"MAY 13, 2021",American Shared Hospital Services Reports First Quarter 2021 Financial Results,https://www.nasdaq.com/press-release/american-shared-hospital-services-reports-first-quarter-2021-financial-results-2021
AMTI,5 DAYS AGO,Applied Molecular Transport Presents Additional Positive Data from Oral AMT-101 Phase 1b in Ulcerative Colitis at ECCO ‘21 Virtual Congress,https://www.nasdaq.com/press-release/applied-molecular-transport-presents-additional-positive-data-from-oral-amt-101-phase
AMYT,2 DAYS AGO,Amryt to Report Q2 2021 Results and Host Conference Call & Webcast on August 6,https://www.nasdaq.com/press-release/amryt-to-report-q2-2021-results-and-host-conference-call-webcast-on-august-6-2021-07
ANAB,"MAY 27, 2021",AnaptysBio to Present at the 2021 Jefferies Virtual Healthcare Conference,https://www.nasdaq.com/press-release/anaptysbio-to-present-at-the-2021-jefferies-virtual-healthcare-conference-2021-05-27
ANCN,,,
ANGN,"JUN 29, 2021",Angion Announces Results from the Phase 2 ALI-201 Study in Patients with COVID-19 Associated Pneumonia,https://www.nasdaq.com/press-release/angion-announces-results-from-the-phase-2-ali-201-study-in-patients-with-covid-19
ANGO,1 DAY AGO,AngioDynamics Reports Fiscal 2021 Fourth Quarter and Full-Year Financial Results,https://www.nasdaq.com/press-release/angiodynamics-reports-fiscal-2021-fourth-quarter-and-full-year-financial-results-2021
ANIK,"JUL 1, 2021",First Anika WristMotion® Total Wrist Arthroplasty Surgery Performed,https://www.nasdaq.com/press-release/first-anika-wristmotionr-total-wrist-arthroplasty-surgery-performed-2021-07-01
ANIP,"JUL 6, 2021",ANI Pharmaceuticals Announces Refiling of Cortrophin sNDA with FDA,https://www.nasdaq.com/press-release/ani-pharmaceuticals-announces-refiling-of-cortrophin-snda-with-fda-2021-07-06
ANIX,"MAY 26, 2021",Anixa Biosciences Announces Support from the National Cancer Institute for Ovarian Cancer Vaccine Developed by Cleveland Clinic,https://www.nasdaq.com/press-release/anixa-biosciences-announces-support-from-the-national-cancer-institute-for-ovarian
ANNX,"JUN 16, 2021",Annexon to Present at the Raymond James Human Health Innovation Conference,https://www.nasdaq.com/press-release/annexon-to-present-at-the-raymond-james-human-health-innovation-conference-2021-06-16
ANPC,"JUN 18, 2021","AnPac Bio’s First Disease Treatment Patent Granted, and Its Cancer Treatment Project Secured Multi-Million Dollar Funds",https://www.nasdaq.com/press-release/anpac-bios-first-disease-treatment-patent-granted-and-its-cancer-treatment-project
ANTM,3 HOURS AGO,Hispanic/Latino Communities Lead Telehealth Visits for Mental Health Services During COVID-19,https://www.nasdaq.com/press-release/hispanic-latino-communities-lead-telehealth-visits-for-mental-health-services-during
ANVS,"JUN 10, 2021",Annovis Bio to Present at 2021 BIO Digital,https://www.nasdaq.com/press-release/annovis-bio-to-present-at-2021-bio-digital-2021-06-10
APEN,"JUN 14, 2021",MERIT Study Investigators Announce Successful Achievement of the Study's Primary Efficacy & Safety Endpoints,https://www.nasdaq.com/press-release/merit-study-investigators-announce-successful-achievement-of-the-studys-primary
APLS,6 DAYS AGO,Apellis Announces Agreements to Exchange Approximately $198.6 Million in Principal Amount of Its 3.500% Convertible Senior Notes Due 2026 for Common Stock,https://www.nasdaq.com/press-release/apellis-announces-agreements-to-exchange-approximately-%24198.6-million-in-principal
APLT,"JUN 28, 2021",Applied Therapeutics Added to Russell Microcap® Index,https://www.nasdaq.com/press-release/applied-therapeutics-added-to-russell-microcapr-index-2021-06-28
APM,2 DAYS AGO,Aptorum Group Announces Further Positive Interim Results of the Phase 1 Clinical Trial of ALS-4 Targeting Staphylococcus aureus,https://www.nasdaq.com/press-release/aptorum-group-announces-further-positive-interim-results-of-the-phase-1-clinical
APOP,"JUN 16, 2021",Cellect Biotechnology Files Registration Statement in Connection with Proposed Strategic Merger Agreement with Quoin Pharmaceuticals,https://www.nasdaq.com/press-release/cellect-biotechnology-files-registration-statement-in-connection-with-proposed
APOPW,,,
APRE,"JUN 16, 2021",Aprea Therapeutics Announces Phase 1/2 Trial of Eprenetapopt + Venetoclax + Azacitidine in TP53 Mutant AML Meets Complete Remission Primary Efficacy Endpoint,https://www.nasdaq.com/press-release/aprea-therapeutics-announces-phase-1-2-trial-of-eprenetapopt-venetoclax-azacitidine
APT,"MAY 24, 2021","ALPHA PRO TECH, LTD.  ANNOUNCES 2021 ANNUAL MEETING OF SHAREHOLDERS TO BE HELD IN VIRTUAL FORMAT ONLY",https://www.nasdaq.com/press-release/alpha-pro-tech-ltd.-announces-2021-annual-meeting-of-shareholders-to-be-held-in
APTO,"JUN 11, 2021",Aptose Presents Highlights from EHA During Corporate Update Event,https://www.nasdaq.com/press-release/aptose-presents-highlights-from-eha-during-corporate-update-event-2021-06-11
APTX,2 DAYS AGO,Aptinyx to Participate in William Blair Biotech Focus Conference 2021,https://www.nasdaq.com/press-release/aptinyx-to-participate-in-william-blair-biotech-focus-conference-2021-2021-07-12
APVO,"JUN 30, 2021",Aptevo Therapeutics' Scientists to Present At Virtual Cell Engager Summit,https://www.nasdaq.com/press-release/aptevo-therapeutics-scientists-to-present-at-virtual-cell-engager-summit-2021-06-30
APYX,1 DAY AGO,"Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2021 Financial Results on August 12, 2021",https://www.nasdaq.com/press-release/apyx-medical-corporation-to-release-second-quarter-of-fiscal-year-2021-financial
AQST,"JUN 24, 2021",Aquestive Therapeutics Resubmits New Drug Application for Libervant™ (diazepam) Buccal Film,https://www.nasdaq.com/press-release/aquestive-therapeutics-resubmits-new-drug-application-for-libervanttm-diazepam-buccal
ARAV,"JUL 7, 2021",Aravive to Participate in Fireside Chat at 2021 William Blair Biotech Focus Conference,https://www.nasdaq.com/press-release/aravive-to-participate-in-fireside-chat-at-2021-william-blair-biotech-focus
ARAY,"JUN 24, 2021",Beloved Family Pet's Lung Cancer is Treated with Targeted Radiotherapy Using the Accuray Radixact® System with Synchrony® Technology,https://www.nasdaq.com/press-release/beloved-family-pets-lung-cancer-is-treated-with-targeted-radiotherapy-using-the
ARCT,"JUL 6, 2021",Arcturus Therapeutics to Present at Upcoming Investor and Scientific Conferences,https://www.nasdaq.com/press-release/arcturus-therapeutics-to-present-at-upcoming-investor-and-scientific-conferences-2
ARDS,1 DAY AGO,Aridis Pharmaceuticals COVID mAb AR-712 Neutralizes SARS-CoV-2 Delta Variant,https://www.nasdaq.com/press-release/aridis-pharmaceuticals-covid-mab-ar-712-neutralizes-sars-cov-2-delta-variant-2021-07
ARDX,"JUN 7, 2021",Ardelyx Announces Presentations at ERA-EDTA Virtual Congress 2021,https://www.nasdaq.com/press-release/ardelyx-announces-presentations-at-era-edta-virtual-congress-2021-2021-06-07
ARGX,11 HOURS AGO,"argenx to Host Virtual R&D Day on July 20, 2021",https://www.nasdaq.com/press-release/argenx-to-host-virtual-rd-day-on-july-20-2021-2021-07-14
ARMP,"JUL 7, 2021",Armata Pharmaceuticals to Present at the Ladenburg Thalmann 2021 Healthcare Conference,https://www.nasdaq.com/press-release/armata-pharmaceuticals-to-present-at-the-ladenburg-thalmann-2021-healthcare
ARNA,"JUN 18, 2021",Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/arena-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14
ARPO,"JUN 4, 2021",Aerpio Provides Second Update on Aadi Bioscience Presentation at the ASCO 2021 Virtual Meeting,https://www.nasdaq.com/press-release/aerpio-provides-second-update-on-aadi-bioscience-presentation-at-the-asco-2021
ARQT,,,
ARTL,2 DAYS AGO,Artelo Biosciences Reports Third Quarter Fiscal 2021 Financial Results and Provides Business Update,https://www.nasdaq.com/press-release/artelo-biosciences-reports-third-quarter-fiscal-2021-financial-results-and-provides
ARTLW,,,
ARVN,"JUN 7, 2021",Arvinas Participates in Groundbreaking Ceremony for New Space Within Downtown Crossing Development in New Haven,https://www.nasdaq.com/press-release/arvinas-participates-in-groundbreaking-ceremony-for-new-space-within-downtown
ARWR,5 HOURS AGO,Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Third Quarter Results,https://www.nasdaq.com/press-release/arrowhead-pharmaceuticals-to-webcast-fiscal-2021-third-quarter-results-2021-07-14
ASLN,1 DAY AGO,ASLAN Pharmaceuticals Announces Loan Facility Providing Up to $45 Million From K2 HealthVentures,https://www.nasdaq.com/press-release/aslan-pharmaceuticals-announces-loan-facility-providing-up-to-%2445-million-from-k2
ASMB,"JUL 2, 2021",Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/assembly-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-8
ASND,"JUL 6, 2021",Ascendis Pharma A/S Announces Target Enrollment Achieved in the Phase 3 PaTHway Trial of TransCon™ PTH (palopegteriparatide) in Adults with Hypoparathyroidism (HP) and Provides a Comprehensive Global Clinical Program Update,https://www.nasdaq.com/press-release/ascendis-pharma-a-s-announces-target-enrollment-achieved-in-the-phase-3-pathway-trial
ASRT,"JUN 4, 2021","Assertio Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement",https://www.nasdaq.com/press-release/assertio-holdings-inc.-regains-compliance-with-nasdaq-minimum-bid-price-requirement
ATEC,2 DAYS AGO,ATEC Announces Select Preliminary Second Quarter 2021 Financial Results,https://www.nasdaq.com/press-release/atec-announces-select-preliminary-second-quarter-2021-financial-results-2021-07-12
ATHA,"JUL 6, 2021",Athira Pharma Announces Initiation of Open Label Extension Study for LIFT-AD and ACT-AD Clinical Trials of ATH-1017 for Alzheimer’s Disease,https://www.nasdaq.com/press-release/athira-pharma-announces-initiation-of-open-label-extension-study-for-lift-ad-and-act
ATHE,,,
ATHX,1 DAY AGO,Athersys to Host Second Quarter Financial Results Call,https://www.nasdaq.com/press-release/athersys-to-host-second-quarter-financial-results-call-2021-07-13
ATNF,2 DAYS AGO,180 Life Sciences Regains Nasdaq Compliance for Listing Rules 5605(b)(1) and 5605(c)(2),https://www.nasdaq.com/press-release/180-life-sciences-regains-nasdaq-compliance-for-listing-rules-5605b1-and-5605c2-2021
ATNFW,,,
ATNM,"JUN 28, 2021",Actinium Pharmaceuticals Announces Inclusion in Russell Microcap® Index,https://www.nasdaq.com/press-release/actinium-pharmaceuticals-announces-inclusion-in-russell-microcapr-index-2021-06-28
ATNX,"JUL 6, 2021",Athenex Provides Update from FDA Type A Meeting Regarding Oral Paclitaxel Plus Encequidar for the Treatment of Metastatic Breast Cancer,https://www.nasdaq.com/press-release/athenex-provides-update-from-fda-type-a-meeting-regarding-oral-paclitaxel-plus
ATOS,"JUL 7, 2021",Atossa Therapeutics Receives Regulatory Approval To Open Clinical Study of AT-H201 in Australia,https://www.nasdaq.com/press-release/atossa-therapeutics-receives-regulatory-approval-to-open-clinical-study-of-at-h201-in
ATRA,"JUL 2, 2021",Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4),https://www.nasdaq.com/press-release/atara-biotherapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6
ATRC,"JUL 7, 2021",AtriCure to Announce Second Quarter 2021 Financial Results,https://www.nasdaq.com/press-release/atricure-to-announce-second-quarter-2021-financial-results-2021-07-07
ATRI,"MAY 21, 2021",Atrion Corporation Declares Quarterly Cash Dividend,https://www.nasdaq.com/press-release/atrion-corporation-declares-quarterly-cash-dividend-2021-05-21
ATRS,"JUL 7, 2021",Antares Pharma to Present at the Ladenburg Thalmann Annual Healthcare Conference,https://www.nasdaq.com/press-release/antares-pharma-to-present-at-the-ladenburg-thalmann-annual-healthcare-conference-2021
ATXI,"JUN 14, 2021",Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol,https://www.nasdaq.com/press-release/avenue-therapeutics-receives-complete-response-letter-from-the-fda-for-iv-tramadol-0
AUPH,"JUN 30, 2021","Aurinia Awards $250,000 in Grants to Support Patient Navigation Programs",https://www.nasdaq.com/press-release/aurinia-awards-%24250000-in-grants-to-support-patient-navigation-programs-2021-06-30
AUTL,6 DAYS AGO,"Autolus Therapeutics to Report Second Quarter 2021 Financial Results on August 5, 2021, and will Participate in the William Blair Biotech Focus Conference 2021 on July 14, 2021",https://www.nasdaq.com/press-release/autolus-therapeutics-to-report-second-quarter-2021-financial-results-on-august-5-2021
AVDL,"JUL 7, 2021",Avadel Pharmaceuticals to Present at the Ladenburg Thalmann Annual Healthcare Conference 2021,https://www.nasdaq.com/press-release/avadel-pharmaceuticals-to-present-at-the-ladenburg-thalmann-annual-healthcare
AVEO,5 DAYS AGO,AVEO Oncology to Host Key Opinion Leader Webinar on FOTIVDA® (tivozanib) for Relapsed or Refractory Renal Cell Carcinoma,https://www.nasdaq.com/press-release/aveo-oncology-to-host-key-opinion-leader-webinar-on-fotivdar-tivozanib-for-relapsed
AVGR,"JUL 6, 2021",Avinger Announces 510(k) Filing for New Pantheris In-Stent Restenosis Indication,https://www.nasdaq.com/press-release/avinger-announces-510k-filing-for-new-pantheris-in-stent-restenosis-indication-2021
AVIR,2 DAYS AGO,Atea Pharmaceuticals to Present at William Blair Biotech Focus Conference,https://www.nasdaq.com/press-release/atea-pharmaceuticals-to-present-at-william-blair-biotech-focus-conference-2021-07-12
AVNS,2 DAYS AGO,"Avanos Medical, Inc. Appoints Moji James as Senior Vice President & General Counsel",https://www.nasdaq.com/press-release/avanos-medical-inc.-appoints-moji-james-as-senior-vice-president-general-counsel-2021
AVRO,6 DAYS AGO,AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/avrobio-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-2021-07-08
AVXL,"JUN 28, 2021",Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Improved both Primary Cognitive and Secondary MDS-UPDRS Efficacy Endpoints with Significant Biomarker Correlation in Placebo-Controlled Phase 2 Clinical Trial for the Treatment of Patients wit...,https://www.nasdaq.com/press-release/anavex-life-sciences-announces-anavexr2-73-blarcamesine-improved-both-primary
AWH,6 DAYS AGO,Aspira Women’s Health Inc. Announces Coverage for OVA1® in the AIM Specialty Health Laboratory Medicine Clinical Guidelines,https://www.nasdaq.com/press-release/aspira-womens-health-inc.-announces-coverage-for-ova1r-in-the-aim-specialty-health
AXGN,5 HOURS AGO,"Axogen, Inc. to Report Second Quarter Financial Results and Host Conference Call on August 4, 2021",https://www.nasdaq.com/press-release/axogen-inc.-to-report-second-quarter-financial-results-and-host-conference-call-on
AXLA,"JUN 30, 2021",Axcella Announces Initiation of EMMPOWER℠ Phase 2 Clinical Trial of AXA1665,https://www.nasdaq.com/press-release/axcella-announces-initiation-of-emmpowersm-phase-2-clinical-trial-of-axa1665-2021-06
AXNX,4 HOURS AGO,BioLife Solutions Announces Changes to Board of Directors,https://www.nasdaq.com/press-release/biolife-solutions-announces-changes-to-board-of-directors-2021-07-14
AXSM,"JUN 15, 2021",Axsome Therapeutics Announces Planned NDA Submission for AXS-14 for the Management of Fibromyalgia,https://www.nasdaq.com/press-release/axsome-therapeutics-announces-planned-nda-submission-for-axs-14-for-the-management-of
AYLA,"JUL 6, 2021",Ayala Pharmaceuticals to Present at Ladenburg Thalmann Healthcare Conference,https://www.nasdaq.com/press-release/ayala-pharmaceuticals-to-present-at-ladenburg-thalmann-healthcare-conference-2021-07
AYTU,"JUN 28, 2021",Aytu BioPharma Announces Peer-Reviewed Publication of Clinical Results from Healight(TM) Pilot Study,https://www.nasdaq.com/press-release/aytu-biopharma-announces-peer-reviewed-publication-of-clinical-results-from
AZN,1 DAY AGO,"HUTCHMED Announces First Commercial Sale of ORPATHYS® in China, Triggering a US$25 million Milestone Payment from AstraZeneca",https://www.nasdaq.com/press-release/hutchmed-announces-first-commercial-sale-of-orpathysr-in-china-triggering-a-us%2425
AZRX,"JUN 8, 2021",AzurRx BioPharma CEO James Sapirstein to Present at 2021 BIO Digital,https://www.nasdaq.com/press-release/azurrx-biopharma-ceo-james-sapirstein-to-present-at-2021-bio-digital-2021-06-08
AZYO,"JUN 7, 2021",Aziyo Biologics Comments on June 2nd Voluntary Recall of One Lot of its FiberCel Fiber Viable Bone Matrix,https://www.nasdaq.com/press-release/aziyo-biologics-comments-on-june-2nd-voluntary-recall-of-one-lot-of-its-fibercel
BASI,,,
BAX,1 DAY AGO,Baxter Declares Quarterly Dividend,https://www.nasdaq.com/press-release/baxter-declares-quarterly-dividend-2021-07-12
BBI,"JUL 6, 2021",Brickell Biotech to Participate at William Blair’s Biotech Focus Conference 2021,https://www.nasdaq.com/press-release/brickell-biotech-to-participate-at-william-blairs-biotech-focus-conference-2021-2021
BBIO,1 DAY AGO,BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2021-07
BCAB,"MAY 12, 2021",BioAtla Announces First Quarter 2021 Financial Results And Provides Business Update,https://www.nasdaq.com/press-release/bioatla-announces-first-quarter-2021-financial-results-and-provides-business-update
BCDA,"JUN 23, 2021",BioCardia Announces Fourth Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Cell Therapy Heart Failure Study as Designed,https://www.nasdaq.com/press-release/biocardia-announces-fourth-positive-dsmb-review-and-recommendation-to-continue-phase
BCDAW,,,
BCEL,"MAY 14, 2021",Atreca to Present at Upcoming Virtual Investor Conferences,https://www.nasdaq.com/press-release/atreca-to-present-at-upcoming-virtual-investor-conferences-2021-05-14
BCLI,"JUN 15, 2021",Brainstorm Announces Expansion of NurOwn® IP Portfolio with Grant and Allowance of Multiple Patents and Applications in Major Markets,https://www.nasdaq.com/press-release/brainstorm-announces-expansion-of-nurownr-ip-portfolio-with-grant-and-allowance-of
BCRX,4 DAYS AGO,BioCryst Reports 96-week Data from APeX-2 Showing ORLADEYO®(berotralstat) Reduced HAE Attack Rate by 80 Percent from Baseline,https://www.nasdaq.com/press-release/biocryst-reports-96-week-data-from-apex-2-showing-orladeyorberotralstat-reduced-hae
BCYC,1 DAY AGO,Bicycle Therapeutics Enters Exclusive License and Collaboration Agreement with Ionis to Develop Targeted Oligonucleotide Therapeutics,https://www.nasdaq.com/press-release/bicycle-therapeutics-enters-exclusive-license-and-collaboration-agreement-with-ionis
BDSI,"MAY 6, 2021",BioDelivery Sciences Reports First Quarter 2021 Results,https://www.nasdaq.com/press-release/biodelivery-sciences-reports-first-quarter-2021-results-2021-05-06
BDSX,"JUN 17, 2021",Biodesix Announces Presentation on Novel Proteomic Techniques in Partnership with Seer,https://www.nasdaq.com/press-release/biodesix-announces-presentation-on-novel-proteomic-techniques-in-partnership-with
BDTX,"MAY 19, 2021","Black Diamond Therapeutics Presents Phase 1 Pharmacokinetic, Safety, and Preliminary Efficacy Data of BDTX-189 in Advanced Solid Tumors Harboring EGFR or HER2 Alterations",https://www.nasdaq.com/press-release/black-diamond-therapeutics-presents-phase-1-pharmacokinetic-safety-and-preliminary
BDX,2 DAYS AGO,BD Announces Two Future Directors for Diabetes Care Spinoff Company,https://www.nasdaq.com/press-release/bd-announces-two-future-directors-for-diabetes-care-spinoff-company-2021-07-12
BDXB,"DEC 2, 2020",BD to Invest $1.2 Billion in Pre-Fillable Syringe Manufacturing Capacity Over Next Four Years,https://www.nasdaq.com/press-release/bd-to-invest-%241.2-billion-in-pre-fillable-syringe-manufacturing-capacity-over-next-0
BEAM,6 DAYS AGO,Beam Therapeutics to Participate in the 2021 William Blair Biotech Focus Conference,https://www.nasdaq.com/press-release/beam-therapeutics-to-participate-in-the-2021-william-blair-biotech-focus-conference
BEAT,"FEB 2, 2021",Investors Bancorp Set to Join S&P SmallCap 600,https://www.nasdaq.com/press-release/investors-bancorp-set-to-join-sp-smallcap-600-2021-02-02
BFRA,"JUL 6, 2021",Biofrontera Inc. seeks IPO in the USA,https://www.nasdaq.com/press-release/biofrontera-inc.-seeks-ipo-in-the-usa-2021-07-06
BGNE,5 DAYS AGO,BeiGene Announces the Approval in China of KYPROLIS® (Carfilzomib) for Injection for Adult Patients with Relapsed or Refractory Multiple Myeloma,https://www.nasdaq.com/press-release/beigene-announces-the-approval-in-china-of-kyprolisr-carfilzomib-for-injection-for
BHC,2 DAYS AGO,Bausch + Lomb Launches Biotrue® Hydration Boost Lubricant Eye Drops and Biotrue® Micellar Eyelid Cleansing Wipes,https://www.nasdaq.com/press-release/bausch-lomb-launches-biotruer-hydration-boost-lubricant-eye-drops-and-biotruer
BHVN,"JUL 7, 2021","Biohaven Announces Preliminary 2Q2021 Net Product Revenue For NURTEC ODT, The First And Only Migraine Medication For Both Acute And Preventive Treatment",https://www.nasdaq.com/press-release/biohaven-announces-preliminary-2q2021-net-product-revenue-for-nurtec-odt-the-first
BIIB,1 DAY AGO,"Biogen and Innocare Announce License and Collaboration Agreement For Orelabrutinib, an Innovative CNS Penetrant BTK Inhibitor For the Potential Treatment of Multiple Sclerosis",https://www.nasdaq.com/press-release/biogen-and-innocare-announce-license-and-collaboration-agreement-for-orelabrutinib-an
BIOC,"JUL 6, 2021","Biocept Receives South Korean Patent for Primer-Switch Platform Used to Identify Rare Genetic Mutations, Including Cancer Biomarkers",https://www.nasdaq.com/press-release/biocept-receives-south-korean-patent-for-primer-switch-platform-used-to-identify-rare
BIOL,"JUN 3, 2021",Recent Studies Demonstrate BIOLASE's Waterlase Laser Technology is Beneficial for Treatment of Peri-Implantitis,https://www.nasdaq.com/press-release/recent-studies-demonstrate-biolases-waterlase-laser-technology-is-beneficial-for
BIVI,"JUN 29, 2021",Development of BioVie’s NE3107 Asset Featured by the American Diabetes Association,https://www.nasdaq.com/press-release/development-of-biovies-ne3107-asset-featured-by-the-american-diabetes-association
BKD,5 DAYS AGO,Brookdale Reports June 2021 Occupancy,https://www.nasdaq.com/press-release/brookdale-reports-june-2021-occupancy-2021-07-09
BLCM,"JUN 28, 2021",Bellicum Enters License Agreement with UNC Lineberger and Mass General for Use of CaspaCIDe® Safety Switch,https://www.nasdaq.com/press-release/bellicum-enters-license-agreement-with-unc-lineberger-and-mass-general-for-use-of
BLFS,4 HOURS AGO,BioLife Solutions Announces Changes to Board of Directors,https://www.nasdaq.com/press-release/biolife-solutions-announces-changes-to-board-of-directors-2021-07-14
BLPH,"MAY 27, 2021",Bellerophon to Present at the Jefferies Virtual Healthcare Conference,https://www.nasdaq.com/press-release/bellerophon-to-present-at-the-jefferies-virtual-healthcare-conference-2021-05-27
BLRX,"MAY 26, 2021",BioLineRx Reports First Quarter 2021 Financial Results and Provides Corporate Update,https://www.nasdaq.com/press-release/biolinerx-reports-first-quarter-2021-financial-results-and-provides-corporate-update
BLU,"MAY 25, 2021",BELLUS Health to Participate in the Jefferies Virtual Healthcare Conference,https://www.nasdaq.com/press-release/bellus-health-to-participate-in-the-jefferies-virtual-healthcare-conference-2021-05
BLUE,5 DAYS AGO,bluebird bio Announces Positive Recommendation by PRAC Regarding Article 20 Safety Referral Review of ZYNTEGLO™ Gene Therapy for Transfusion-Dependent β-thalassemia and Marketing to Resume in EU,https://www.nasdaq.com/press-release/bluebird-bio-announces-positive-recommendation-by-prac-regarding-article-20-safety
BMRA,6 DAYS AGO,"50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021",https://www.nasdaq.com/press-release/50-companies-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-0
BMRN,4 HOURS AGO,"BioMarin to Host Second Quarter 2021 Financial Results Conference Call and Webcast on Wednesday, July 28 at 4:30pm ET",https://www.nasdaq.com/press-release/biomarin-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on
BMY,"JUN 29, 2021",Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the Treatment of Mismatch Repair Deficient or Microsatellite Instability–High Metastatic Colorectal Cancer After Prior Chemotherapy,https://www.nasdaq.com/press-release/bristol-myers-squibb-receives-european-commission-approval-for-opdivo-nivolumab-1
BNR,"MAY 25, 2021",Burning Rock Reports First Quarter 2021 Financial Results,https://www.nasdaq.com/press-release/burning-rock-reports-first-quarter-2021-financial-results-2021-05-25
BNTC,"APR 27, 2021",Benitec Biopharma Increases Previously Announced Bought Deal Offering of Common Stock to $12.9 Million,https://www.nasdaq.com/press-release/benitec-biopharma-increases-previously-announced-bought-deal-offering-of-common-stock
BNTX,"JUN 18, 2021",BioNTech Announces First Patient Dosed in Phase 2 Clinical Trial of mRNA-based BNT111 in Patients with Advanced Melanoma,https://www.nasdaq.com/press-release/biontech-announces-first-patient-dosed-in-phase-2-clinical-trial-of-mrna-based-bnt111
BOLT,"JUN 4, 2021",Bolt Biotherapeutics Presents Preliminary Results from Phase 1/2 Trial of Lead HER2-targeting Boltbody™ ISAC BDC-1001 at ASCO 2021,https://www.nasdaq.com/press-release/bolt-biotherapeutics-presents-preliminary-results-from-phase-1-2-trial-of-lead-her2
BPMC,6 DAYS AGO,Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/blueprint-medicines-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-11
BPTH,"JUN 22, 2021",Bio-Path Granted Key Mechanism of Action U.S. Patent for BP1003,https://www.nasdaq.com/press-release/bio-path-granted-key-mechanism-of-action-u.s.-patent-for-bp1003-2021-06-22
BSGM,22 HOURS AGO,BioSig Latest Installation Broadens Clinical Footprint for its Signal Processing Technology for Electrophysiology,https://www.nasdaq.com/press-release/biosig-latest-installation-broadens-clinical-footprint-for-its-signal-processing
BSX,"JUN 29, 2021",Boston Scientific Announces Conference Call Discussing Second Quarter 2021 Results,https://www.nasdaq.com/press-release/boston-scientific-announces-conference-call-discussing-second-quarter-2021-results
BTAI,"JUN 23, 2021",BioXcel Therapeutics Announces Pricing of Public Offering of Common Stock,https://www.nasdaq.com/press-release/bioxcel-therapeutics-announces-pricing-of-public-offering-of-common-stock-2021-06-23
BVXV,"JUN 23, 2021",BiondVax Announces First Quarter 2021 Financial Results and Provides Business Update,https://www.nasdaq.com/press-release/biondvax-announces-first-quarter-2021-financial-results-and-provides-business-update
BWAY,1 DAY AGO,MindPath Care Centers Hosts Open House in Charlotte to Introduce FDA-Cleared Deep TMS™ Treatment for Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD),https://www.nasdaq.com/press-release/mindpath-care-centers-hosts-open-house-in-charlotte-to-introduce-fda-cleared-deep
BXRX,"JUL 1, 2021",Leading Independent Proxy Advisory Firm Glass Lewis & Co. Recommends Baudax Bio Shareholders Vote “For” the Proposed Additional Authorized Shares at Upcoming Special Meeting of Shareholders,https://www.nasdaq.com/press-release/leading-independent-proxy-advisory-firm-glass-lewis-co.-recommends-baudax-bio-0
BYSI,5 HOURS AGO,BeyondSpring Strengthens Board with the Addition of Ex-Immunomedics and Constellation Commercial Head Brendan Delaney,https://www.nasdaq.com/press-release/beyondspring-strengthens-board-with-the-addition-of-ex-immunomedics-and-constellation
CABA,"JUN 28, 2021","Cabaletta Bio Appoints Biopharmaceutical Leader Scott Brun, M.D. to Board of Directors",https://www.nasdaq.com/press-release/cabaletta-bio-appoints-biopharmaceutical-leader-scott-brun-m.d.-to-board-of-directors
CAH,"JUN 24, 2021",Cardinal Health to Webcast Discussion of Fourth-Quarter and Year-End Results for Fiscal Year 2021 on August 5,https://www.nasdaq.com/press-release/cardinal-health-to-webcast-discussion-of-fourth-quarter-and-year-end-results-for-1
CALA,"JUN 7, 2021",Final Data from Calithera Biosciences’ Phase 2 CANTATA Study in Renal Cell Carcinoma Presented at 2021 ASCO Annual Meeting,https://www.nasdaq.com/press-release/final-data-from-calithera-biosciences-phase-2-cantata-study-in-renal-cell-carcinoma
CALT,"MAY 28, 2021",Calliditas Announces Submission of Marketing Authorisation Application for Nefecon to the European Medicines Agency,https://www.nasdaq.com/press-release/calliditas-announces-submission-of-marketing-authorisation-application-for-nefecon-to
CANF,6 DAYS AGO,Can-Fite Gears Up to Initiate Pivotal Phase III Liver Cancer Study,https://www.nasdaq.com/press-release/can-fite-gears-up-to-initiate-pivotal-phase-iii-liver-cancer-study-2021-07-08
CAPR,"JUN 17, 2021",Capricor Therapeutics to Present Findings from HOPE-2 Open-Label Extension Study at Parent Project Muscular Dystrophy (PPMD) 2021 Virtual Annual Conference,https://www.nasdaq.com/press-release/capricor-therapeutics-to-present-findings-from-hope-2-open-label-extension-study-at
CARA,"JUN 11, 2021","SWK Holdings' Subsidiary, Enteris BioPharma, Receives $10 Million Milestone Payment from Cara Therapeutics",https://www.nasdaq.com/press-release/swk-holdings-subsidiary-enteris-biopharma-receives-%2410-million-milestone-payment-from
CASI,"JUN 10, 2021",CASI Pharmaceuticals Announces Dosing Of First Patient Of CID-103 In Phase 1 Clinical Trial For Relapsed Or Refractory Multiple Myeloma,https://www.nasdaq.com/press-release/casi-pharmaceuticals-announces-dosing-of-first-patient-of-cid-103-in-phase-1-clinical
CATB,"JUL 7, 2021",Catabasis Pharmaceuticals To Present At Ladenburg Thalmann 2021 Healthcare Conference,https://www.nasdaq.com/press-release/catabasis-pharmaceuticals-to-present-at-ladenburg-thalmann-2021-healthcare-conference
CBAY,"JUN 21, 2021",CymaBay Therapeutics Presents Positive PBC Data at the International Liver Congress™ 2021,https://www.nasdaq.com/press-release/cymabay-therapeutics-presents-positive-pbc-data-at-the-international-liver-congresstm
CBIO,4 HOURS AGO,Catalyst Biosciences Announces Key Leadership Changes in its Ongoing Transition to an Integrated Protease Medicines Company,https://www.nasdaq.com/press-release/catalyst-biosciences-announces-key-leadership-changes-in-its-ongoing-transition-to-an
CBLI,"JUL 6, 2021","Cleveland BioLabs, Inc. and Cytocom Inc. Announce Call to Discuss Stockholder Meeting Vote Results and Proposed Merger",https://www.nasdaq.com/press-release/cleveland-biolabs-inc.-and-cytocom-inc.-announce-call-to-discuss-stockholder-meeting
CBMG,"FEB 19, 2021","Cellular Biomedicine Group, Inc. Announces Completion of Merger",https://www.nasdaq.com/press-release/cellular-biomedicine-group-inc.-announces-completion-of-merger-2021-02-19
CBPO,"APR 20, 2021",China Biologic Announces Completion of Going Private Transaction,https://www.nasdaq.com/press-release/china-biologic-announces-completion-of-going-private-transaction-2021-04-20
CCCC,,,
CCM,"JUN 11, 2021",Concord Medical Officially Opens New Specialty Cancer Hospital in Guangzhou,https://www.nasdaq.com/press-release/concord-medical-officially-opens-new-specialty-cancer-hospital-in-guangzhou-2021-06
CCXI,"JUL 6, 2021",ChemoCentryx Announces Filing of Amendment to NDA Submission and Extension of the PDUFA Review Period for Avacopan in the Treatment of ANCA-Associated Vasculitis,https://www.nasdaq.com/press-release/chemocentryx-announces-filing-of-amendment-to-nda-submission-and-extension-of-the
CDAK,"JUL 7, 2021",Codiak BioSciences to Present at the Virtual William Blair Biotech Focus Conference 2021,https://www.nasdaq.com/press-release/codiak-biosciences-to-present-at-the-virtual-william-blair-biotech-focus-conference
CDMO,"JUL 1, 2021","Avid Bioservices Announces Appointment of Esther M. Alegria, Ph.D., to Board of Directors",https://www.nasdaq.com/press-release/avid-bioservices-announces-appointment-of-esther-m.-alegria-ph.d.-to-board-of
CDMOP,"APR 15, 2021",Avid Bioservices Announces Completion of Redemption of Series E Convertible Preferred Stock,https://www.nasdaq.com/press-release/avid-bioservices-announces-completion-of-redemption-of-series-e-convertible-preferred
CDNA,"JUL 1, 2021","CareDx Transplant Patient App, AlloCare, Expands Access to the Majority of Transplant Patients",https://www.nasdaq.com/press-release/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant
CDTX,2 DAYS AGO,Cidara Therapeutics Presents New Analyses from Multiple Rezafungin Studies at ECCMID 2021,https://www.nasdaq.com/press-release/cidara-therapeutics-presents-new-analyses-from-multiple-rezafungin-studies-at-eccmid
CELC,5 DAYS AGO,Celcuity to Participate in the William Blair Biotech Focus Conference,https://www.nasdaq.com/press-release/celcuity-to-participate-in-the-william-blair-biotech-focus-conference-2021-07-08
CEMI,"MAY 6, 2021",Chembio Diagnostics Reports First Quarter 2021 Financial Results,https://www.nasdaq.com/press-release/chembio-diagnostics-reports-first-quarter-2021-financial-results-2021-05-06
CERC,"JUN 23, 2021",Cerecor Licenses Immune Checkpoint Program from Sanford Burnham Prebys Further Expanding Pipeline of Immunology and Immuno-oncology Targets,https://www.nasdaq.com/press-release/cerecor-licenses-immune-checkpoint-program-from-sanford-burnham-prebys-further
CERE,"JUL 1, 2021",Cerevel Therapeutics Announces Pricing of $350 Million Public Offering of Common Stock,https://www.nasdaq.com/press-release/cerevel-therapeutics-announces-pricing-of-%24350-million-public-offering-of-common
CEREW,,,
CERS,4 HOURS AGO,Cerus Corporation and the Swiss Red Cross Celebrate 10 Years of Routine Use of INTERCEPT Blood System for Platelets,https://www.nasdaq.com/press-release/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of
CFMS,"JUL 7, 2021","Conformis, Inc. Announces Settlement of Wright Medical Patent Litigation",https://www.nasdaq.com/press-release/conformis-inc.-announces-settlement-of-wright-medical-patent-litigation-2021-07-07
CFRX,"JUN 17, 2021","ContraFect Appoints Gary Woodnutt, Ph.D. as Senior Vice President of Translational Sciences and Preclinical Development",https://www.nasdaq.com/press-release/contrafect-appoints-gary-woodnutt-ph.d.-as-senior-vice-president-of-translational
CGEM,,,
CGEN,5 HOURS AGO,"Compugen to Release Second Quarter 2021 Results on Wednesday, July 28, 2021",https://www.nasdaq.com/press-release/compugen-to-release-second-quarter-2021-results-on-wednesday-july-28-2021-2021-07-14
CGIX,,,
CHE,"JUL 2, 2021","Chemed To Report Second-Quarter 2021 Earnings July 27, Related Conference Call To Be Held On July 28",https://www.nasdaq.com/press-release/chemed-to-report-second-quarter-2021-earnings-july-27-related-conference-call-to-be
CHEK,"JUN 30, 2021",Check-Cap Ltd. Announces $35 Million Registered Direct Offering,https://www.nasdaq.com/press-release/check-cap-ltd.-announces-%2435-million-registered-direct-offering-2021-06-30
CHEKZ,,,
CHFS,,,
CHMA,"JUN 28, 2021",Chiasma Announces Submission of Marketing Authorization Application for MYCAPSSA® to the European Medicines Agency,https://www.nasdaq.com/press-release/chiasma-announces-submission-of-marketing-authorization-application-for-mycapssar-to
CHRS,1 DAY AGO,Coherus BioSciences Announces New Employment Inducement Grants,https://www.nasdaq.com/press-release/coherus-biosciences-announces-new-employment-inducement-grants-2021-07-12
CI,1 DAY AGO,Bonnie Evelyn Named Cigna Market President for Georgia/Alabama,https://www.nasdaq.com/press-release/bonnie-evelyn-named-cigna-market-president-for-georgia-alabama-2021-07-13
CJJD,4 HOURS AGO,China Jo-Jo Drugstores Selected as one of the First Batch of Four-star Livelihood Pharmaceutical Service Stations in Hangzhou,https://www.nasdaq.com/press-release/china-jo-jo-drugstores-selected-as-one-of-the-first-batch-of-four-star-livelihood
CKPT,6 DAYS AGO,Checkpoint Therapeutics to Participate in the Ladenburg Thalmann 2021 Healthcare Conference,https://www.nasdaq.com/press-release/checkpoint-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare
CLBS,"JUN 22, 2021",Caladrius Biosciences to Assess its CLBS201 CD34+ Cell Therapy in Diabetic Kidney Disease,https://www.nasdaq.com/press-release/caladrius-biosciences-to-assess-its-clbs201-cd34-cell-therapy-in-diabetic-kidney
CLDX,16 HOURS AGO,Celldex Therapeutics Announces Pricing of Upsized $250 Million Public Offering of Common Stock,https://www.nasdaq.com/press-release/celldex-therapeutics-announces-pricing-of-upsized-%24250-million-public-offering-of
CLLS,1 DAY AGO,Monthly information on share capital and company voting rights,https://www.nasdaq.com/press-release/monthly-information-on-share-capital-and-company-voting-rights-2021-07-12
CLNN,"JUN 30, 2021",Clene to Host Expert Perspectives Webinar on Cellular Energetic Failure and the Unmet Medical Needs in ALS and MS,https://www.nasdaq.com/press-release/clene-to-host-expert-perspectives-webinar-on-cellular-energetic-failure-and-the-unmet
CLNNW,,,
CLOV,5 DAYS AGO,"Clover Health Expands Management Team, Appointing Prabhdeep Singh as Chief Growth Officer and Justin Joseph as Chief Strategy & Development Officer",https://www.nasdaq.com/press-release/clover-health-expands-management-team-appointing-prabhdeep-singh-as-chief-growth
CLOVW,,,
CLPT,"JUN 16, 2021","ClearPoint Neuro, Inc. Announces Installation of ClearPoint® 2.0 Software at Mazowiecki Szpital Bródnowski in Poland",https://www.nasdaq.com/press-release/clearpoint-neuro-inc.-announces-installation-of-clearpointr-2.0-software-at
CLRB,1 DAY AGO,Cellectar Announces Expansion of Ongoing Collaboration Agreement with IntoCell Inc.,https://www.nasdaq.com/press-release/cellectar-announces-expansion-of-ongoing-collaboration-agreement-with-intocell-inc.
CLRBZ,,,
CLSD,"JUN 15, 2021",Clearside Biomedical Announces Positive Safety Results from Cohort 1 of OASIS Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension) for the Treatment of Wet AMD,https://www.nasdaq.com/press-release/clearside-biomedical-announces-positive-safety-results-from-cohort-1-of-oasis-phase-1
CLSN,"JUL 1, 2021",Celsion GmbH Announces Commencement of Enrollment in Oxford University’s Phase 1 Study with ThermoDox® and Focused Ultrasound in Pancreatic Cancer,https://www.nasdaq.com/press-release/celsion-gmbh-announces-commencement-of-enrollment-in-oxford-universitys-phase-1-study
CLVR,"JUL 1, 2021",Cannabis Industry Investor Presentations Now Available for On-Demand Viewing,https://www.nasdaq.com/press-release/cannabis-industry-investor-presentations-now-available-for-on-demand-viewing-2021-07
CLVRW,,,
CLVS,1 DAY AGO,Clovis Oncology Appoints Dr. Ronit Simantov to its Board of Directors,https://www.nasdaq.com/press-release/clovis-oncology-appoints-dr.-ronit-simantov-to-its-board-of-directors-2021-07-12
CMD,"MAY 26, 2021",Crocs Set to Join S&P MidCap 400 and Organogenesis to Join S&P SmallCap 600,https://www.nasdaq.com/press-release/crocs-set-to-join-sp-midcap-400-and-organogenesis-to-join-sp-smallcap-600-2021-05-26
CMPI,"MAY 20, 2021",Checkmate Pharmaceuticals to Present at the Jefferies 2021 Virtual Healthcare Conference,https://www.nasdaq.com/press-release/checkmate-pharmaceuticals-to-present-at-the-jefferies-2021-virtual-healthcare
CMPS,,,
CMRX,"JUN 4, 2021",Chimerix Receives U.S. Food and Drug Administration Approval for TEMBEXA® (brincidofovir) for the Treatment of Smallpox,https://www.nasdaq.com/press-release/chimerix-receives-u.s.-food-and-drug-administration-approval-for-tembexar
CNC,20 HOURS AGO,"Centene Announces Organizational Enhancements, Establishes The Office Of The President",https://www.nasdaq.com/press-release/centene-announces-organizational-enhancements-establishes-the-office-of-the-president
CNCE,"JUL 1, 2021",Concert Pharmaceuticals Presents Update on CTP-543 Long-Term Extension Study in Alopecia Areata During 2nd JAK Inhibitors Drug Development Summit,https://www.nasdaq.com/press-release/concert-pharmaceuticals-presents-update-on-ctp-543-long-term-extension-study-in
CNMD,"JUL 1, 2021","CONMED Corporation to Announce Second Quarter 2021 Financial Results on July 28, 2021",https://www.nasdaq.com/press-release/conmed-corporation-to-announce-second-quarter-2021-financial-results-on-july-28-2021
CNSP,2 DAYS AGO,WPD Pharmaceuticals’ Licensor Receives FDA Fast Track Designation for Berubicin for the Treatment of Recurrent Glioblastoma Multiforme; WPD Poland Arranges Loans,https://www.nasdaq.com/press-release/wpd-pharmaceuticals-licensor-receives-fda-fast-track-designation-for-berubicin-for
CNST,"JUL 1, 2021",MorphoSys Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Constellation Pharmaceuticals,https://www.nasdaq.com/press-release/morphosys-announces-expiration-of-the-hart-scott-rodino-waiting-period-for
CNTG,"JUN 25, 2021",CENTOGENE Announces Shareholders Approve All Resolutions at Annual General Meeting,https://www.nasdaq.com/press-release/centogene-announces-shareholders-approve-all-resolutions-at-annual-general-meeting
CO,"JUN 28, 2021",Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2021,https://www.nasdaq.com/press-release/global-cord-blood-corporation-reports-financial-results-for-the-fourth-quarter-and-0
COCP,"JUN 28, 2021",Cocrystal Joins Russell Microcap® Index,https://www.nasdaq.com/press-release/cocrystal-joins-russell-microcapr-index-2021-06-28
CODX,"JUN 18, 2021","Co-Diagnostics, Inc Receives CE Marking for Direct Saliva SARS-CoV-2 Test",https://www.nasdaq.com/press-release/co-diagnostics-inc-receives-ce-marking-for-direct-saliva-sars-cov-2-test-2021-06-18
COGT,"JUN 29, 2021",Cogent Biosciences to Present at Ladenburg Thalmann Virtual Healthcare Conference 2021,https://www.nasdaq.com/press-release/cogent-biosciences-to-present-at-ladenburg-thalmann-virtual-healthcare-conference
COLL,"JUN 16, 2021",Collegium Announces Publication of Real-World Data in Journal of Pain Research,https://www.nasdaq.com/press-release/collegium-announces-publication-of-real-world-data-in-journal-of-pain-research-2021
COO,3 HOURS AGO,clariti® 1 day Becomes First Net Plastic Neutral Contact Lens in the U.S.,https://www.nasdaq.com/press-release/claritir-1-day-becomes-first-net-plastic-neutral-contact-lens-in-the-u.s.-2021-07-14
CORT,2 DAYS AGO,Former Gilead Sciences Executive Amy E. Flood Joins Corcept Therapeutics as Chief Human Resources and Communications Officer,https://www.nasdaq.com/press-release/former-gilead-sciences-executive-amy-e.-flood-joins-corcept-therapeutics-as-chief
CPHI,"JUN 9, 2021",China Pharma to Launch Highly Purified NMN+PQQ Product,https://www.nasdaq.com/press-release/china-pharma-to-launch-highly-purified-nmnpqq-product-2021-06-09
CPIX,"JUN 21, 2021",Vibativ® Effectively Helps Treat Secondary Bacterial Infections In COVID-19 Patients,https://www.nasdaq.com/press-release/vibativr-effectively-helps-treat-secondary-bacterial-infections-in-covid-19-patients
CPRX,"JUL 6, 2021","Catalyst Pharmaceuticals Expands Leadership Team with Appointment of Preethi Sundaram, Ph.D. as Chief Product Development Officer",https://www.nasdaq.com/press-release/catalyst-pharmaceuticals-expands-leadership-team-with-appointment-of-preethi-sundaram
CRBP,"JUN 24, 2021",Corbus Pharmaceuticals Announces Topline Results from DETERMINE Phase 3 Study of Lenabasum for Treatment of Dermatomyositis,https://www.nasdaq.com/press-release/corbus-pharmaceuticals-announces-topline-results-from-determine-phase-3-study-of
CRDF,2 DAYS AGO,"Cardiff Oncology Announces the Appointments of Katherine L. Ruffner, M.D., as Chief Medical Officer and James E. Levine as Chief Financial Officer",https://www.nasdaq.com/press-release/cardiff-oncology-announces-the-appointments-of-katherine-l.-ruffner-m.d.-as-chief
CRHM,"APR 19, 2021",WELL Health Provides an Update on its Proposed Acquisition of CRH Medical,https://www.nasdaq.com/press-release/well-health-provides-an-update-on-its-proposed-acquisition-of-crh-medical-2021-04-19
CRIS,6 DAYS AGO,Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/curis-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2021-07-07
CRL,1 DAY AGO,Charles River Laboratories Schedules Second-Quarter 2021 Earnings Release and Conference Call,https://www.nasdaq.com/press-release/charles-river-laboratories-schedules-second-quarter-2021-earnings-release-and
CRMD,"JUN 10, 2021",CorMedix Inc. Completes Sale of $1.3 Million of NOL Tax Benefits Through The New Jersey Economic Development Authority Program,https://www.nasdaq.com/press-release/cormedix-inc.-completes-sale-of-%241.3-million-of-nol-tax-benefits-through-the-new
CRNX,"JUN 28, 2021",Crinetics Pharmaceuticals Announces Dosing of First Patient in Phase 3 PATHFNDR-1 Study Evaluating Oral Paltusotine for the Treatment of Acromegaly,https://www.nasdaq.com/press-release/crinetics-pharmaceuticals-announces-dosing-of-first-patient-in-phase-3-pathfndr-1
CRSP,"JUN 15, 2021",CRISPR Therapeutics and Capsida Biotherapeutics Announce Strategic Collaboration to Develop Gene-Edited Therapies for Amyotrophic Lateral Sclerosis and Friedreich’s Ataxia  ,https://www.nasdaq.com/press-release/crispr-therapeutics-and-capsida-biotherapeutics-announce-strategic-collaboration-to
CRTX,6 DAYS AGO,Cortexyme to Host Two-Part Key Opinion Leader Webinar Series on Atuzaginstat,https://www.nasdaq.com/press-release/cortexyme-to-host-two-part-key-opinion-leader-webinar-series-on-atuzaginstat-2021-07
CRVS,"MAY 25, 2021",Corvus Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference,https://www.nasdaq.com/press-release/corvus-pharmaceuticals-to-present-at-the-jefferies-virtual-healthcare-conference-2021
CRY,"MAY 18, 2021",CryoLife to Participate in the UBS Global Healthcare Virtual Conference,https://www.nasdaq.com/press-release/cryolife-to-participate-in-the-ubs-global-healthcare-virtual-conference-2021-05-18
CSBR,4 HOURS AGO,"Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 22, 2021",https://www.nasdaq.com/press-release/champions-oncology-to-announce-fourth-quarter-financial-results-on-thursday-july-22
CSII,5 HOURS AGO,"Cardiovascular Systems, Inc. to Webcast Fiscal 2021 Fourth-Quarter Earnings Conference Call Wednesday, August 4",https://www.nasdaq.com/press-release/cardiovascular-systems-inc.-to-webcast-fiscal-2021-fourth-quarter-earnings-conference
CSTL,"JUN 21, 2021",Castle Biosciences is Listed in the Houston Chronicle’s “CHRON 100” as One of the 100 Most Successful Publicly Traded Companies in Houston,https://www.nasdaq.com/press-release/castle-biosciences-is-listed-in-the-houston-chronicles-chron-100-as-one-of-the-100
CSU,"JUN 21, 2021",Capital Senior Living Announces May 2021 Occupancy,https://www.nasdaq.com/press-release/capital-senior-living-announces-may-2021-occupancy-2021-06-21
CTIC,5 DAYS AGO,CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/cti-biopharma-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-2021-07-09
CTLT,"JUN 28, 2021",Cybin Inc. Releases Annual Financials and Provides Business Highlights,https://www.nasdaq.com/press-release/cybin-inc.-releases-annual-financials-and-provides-business-highlights-2021-06-28
CTMX,"JUN 21, 2021",CytomX Therapeutics Announces Publication of First-in-Human Data for CX-2029 in Clinical Cancer Research,https://www.nasdaq.com/press-release/cytomx-therapeutics-announces-publication-of-first-in-human-data-for-cx-2029-in
CTSO,"JUL 6, 2021",CytoSorbents Receives Full FDA Approval of Investigational Device Exemption (IDE) for U.S. STAR-T Trial on Ticagrelor Removal During Cardiothoracic Surgery,https://www.nasdaq.com/press-release/cytosorbents-receives-full-fda-approval-of-investigational-device-exemption-ide-for-u
CTXR,"JUL 7, 2021","Citius Pharmaceuticals, Inc. Provides First Half 2021 Business Update, Highlights Upcoming Milestones",https://www.nasdaq.com/press-release/citius-pharmaceuticals-inc.-provides-first-half-2021-business-update-highlights
CTXRW,,,
CUE,"JUN 14, 2021",Cue Biopharma to Present at the Upcoming JMP Securities Life Sciences Conference,https://www.nasdaq.com/press-release/cue-biopharma-to-present-at-the-upcoming-jmp-securities-life-sciences-conference-2021
CUTR,"JUN 16, 2021",Cutera Announces Renewal of Distribution Agreement with ZO Skin Health,https://www.nasdaq.com/press-release/cutera-announces-renewal-of-distribution-agreement-with-zo-skin-health-2021-06-16
CVAC,"JUN 30, 2021","CureVac Final Data from Phase 2b/3 Trial of First-Generation COVID-19 Vaccine Candidate, CVnCoV, Demonstrates Protection in Age Group of 18 to 60",https://www.nasdaq.com/press-release/curevac-final-data-from-phase-2b-3-trial-of-first-generation-covid-19-vaccine
CVET,"JUN 30, 2021","Covetrus to Acquire VCP, Market-Leading Veterinary Wellness Platform",https://www.nasdaq.com/press-release/covetrus-to-acquire-vcp-market-leading-veterinary-wellness-platform-2021-06-30
CVM,"JUL 7, 2021",CEL-SCI Corporation Issues Letter to Shareholders,https://www.nasdaq.com/press-release/cel-sci-corporation-issues-letter-to-shareholders-2021-07-07
CVS,1 HOUR AGO,MinuteClinic Video Visit Telehealth Offering Now Available in Nevada,https://www.nasdaq.com/press-release/minuteclinic-video-visit-telehealth-offering-now-available-in-nevada-2021-07-14
CWBR,3 HOURS AGO,CohBar Provides Update on the Phase 1a/1b Clinical Trial for CB4211 Under Development for NASH and Obesity,https://www.nasdaq.com/press-release/cohbar-provides-update-on-the-phase-1a-1b-clinical-trial-for-cb4211-under-development
CYAD,20 HOURS AGO,Celyad Oncology to Host Virtual Research & Development Webinar on July 20th,https://www.nasdaq.com/press-release/celyad-oncology-to-host-virtual-research-development-webinar-on-july-20th-2021-07-0
CYCC,1 DAY AGO,Cyclacel Announces Dosing of First Patient in Phase 1/2 Study of Oral Fadraciclib in Patients With Advanced Solid Tumors and Aggressive Lymphomas,https://www.nasdaq.com/press-release/cyclacel-announces-dosing-of-first-patient-in-phase-1-2-study-of-oral-fadraciclib-in
CYCCP,1 DAY AGO,Cyclacel Announces Dosing of First Patient in Phase 1/2 Study of Oral Fadraciclib in Patients With Advanced Solid Tumors and Aggressive Lymphomas,https://www.nasdaq.com/press-release/cyclacel-announces-dosing-of-first-patient-in-phase-1-2-study-of-oral-fadraciclib-in
CYCN,5 DAYS AGO,Beacon Biosignals and Cyclerion Therapeutics Announce Strategic Partnership,https://www.nasdaq.com/press-release/beacon-biosignals-and-cyclerion-therapeutics-announce-strategic-partnership-2021-07
CYH,"MAY 26, 2021",Community Health Systems to Participate in the Jefferies Virtual Healthcare Conference,https://www.nasdaq.com/press-release/community-health-systems-to-participate-in-the-jefferies-virtual-healthcare
CYRX,"JUN 22, 2021","Cellenkos® Selects Cryoport to Support On-Demand, Flexible COVID-19 Therapy Shipments to Patients in Need",https://www.nasdaq.com/press-release/cellenkosr-selects-cryoport-to-support-on-demand-flexible-covid-19-therapy-shipments
CYTK,"JUL 1, 2021",Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/cytokinetics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-2021-07-01
DARE,2 DAYS AGO,"Daré Announces Collaborative Research Agreement (CRADA) for the Pivotal Phase 3 Study of Ovaprene®, an Investigational Hormone-Free Monthly Contraceptive",https://www.nasdaq.com/press-release/dare-announces-collaborative-research-agreement-crada-for-the-pivotal-phase-3-study
DBVT,6 DAYS AGO,"Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2021",https://www.nasdaq.com/press-release/monthly-information-regarding-the-total-number-of-voting-rights-and-total-number-34
DCPH,"JUN 30, 2021",Deciphera Announces First Patient Treated in Phase 1 Study of DCC-3116 in Patients with Advanced or Metastatic Tumors with a Mutant RAS or RAF Gene,https://www.nasdaq.com/press-release/deciphera-announces-first-patient-treated-in-phase-1-study-of-dcc-3116-in-patients
DCTH,6 DAYS AGO,"50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021",https://www.nasdaq.com/press-release/50-companies-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-0
DFFN,"JUN 30, 2021",Diffusion Pharmaceuticals Reports Positive Trend in Oxygenation from TCOM Trial,https://www.nasdaq.com/press-release/diffusion-pharmaceuticals-reports-positive-trend-in-oxygenation-from-tcom-trial-2021
DFHT,,,
DFHTU,"JUN 8, 2021",Deerfield Healthcare Technology Acquisitions Corp. Announces Closing of Business Combination With CareMax,https://www.nasdaq.com/press-release/deerfield-healthcare-technology-acquisitions-corp.-announces-closing-of-business
DFHTW,,,
DGX,1 HOUR AGO,"Quest Diagnostics Named a ""Best Place to Work for Disability Inclusion"" for Fourth Consecutive Year",https://www.nasdaq.com/press-release/quest-diagnostics-named-a-best-place-to-work-for-disability-inclusion-for-fourth
DMAC,"JUN 29, 2021",DiaMedica Therapeutics Announces Positive Interim Results from Phase 2 REDUX Study in CKD,https://www.nasdaq.com/press-release/diamedica-therapeutics-announces-positive-interim-results-from-phase-2-redux-study-in
DMTK,"JUL 6, 2021",DermTech Announces New Appointment of Monica Tellado to its Board of Directors,https://www.nasdaq.com/press-release/dermtech-announces-new-appointment-of-monica-tellado-to-its-board-of-directors-2021
DNLI,"JUN 28, 2021",Denali Therapeutics Announces Initiation of Phase 2 Study by Partner Sanofi of RIPK1-Inhibitor DNL758 (SAR443122) in Cutaneous Lupus Erythematosus (CLE) Patients,https://www.nasdaq.com/press-release/denali-therapeutics-announces-initiation-of-phase-2-study-by-partner-sanofi-of-ripk1
DRIO,1 DAY AGO,"DarioHealth Chief Medical Officer Omar Manejwala, M.D., to Present on the Role of Digital Therapeutics in Post-Pandemic Healthcare at DTx Europe",https://www.nasdaq.com/press-release/dariohealth-chief-medical-officer-omar-manejwala-m.d.-to-present-on-the-role-of
DRIOW,,,
DRNA,"JUL 1, 2021",Dicerna Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/dicerna-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2021-07-01
DRRX,"JUN 23, 2021",DURECT Corporation Presents Additional Clinical Data from DUR-928 Phase 1b Trial in NASH and Phase 1 Trial in Hepatic Impairment at the International Liver Conference 2021 (EASL),https://www.nasdaq.com/press-release/durect-corporation-presents-additional-clinical-data-from-dur-928-phase-1b-trial-in
DTIL,"JUL 1, 2021",Precision BioSciences Doses First Patient in Phase 1 Allogeneic CAR T Clinical Trial of PBCAR19B Immune Evading Stealth Cell for Relapsed/Refractory Non-Hodgkin Lymphoma,https://www.nasdaq.com/press-release/precision-biosciences-doses-first-patient-in-phase-1-allogeneic-car-t-clinical-trial
DVA,"JUN 10, 2021",DaVita and the National Kidney Foundation Join Forces to Improve Health Equity in Kidney Transplantation,https://www.nasdaq.com/press-release/davita-and-the-national-kidney-foundation-join-forces-to-improve-health-equity-in
DVAX,"JUL 6, 2021",Dynavax and Biological E Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Biological E's COVID-19 Vaccine Candidate,https://www.nasdaq.com/press-release/dynavax-and-biological-e-announce-commercial-supply-agreement-of-dynavaxs-cpg-1018
DXCM,"JUL 7, 2021","Dexcom Schedules Second Quarter 2021 Earnings Release and Conference Call for July 29, 2021 at 4:30 p.m. Eastern Time",https://www.nasdaq.com/press-release/dexcom-schedules-second-quarter-2021-earnings-release-and-conference-call-for-july-29
DXR,1 DAY AGO,American College of Cardiology (ACC) Features Expert Analysis on the Importance of Addressing Anemia With Blood Volume Analysis in Heart Failure Patients,https://www.nasdaq.com/press-release/american-college-of-cardiology-acc-features-expert-analysis-on-the-importance-of
DYAI,"JUN 28, 2021",Dyadic’s C1 Production Platform Utilized in ZAPI Study Published in “VACCINES” a Leading Peer-Reviewed Scientific Journal,https://www.nasdaq.com/press-release/dyadics-c1-production-platform-utilized-in-zapi-study-published-in-vaccines-a-leading
DYN,"JUN 25, 2021",Dyne Therapeutics Presents Preclinical Data from its Facioscapulohumeral Muscular Dystrophy Program During the FSHD Society International Research Congress,https://www.nasdaq.com/press-release/dyne-therapeutics-presents-preclinical-data-from-its-facioscapulohumeral-muscular
DYNT,6 DAYS AGO,Dynatronics Corporation Announces Promotion of Sarah Rome-Mealman to Vice President of Marketing,https://www.nasdaq.com/press-release/dynatronics-corporation-announces-promotion-of-sarah-rome-mealman-to-vice-president
EAR,1 DAY AGO,Eargo Launches Eargo 5 Hearing Aid with Sound Match™ Technology,https://www.nasdaq.com/press-release/eargo-launches-eargo-5-hearing-aid-with-sound-matchtm-technology-2021-07-13
EARS,3 HOURS AGO,Auris Medical Announces Publication of Data from Preclinical Studies with Bentrio™ Nasal Spray in Prevention and Mitigation of SARS-CoV-2,https://www.nasdaq.com/press-release/auris-medical-announces-publication-of-data-from-preclinical-studies-with-bentriotm
EBS,"JUN 11, 2021",COVID-19 Vaccine Drug Substance Manufactured by Emergent BioSolutions Authorized as Part of Johnson & Johnson’s Emergency Use Authorization,https://www.nasdaq.com/press-release/covid-19-vaccine-drug-substance-manufactured-by-emergent-biosolutions-authorized-as
ECOR,1 DAY AGO,electroCore Provides Business Update and Select Second Quarter 2021 Financial Guidance,https://www.nasdaq.com/press-release/electrocore-provides-business-update-and-select-second-quarter-2021-financial
EDAP,"JUN 15, 2021",EDAP Announces Hiring of MedTech Industry Veteran Ryan Rhodes as CEO of Company’s U.S. Subsidiary,https://www.nasdaq.com/press-release/edap-announces-hiring-of-medtech-industry-veteran-ryan-rhodes-as-ceo-of-companys-u.s.
EDIT,"JUN 23, 2021",Editas Medicine Announces Enrollment of the First Pediatric Cohort in the BRILLIANCE Clinical Trial of EDIT-101 for the Treatment of LCA10 Following IDMC Endorsement,https://www.nasdaq.com/press-release/editas-medicine-announces-enrollment-of-the-first-pediatric-cohort-in-the-brilliance
EDSA,1 DAY AGO,Edesa Biotech Extends Dermatitis Study to Canada,https://www.nasdaq.com/press-release/edesa-biotech-extends-dermatitis-study-to-canada-2021-07-13
EGRX,"JUN 24, 2021",Eagle Pharmaceuticals Announces FDA Maintains Prioritization of ANDA for Vasopressin,https://www.nasdaq.com/press-release/eagle-pharmaceuticals-announces-fda-maintains-prioritization-of-anda-for-vasopressin
EHC,"JUL 1, 2021","Encompass Health announces plans to build a 40-bed inpatient rehabilitation hospital in the greater Madison, Wisconsin area",https://www.nasdaq.com/press-release/encompass-health-announces-plans-to-build-a-40-bed-inpatient-rehabilitation-0
EIGR,"JUL 7, 2021",Eiger BioPharmaceuticals to Present at Ladenburg Thalmann 2021 Virtual Healthcare Conference,https://www.nasdaq.com/press-release/eiger-biopharmaceuticals-to-present-at-ladenburg-thalmann-2021-virtual-healthcare
ELAN,2 DAYS AGO,Elanco Confirms Date and Conference Call for Second Quarter 2021 Financial Results Announcement,https://www.nasdaq.com/press-release/elanco-confirms-date-and-conference-call-for-second-quarter-2021-financial-results
ELAT,,,
ELDN,"JUL 2, 2021","Eledon Pharmaceuticals Appoints Jan Hillson, M.D., to its Board of Directors",https://www.nasdaq.com/press-release/eledon-pharmaceuticals-appoints-jan-hillson-m.d.-to-its-board-of-directors-2021-07-02
ELMD,"MAY 27, 2021","Electromed, Inc. Announces Authorization of $3.0 Million Stock Repurchase Program",https://www.nasdaq.com/press-release/electromed-inc.-announces-authorization-of-%243.0-million-stock-repurchase-program-2021
ELOX,"JUL 6, 2021",Eloxx Pharmaceuticals Provides Enrollment Update for Ongoing Phase 2 Clinical Studies for Cystic Fibrosis,https://www.nasdaq.com/press-release/eloxx-pharmaceuticals-provides-enrollment-update-for-ongoing-phase-2-clinical-studies
ENDP,"JUN 24, 2021",Endo to Announce Second Quarter 2021 Financial Results,https://www.nasdaq.com/press-release/endo-to-announce-second-quarter-2021-financial-results-2021-06-24
ENLV,5 HOURS AGO,Enlivex to Present at the ARDS Drug Development Summit 2021,https://www.nasdaq.com/press-release/enlivex-to-present-at-the-ards-drug-development-summit-2021-2021-07-14
ENOB,2 DAYS AGO,Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential Cure for Hepatitis B Virus Infection,https://www.nasdaq.com/press-release/enochian-biosciences-announces-fda-acceptance-of-pre-ind-request-for-potential-cure
ENSG,"JUN 18, 2021","The Ensign Group, Inc. Declares Quarterly Dividend of $0.0525 Per Share",https://www.nasdaq.com/press-release/the-ensign-group-inc.-declares-quarterly-dividend-of-%240.0525-per-share-2021-06-18
ENTA,"JUN 23, 2021","Enanta Pharmaceuticals Presents New Data for EDP-721, an Oral Hepatitis B Virus RNA Destabilizer, at the European Association for the Study of the Liver (EASL) International Liver Congress™",https://www.nasdaq.com/press-release/enanta-pharmaceuticals-presents-new-data-for-edp-721-an-oral-hepatitis-b-virus-rna
ENTX,"JUN 28, 2021",Entera Bio to Conduct Conference Call on June 30 to Discuss Phase 2 Results for EB613 Positioned to be the First Oral Bone-Building Agent for the Treatment of Osteoporosis,https://www.nasdaq.com/press-release/entera-bio-to-conduct-conference-call-on-june-30-to-discuss-phase-2-results-for-eb613
ENTXW,,,
ENZ,"JUN 15, 2021",Enzo Biochem Announces Online Service with TrustAssure to Schedule Timely PCR Testing Required for International Travel,https://www.nasdaq.com/press-release/enzo-biochem-announces-online-service-with-trustassure-to-schedule-timely-pcr-testing
EOLS,"JUN 30, 2021","Evolus Announces Appointment of David K. Erickson as Vice President, Investor Relations",https://www.nasdaq.com/press-release/evolus-announces-appointment-of-david-k.-erickson-as-vice-president-investor
EPIX,"MAY 25, 2021",ESSA Pharma to Present at the Jefferies Virtual Healthcare Conference,https://www.nasdaq.com/press-release/essa-pharma-to-present-at-the-jefferies-virtual-healthcare-conference-2021-05-25
EPZM,"JUN 16, 2021",Epizyme Launches EZH2Now Testing Program with Quest Diagnostics for Relapsed or Refractory Follicular Lymphoma Patients,https://www.nasdaq.com/press-release/epizyme-launches-ezh2now-testing-program-with-quest-diagnostics-for-relapsed-or
EQ,1 DAY AGO,Equillium Announces Plans to Initiate Phase 3 Pivotal Study of Itolizumab in First-line Treatment of Acute Graft-Versus-Host Disease Following End-of-Phase 1 Meeting with the FDA,https://www.nasdaq.com/press-release/equillium-announces-plans-to-initiate-phase-3-pivotal-study-of-itolizumab-in-first
ERYP,"JUL 6, 2021","Monthly information related to total number of voting rights and shares composing the share capital – June 30, 2021",https://www.nasdaq.com/press-release/monthly-information-related-to-total-number-of-voting-rights-and-shares-composing-32
ESPR,1 DAY AGO,"Esperion to Report Second Quarter 2021 Financial Results August 3, 2021",https://www.nasdaq.com/press-release/esperion-to-report-second-quarter-2021-financial-results-august-3-2021-2021-07-13
ESTA,2 DAYS AGO,Establishment Labs Announces Departure of CFO and Appointment of Raj Denhoy as Interim CFO,https://www.nasdaq.com/press-release/establishment-labs-announces-departure-of-cfo-and-appointment-of-raj-denhoy-as
ETNB,"JUN 16, 2021",89bio to Participate in Upcoming Investor Conferences,https://www.nasdaq.com/press-release/89bio-to-participate-in-upcoming-investor-conferences-2021-06-16
ETON,"JUN 15, 2021",Eton Pharmaceuticals Acquires U.S. and Canadian Rights to ZENEO® Hydrocortisone Autoinjector,https://www.nasdaq.com/press-release/eton-pharmaceuticals-acquires-u.s.-and-canadian-rights-to-zeneor-hydrocortisone
ETTX,5 HOURS AGO,Entasis Therapeutics Expands Executive Leadership Team with the Appointment of Anna Diaz Triola as Chief Commercial Officer,https://www.nasdaq.com/press-release/entasis-therapeutics-expands-executive-leadership-team-with-the-appointment-of-anna
EVFM,5 HOURS AGO,Early Look at Second Quarter Metrics for Phexxi® Reveals Strong Growth,https://www.nasdaq.com/press-release/early-look-at-second-quarter-metrics-for-phexxir-reveals-strong-growth-2021-07-14
EVLO,"JUN 16, 2021",Evelo Biosciences Announces Grant of Inducement Award,https://www.nasdaq.com/press-release/evelo-biosciences-announces-grant-of-inducement-award-2021-06-16
EVOK,4 HOURS AGO,Evoke Pharma Launches Gimoti® Patient and Physician Experience Program,https://www.nasdaq.com/press-release/evoke-pharma-launches-gimotir-patient-and-physician-experience-program-2021-07-14
EW,"JUN 1, 2021",Edwards Receives Clearance For Hypotension Prediction Index Software For Noninvasive Acumen IQ Cuff,https://www.nasdaq.com/press-release/edwards-receives-clearance-for-hypotension-prediction-index-software-for-noninvasive
EXAS,6 DAYS AGO,Exact Sciences schedules second quarter 2021 earnings call,https://www.nasdaq.com/press-release/exact-sciences-schedules-second-quarter-2021-earnings-call-2021-07-08
EXEL,5 DAYS AGO,"Exelixis to Present at the Virtual William Blair Biotech Focus Conference on July 15, 2021",https://www.nasdaq.com/press-release/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15
EYE,1 DAY AGO,"National Vision Expands Annual Continuing Education Symposium to Three Regional Events, Attracting Record Number of Optometrists",https://www.nasdaq.com/press-release/national-vision-expands-annual-continuing-education-symposium-to-three-regional
EYEG,"JUN 14, 2021",EyeGate Pharma Announces First Patient Dosed for PP-001 in a Phase 2 Proof-of-Concept Ocular Surface Inflammation Study,https://www.nasdaq.com/press-release/eyegate-pharma-announces-first-patient-dosed-for-pp-001-in-a-phase-2-proof-of-concept
EYEN,6 DAYS AGO,Eyenovia to Participate in Two Upcoming Investor Conferences,https://www.nasdaq.com/press-release/eyenovia-to-participate-in-two-upcoming-investor-conferences-2021-07-07
EYES,"JUN 25, 2021",Second Sight Medical Products Announces Closing of Public Offering,https://www.nasdaq.com/press-release/second-sight-medical-products-announces-closing-of-public-offering-2021-06-25
EYESW,,,
FATE,"JUN 15, 2021","Fate Therapeutics Appoints Mark Plavsic, DVM, PhD, RAC as Chief Technical Officer",https://www.nasdaq.com/press-release/fate-therapeutics-appoints-mark-plavsic-dvm-phd-rac-as-chief-technical-officer-2021
FBIO,6 DAYS AGO,Checkpoint Therapeutics to Participate in the Ladenburg Thalmann 2021 Healthcare Conference,https://www.nasdaq.com/press-release/checkpoint-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare
FBIOP,,,
FBRX,1 DAY AGO,"Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules",https://www.nasdaq.com/press-release/forte-biosciences-inc.-reports-inducement-grants-under-nasdaq-listing-rules-2021-07-0
FDMT,"JUN 24, 2021","4D Molecular Therapeutics Announces Rare Disease Ophthalmology Product Candidate Portfolio Update, Including Initial Clinical Safety and Tolerability Data for 4D-110 for Choroideremia and 4D-125 for XLRP, and Termination of Roche Collaboration and Lic...",https://www.nasdaq.com/press-release/4d-molecular-therapeutics-announces-rare-disease-ophthalmology-product-candidate
FENC,"JUN 29, 2021",Fennec Announces Results of Annual Meeting,https://www.nasdaq.com/press-release/fennec-announces-results-of-annual-meeting-2021-06-29
FGEN,2 DAYS AGO,"FibroGen Appoints John Hunter, Ph.D. as Chief Scientific Officer",https://www.nasdaq.com/press-release/fibrogen-appoints-john-hunter-ph.d.-as-chief-scientific-officer-2021-07-12
FHTX,5 DAYS AGO,Foghorn Therapeutics to Participate at the William Blair Biotech Focus Conference 2021,https://www.nasdaq.com/press-release/foghorn-therapeutics-to-participate-at-the-william-blair-biotech-focus-conference
FIXX,"MAY 13, 2021",Homology Medicines Announces Presentations on its Expanding Genetic Medicines Platform and Internal GMP Manufacturing at the American Society of Gene & Cell Therapy Annual Meeting,https://www.nasdaq.com/press-release/homology-medicines-announces-presentations-on-its-expanding-genetic-medicines
FLGT,"MAY 10, 2021","Fulgent Genetics Announces Incremental Strategic Investment in Chinese Joint Venture, FF Gene Biotech",https://www.nasdaq.com/press-release/fulgent-genetics-announces-incremental-strategic-investment-in-chinese-joint-venture
FLXN,1 DAY AGO,Flexion Therapeutics Announces Appointment of Utpal Koppikar to its Board of Directors,https://www.nasdaq.com/press-release/flexion-therapeutics-announces-appointment-of-utpal-koppikar-to-its-board-of
FMS,1 DAY AGO,Xenios AG receives approval in China for ECMO devices,https://www.nasdaq.com/press-release/xenios-ag-receives-approval-in-china-for-ecmo-devices-2021-07-13
FMTX,"JUN 14, 2021","Forma Therapeutics Announces Appointment of Industry Veteran John E. Bishop, Ph.D., as Chief Technology Officer",https://www.nasdaq.com/press-release/forma-therapeutics-announces-appointment-of-industry-veteran-john-e.-bishop-ph.d.-as
FOLD,"JUN 14, 2021","Amicus Therapeutics Appoints Eiry W. Roberts, M.D. to its Board of Directors",https://www.nasdaq.com/press-release/amicus-therapeutics-appoints-eiry-w.-roberts-m.d.-to-its-board-of-directors-2021-06
FONR,"MAY 13, 2021",Fonar Announces 3rd Quarter and Nine Months Results for Fiscal 2021; Income Increases 125%,https://www.nasdaq.com/press-release/fonar-announces-3rd-quarter-and-nine-months-results-for-fiscal-2021-income-increases
FPRX,"APR 16, 2021",Amgen Successfully Completes Acquisition Of Five Prime Therapeutics,https://www.nasdaq.com/press-release/amgen-successfully-completes-acquisition-of-five-prime-therapeutics-2021-04-16
FREQ,"JUN 4, 2021","Notice of Lead Plaintiff Deadline for Shareholders in the Frequency Therapeutics, Inc. Class Action Lawsuit",https://www.nasdaq.com/press-release/notice-of-lead-plaintiff-deadline-for-shareholders-in-the-frequency-therapeutics-inc.
FRLN,"JUN 30, 2021",Freeline Announces Executive Leadership Changes,https://www.nasdaq.com/press-release/freeline-announces-executive-leadership-changes-2021-06-30
FSTX,5 DAYS AGO,F-star Therapeutics to Present at Upcoming Investor Conferences,https://www.nasdaq.com/press-release/f-star-therapeutics-to-present-at-upcoming-investor-conferences-2021-07-09
FULC,"JUN 24, 2021",Fulcrum Therapeutics Announces Results from ReDUX4 Trial with Losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD) Demonstrating Slowed Disease Progression and Improved Function,https://www.nasdaq.com/press-release/fulcrum-therapeutics-announces-results-from-redux4-trial-with-losmapimod-in
FUSN,"JUL 7, 2021",Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/fusion-pharmaceuticals-announces-inducement-grants-under-nasdaq-listing-rule-5635c4
FVE,"JUL 6, 2021","Five Star Senior Living Inc. Second Quarter 2021 Conference Call Scheduled for Thursday, August 5th",https://www.nasdaq.com/press-release/five-star-senior-living-inc.-second-quarter-2021-conference-call-scheduled-for
FWP,"APR 14, 2021","Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2020",https://www.nasdaq.com/press-release/forward-pharma-reports-financial-and-operational-results-from-the-year-ended-0
GALT,5 DAYS AGO,Galectin Therapeutics Announces Positive Top-Line Results from a Phase 1b Clinical Trial Extension of Belapectin in Combination with KEYTRUDA® in Advanced Metastatic Melanoma and Head and Neck Cancer,https://www.nasdaq.com/press-release/galectin-therapeutics-announces-positive-top-line-results-from-a-phase-1b-clinical
GBIO,5 HOURS AGO,Generation Bio Announces Plan to Scale Next-Generation Rapid Enzymatic Manufacturing Process Across Portfolio and Provides Pipeline Update,https://www.nasdaq.com/press-release/generation-bio-announces-plan-to-scale-next-generation-rapid-enzymatic-manufacturing
GBS,6 DAYS AGO,GBS Awarded $4.7 Million Australian Federal Government Science Grant To Manufacture Biosensor Technology,https://www.nasdaq.com/press-release/gbs-awarded-%244.7-million-australian-federal-government-science-grant-to-manufacture
GBT,5 DAYS AGO,GBT Announces New Employment Inducement Grants,https://www.nasdaq.com/press-release/gbt-announces-new-employment-inducement-grants-2021-07-09
GEN           ,"MAR 23, 2021","Highly Regarded Turnaround Specialist, Harry Wilson, Appointed CEO of Genesis HealthCare",https://www.nasdaq.com/press-release/highly-regarded-turnaround-specialist-harry-wilson-appointed-ceo-of-genesis
GENE,5 DAYS AGO,Genetic Technologies Continues to Break New Ground as it Advances Development of its Predictive Risk Test for Multiple Cancers & Morbidities,https://www.nasdaq.com/press-release/genetic-technologies-continues-to-break-new-ground-as-it-advances-development-of-its
GERN,"JUN 17, 2021",Geron Announces Publication of IMbark Phase 2 Data in Journal of Clinical Oncology,https://www.nasdaq.com/press-release/geron-announces-publication-of-imbark-phase-2-data-in-journal-of-clinical-oncology
GH,1 DAY AGO,"Guardant Health to Report Second Quarter Financial Results on August 5, 2021",https://www.nasdaq.com/press-release/guardant-health-to-report-second-quarter-financial-results-on-august-5-2021-2021-07
GHSI,"JUN 14, 2021",Guardion Health Sciences to Be Added to the Russell 3000 Index,https://www.nasdaq.com/press-release/guardion-health-sciences-to-be-added-to-the-russell-3000-index-2021-06-14
GILD,2 DAYS AGO,Gilead to Present New Data at IAS 2021 Demonstrating the Company’s Commitment to Advancing Innovation in HIV Research,https://www.nasdaq.com/press-release/gilead-to-present-new-data-at-ias-2021-demonstrating-the-companys-commitment-to
GKOS,11 HOURS AGO,Glaukos Comments on the Centers for Medicare and Medicaid Services 2022 Proposed Physician Fee Schedule,https://www.nasdaq.com/press-release/glaukos-comments-on-the-centers-for-medicare-and-medicaid-services-2022-proposed
GLMD,"MAY 13, 2021",Galmed Pharmaceuticals Provides Business Updates and Reports First Quarter 2021 Financial Results,https://www.nasdaq.com/press-release/galmed-pharmaceuticals-provides-business-updates-and-reports-first-quarter-2021
GLPG,4 DAYS AGO,Galapagos announces new data supporting rapid symptom improvement and sustained steroid-free remission with filgotinib in patients with Ulcerative Colitis,https://www.nasdaq.com/press-release/galapagos-announces-new-data-supporting-rapid-symptom-improvement-and-sustained
GLSI,"JUN 8, 2021",Greenwich LifeSciences Set to Join Russell 2000® Index,https://www.nasdaq.com/press-release/greenwich-lifesciences-set-to-join-russell-2000r-index-2021-06-08
GLTO,1 DAY AGO,Galecto Resumes Recruitment in Phase 2b Global GALACTIC-1 Trial of GB0139 for Idiopathic Pulmonary Fibrosis,https://www.nasdaq.com/press-release/galecto-resumes-recruitment-in-phase-2b-global-galactic-1-trial-of-gb0139-for
GLYC,2 DAYS AGO,GlycoMimetics Announces Initiation of Clinical Trial Evaluating Uproleselan in Combination With Venetoclax and Azacitidine,https://www.nasdaq.com/press-release/glycomimetics-announces-initiation-of-clinical-trial-evaluating-uproleselan-in
GMAB,"JUL 6, 2021",Capital Increase in Genmab as a Result of Employee Warrant Exercise,https://www.nasdaq.com/press-release/capital-increase-in-genmab-as-a-result-of-employee-warrant-exercise-2021-07-06
GMDA,"JUN 23, 2021","Gamida Cell Announces Publication in Blood, the Journal of the American Society of Hematology, of the First Pivotal Trial to Evaluate a Cell Therapy (Omidubicel) for Patients with Blood Cancer who Require an Allogeneic Stem Cell Transplant",https://www.nasdaq.com/press-release/gamida-cell-announces-publication-in-blood-the-journal-of-the-american-society-of
GMED,"MAY 4, 2021",Globus Medical Reports First Quarter 2021 Results,https://www.nasdaq.com/press-release/globus-medical-reports-first-quarter-2021-results-2021-05-04
GMTX,"JUN 22, 2021",Gemini Therapeutics Announces Initial Data From Its Ongoing Phase 2a Study of GEM103 in Patients With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration,https://www.nasdaq.com/press-release/gemini-therapeutics-announces-initial-data-from-its-ongoing-phase-2a-study-of-gem103
GNCA,1 DAY AGO,Genocea Doses First Patient in Phase 1/2a TiTAN Clinical Trial for GEN-011 Neoantigen-Targeted T cell Therapy,https://www.nasdaq.com/press-release/genocea-doses-first-patient-in-phase-1-2a-titan-clinical-trial-for-gen-011-neoantigen
GNFT,4 DAYS AGO,GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial,https://www.nasdaq.com/press-release/genfit%3A-half-year-report-of-liquidity-contract-with-credit-industriel-et-commercial-3
GNMK,"FEB 25, 2021",GenMark Diagnostics Reports Fourth Quarter and Full Year 2020 Results,https://www.nasdaq.com/press-release/genmark-diagnostics-reports-fourth-quarter-and-full-year-2020-results-2021-02-25
GNPX,"JUN 23, 2021",Genprex Announces Initiation of its Phase 1/2 Acclaim-1 Clinical Trial for REQORSA™ Immunogene Therapy in Combination with Tagrisso® to Treat Non-Small Cell Lung Cancer Following FDA Review,https://www.nasdaq.com/press-release/genprex-announces-initiation-of-its-phase-1-2-acclaim-1-clinical-trial-for-reqorsatm
GOSS,"JUL 7, 2021",Gossamer Bio Announces GB004 Clinical Trial Data Presentations at 2021 Virtual Congress of the European Crohn’s and Colitis Organisation,https://www.nasdaq.com/press-release/gossamer-bio-announces-gb004-clinical-trial-data-presentations-at-2021-virtual
GOVX,"JUL 7, 2021",GeoVax Announces Issuance of Hepatitis B Vaccine Patent,https://www.nasdaq.com/press-release/geovax-announces-issuance-of-hepatitis-b-vaccine-patent-2021-07-07
GOVXW,,,
GRAY,"MAY 12, 2021",Graybug Vision Announces First Quarter 2021 Financial Results and Recent Corporate Developments,https://www.nasdaq.com/press-release/graybug-vision-announces-first-quarter-2021-financial-results-and-recent-corporate
GRCL,"JUN 2, 2021","Gracell Biotechnologies Reschedules Clinical Update Conference Call and Webcast to June 14, 2021",https://www.nasdaq.com/press-release/gracell-biotechnologies-reschedules-clinical-update-conference-call-and-webcast-to
GRFS,3 HOURS AGO,"GigaGen Publishes Research Describing Novel Mechanism of Action and Therapeutic Potential of its anti-CTLA-4 Drug Candidate, GIGA-564",https://www.nasdaq.com/press-release/gigagen-publishes-research-describing-novel-mechanism-of-action-and-therapeutic
GRNV,5 HOURS AGO,Li-Cycle and Helbiz Partner to Advance Battery Recycling in Micro-Mobility,https://www.nasdaq.com/press-release/li-cycle-and-helbiz-partner-to-advance-battery-recycling-in-micro-mobility-2021-07-14
GRNVR,,,
GRNVU,5 HOURS AGO,Li-Cycle and Helbiz Partner to Advance Battery Recycling in Micro-Mobility,https://www.nasdaq.com/press-release/li-cycle-and-helbiz-partner-to-advance-battery-recycling-in-micro-mobility-2021-07-14
GRNVW,,,
GRTS,"JUN 23, 2021","Gritstone Announces Management Changes, Including the Appointment of Celia Economides as Chief Financial Officer",https://www.nasdaq.com/press-release/gritstone-announces-management-changes-including-the-appointment-of-celia-economides
GRTX,"JUN 28, 2021",Galera Announces Completion of Enrollment in Pivotal 455-Patient Phase 3 Trial of Avasopasem for Severe Oral Mucositis,https://www.nasdaq.com/press-release/galera-announces-completion-of-enrollment-in-pivotal-455-patient-phase-3-trial-of
GSK,"JUN 29, 2021","TUMS® Fuels the Autoburn, a Road Trip to America's Spiciest Destinations, with Hot Food Expert Sean Evans",https://www.nasdaq.com/press-release/tumsr-fuels-the-autoburn-a-road-trip-to-americas-spiciest-destinations-with-hot-food
GTH,1 DAY AGO,Genetron Health Receives CE Mark for 8-Gene Lung Cancer Assay and Provides FDA Reference Panel Comparative Data of its SARS-CoV-2 RNA Test,https://www.nasdaq.com/press-release/genetron-health-receives-ce-mark-for-8-gene-lung-cancer-assay-and-provides-fda
GTHX,"JUL 2, 2021",G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/g1-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-2021-07
GWPH,"MAY 5, 2021",Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc,https://www.nasdaq.com/press-release/jazz-pharmaceuticals-completes-acquisition-of-gw-pharmaceuticals-plc-2021-05-05
GXGX,"MAY 14, 2021",GX Acquisition Corp. Announces Shareholder Approval of Extension Proposal,https://www.nasdaq.com/press-release/gx-acquisition-corp.-announces-shareholder-approval-of-extension-proposal-2021-05-14
GXGXU,"MAY 5, 2021",Celularity Enters into Multi-Year Strategic Partnership with Palantir Technologies,https://www.nasdaq.com/press-release/celularity-enters-into-multi-year-strategic-partnership-with-palantir-technologies
GXGXW,,,
HAE,4 DAYS AGO,/C O R R E C T I O N -- Haemonetics Corporation/,https://www.nasdaq.com/press-release/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation-2021-07-09
HALO,"JUN 22, 2021",Halozyme Announces Janssen Receives European Marketing Authorizations for DARZALEX® (daratumumab) Subcutaneous Formulation for Newly Diagnosed Systemic Light-chain Amyloidosis and Pre-Treated Multiple Myeloma,https://www.nasdaq.com/press-release/halozyme-announces-janssen-receives-european-marketing-authorizations-for-darzalexr
HARP,"JUN 4, 2021",Harpoon Therapeutics Provides Progress Update for TriTAC® Clinical Programs and ProTriTAC™ Platform,https://www.nasdaq.com/press-release/harpoon-therapeutics-provides-progress-update-for-tritacr-clinical-programs-and
HCA,"JUL 1, 2021",HCA Healthcare Completes Previously Announced Purchase of Majority Stake in Brookdale Health Care Services,https://www.nasdaq.com/press-release/hca-healthcare-completes-previously-announced-purchase-of-majority-stake-in-brookdale
HCM,1 DAY AGO,"HUTCHMED Announces First Commercial Sale of ORPATHYS® in China, Triggering a US$25 million Milestone Payment from AstraZeneca",https://www.nasdaq.com/press-release/hutchmed-announces-first-commercial-sale-of-orpathysr-in-china-triggering-a-us%2425
HCSG,"APR 21, 2021","Healthcare Services Group, Inc. Reports Q1 2021 Results",https://www.nasdaq.com/press-release/healthcare-services-group-inc.-reports-q1-2021-results-2021-04-21
HEC,,,
HECCU,"JUN 22, 2021","Talkspace, a Leading Virtual Behavioral Healthcare Company, Completes Merger with Hudson Executive Investment Corp. and Will Begin Trading on Nasdaq Under the Symbol ""TALK""",https://www.nasdaq.com/press-release/talkspace-a-leading-virtual-behavioral-healthcare-company-completes-merger-with
HECCW,,,
HEPA,1 DAY AGO,Hepion Pharmaceuticals Announces Positive Topline Data from Phase 2a ‘AMBITION’ NASH Trial; All Primary Endpoints Achieved,https://www.nasdaq.com/press-release/hepion-pharmaceuticals-announces-positive-topline-data-from-phase-2a-ambition-nash
HGEN,5 DAYS AGO,UK’s MHRA accepts Humanigen’s submission of Lenzilumab for Marketing Authorization in COVID-19 for expedited rolling review,https://www.nasdaq.com/press-release/uks-mhra-accepts-humanigens-submission-of-lenzilumab-for-marketing-authorization-in
HIMS,1 DAY AGO,"The Pandemic’s Impact on Americans’ Mental Health: New Hims & Hers Survey Shows 70% Remain Anxious Around Post-Pandemic ‘Normal’, Half Have Considered Therapy for the First Time",https://www.nasdaq.com/press-release/the-pandemics-impact-on-americans-mental-health%3A-new-hims-hers-survey-shows-70-remain
HJLI,6 DAYS AGO,Hancock Jaffe to Present at the Ladenburg Thalmann 2021 Healthcare Conference,https://www.nasdaq.com/press-release/hancock-jaffe-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference-2021-07
HJLIW,,,
HLF,"JUL 6, 2021",Herbalife Nutrition Ltd. Announces Second Quarter 2021 Earnings Release Date and Investor Call,https://www.nasdaq.com/press-release/herbalife-nutrition-ltd.-announces-second-quarter-2021-earnings-release-date-and
HNGR,5 HOURS AGO,Hanger Announces Date of 2021 Second Quarter Earnings Release and Conference Call,https://www.nasdaq.com/press-release/hanger-announces-date-of-2021-second-quarter-earnings-release-and-conference-call
HOLX,11 HOURS AGO,Hologic Obtains European CE Mark for Use of Saliva Samples with COVID-19 Test,https://www.nasdaq.com/press-release/hologic-obtains-european-ce-mark-for-use-of-saliva-samples-with-covid-19-test-2021-07
HOOK,"JUN 10, 2021",HOOKIPA Pharma to Participate in Upcoming Investor Conferences in June,https://www.nasdaq.com/press-release/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-june-2021-06-10
HOTH,1 DAY AGO,Hoth Therapeutics Announces Positive Confirmatory Results from In Vivo Model of HT-003 Assets as Potential Treatment Against Acne,https://www.nasdaq.com/press-release/hoth-therapeutics-announces-positive-confirmatory-results-from-in-vivo-model-of-ht
HRC,2 DAYS AGO,Hillrom Comments On Delaware Court Of Chancery Ruling,https://www.nasdaq.com/press-release/hillrom-comments-on-delaware-court-of-chancery-ruling-2021-07-12
HRMY,"JUN 29, 2021",Harmony Biosciences Initiates A Phase 2 Clinical Trial In Myotonic Dystrophy,https://www.nasdaq.com/press-release/harmony-biosciences-initiates-a-phase-2-clinical-trial-in-myotonic-dystrophy-2021-06
HROW,"JUN 17, 2021",Harrow Health Announces Closing of $20 Million Aggregate Principal Amount Offering of 8.625% Senior Notes Due 2026,https://www.nasdaq.com/press-release/harrow-health-announces-closing-of-%2420-million-aggregate-principal-amount-offering-of
HRTX,"JUL 6, 2021",Heron Therapeutics Announces 340B Prime Vendor Contract with Apexus for ZYNRELEF™,https://www.nasdaq.com/press-release/heron-therapeutics-announces-340b-prime-vendor-contract-with-apexus-for-zynreleftm
HSDT,1 DAY AGO,"Helius Medical Technologies, Inc. to Present at Two Upcoming Investor Conferences in July",https://www.nasdaq.com/press-release/helius-medical-technologies-inc.-to-present-at-two-upcoming-investor-conferences-in
HSIC,"JUN 21, 2021",Henry Schein Opens Customer Assistance Hotline in Response to Tropical Storm Claudette,https://www.nasdaq.com/press-release/henry-schein-opens-customer-assistance-hotline-in-response-to-tropical-storm
HSKA,1 DAY AGO,"Heska Second Quarter 2021 Financial Results and Earnings Call Scheduled for August 3, 2021",https://www.nasdaq.com/press-release/heska-second-quarter-2021-financial-results-and-earnings-call-scheduled-for-august-3
HSTO,"JUN 30, 2021",Histogen Announces Initiation of HST 003 Phase 1/2 Trial for Knee Cartilage Regeneration,https://www.nasdaq.com/press-release/histogen-announces-initiation-of-hst-003-phase-1-2-trial-for-knee-cartilage
HTBX,"JUN 28, 2021",Heat Biologics Joins Russell Microcap® Index,https://www.nasdaq.com/press-release/heat-biologics-joins-russell-microcapr-index-2021-06-28
HUGE,"JUN 3, 2021",FSD Pharma Inc. Appoints a New Independent Director,https://www.nasdaq.com/press-release/fsd-pharma-inc.-appoints-a-new-independent-director-2021-06-03
HUM,2 DAYS AGO,Louisville Nonprofits Receive $1.7 Million through The Humana Foundation’s Community Partners Program,https://www.nasdaq.com/press-release/louisville-nonprofits-receive-%241.7-million-through-the-humana-foundations-community
HZNP,6 DAYS AGO,"Horizon Therapeutics plc to Release Second-Quarter 2021 Financial Results and Host Webcast on Aug. 4, 2021",https://www.nasdaq.com/press-release/horizon-therapeutics-plc-to-release-second-quarter-2021-financial-results-and-host
IART,6 DAYS AGO,"Integra LifeSciences to Host Second Quarter 2021 Financial Results Conference Call on July 28, 2021",https://www.nasdaq.com/press-release/integra-lifesciences-to-host-second-quarter-2021-financial-results-conference-call-on
IBIO,5 DAYS AGO,iBio Establishes Oncology Drug Discovery Pipeline with Three New Antibody Programs,https://www.nasdaq.com/press-release/ibio-establishes-oncology-drug-discovery-pipeline-with-three-new-antibody-programs
ICAD,"JUN 14, 2021",iCAD’s ProFound AI for Digital Breast Tomosynthesis Version 3.0 Receives CE Mark Approval,https://www.nasdaq.com/press-release/icads-profound-ai-for-digital-breast-tomosynthesis-version-3.0-receives-ce-mark
ICCC,"JUL 7, 2021","ImmuCell Announces Strong Preliminary, Unaudited Sales Results for Second Quarter of 2021",https://www.nasdaq.com/press-release/immucell-announces-strong-preliminary-unaudited-sales-results-for-second-quarter-of
ICLR,"JUL 1, 2021",ICON acquisition creates world-leading healthcare intelligence and clinical research organisation,https://www.nasdaq.com/press-release/icon-acquisition-creates-world-leading-healthcare-intelligence-and-clinical-research
ICPT,"JUN 21, 2021",Intercept to Present New NASH and PBC Data at the Digital International Liver Congress™ 2021,https://www.nasdaq.com/press-release/intercept-to-present-new-nash-and-pbc-data-at-the-digital-international-liver-0
ICUI,"MAY 6, 2021","ICU Medical, Inc. Announces First Quarter 2021 Results",https://www.nasdaq.com/press-release/icu-medical-inc.-announces-first-quarter-2021-results-2021-05-06
IDRA,"MAY 18, 2021",Idera Pharmaceuticals Announces Corporate Updates,https://www.nasdaq.com/press-release/idera-pharmaceuticals-announces-corporate-updates-2021-05-18
IDXG,"MAY 17, 2021",Interpace Pharma Solutions Announces New Capability in Spatial Biology/Precision Oncology Services,https://www.nasdaq.com/press-release/interpace-pharma-solutions-announces-new-capability-in-spatial-biology-precision
IDXX,"JUN 30, 2021",IDEXX Laboratories to Release 2021 Second Quarter Financial Results,https://www.nasdaq.com/press-release/idexx-laboratories-to-release-2021-second-quarter-financial-results-2021-06-30
IDYA,1 DAY AGO,IDEAYA Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares,https://www.nasdaq.com/press-release/ideaya-announces-closing-of-public-offering-of-common-stock-and-full-exercise-of
IGMS,"JUN 3, 2021","IGM Biosciences Announces Expansion of IgM Platform into Infectious Diseases, Publication of Preclinical Data in Nature Demonstrating Engineered IgM Antibody Antiviral Activity for the Treatment and Prevention of COVID-19",https://www.nasdaq.com/press-release/igm-biosciences-announces-expansion-of-igm-platform-into-infectious-diseases
IKT,"JUN 18, 2021",Inhibikase Therapeutics Announces Closing of Follow-On Offering of Common Stock,https://www.nasdaq.com/press-release/inhibikase-therapeutics-announces-closing-of-follow-on-offering-of-common-stock-2021
IMAB,5 DAYS AGO,"ABL Bio Announces Publication of Preclinical Data Demonstrating Safety and Efficacy of ABL503/TJ-L14B, a Novel Anti-PD-L1 X 4-1BB Bispecific Antibody",https://www.nasdaq.com/press-release/abl-bio-announces-publication-of-preclinical-data-demonstrating-safety-and-efficacy
IMAC,1 DAY AGO,"IMAC Holdings, Inc. Announces Initiation of Second Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease ",https://www.nasdaq.com/press-release/imac-holdings-inc.-announces-initiation-of-second-cohort-of-its-phase-1-clinical
IMACW,,,
IMCR,"JUN 4, 2021",Immunocore presents clinical data further characterizing the overall survival benefit of tebentafusp in metastatic uveal melanoma at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting,https://www.nasdaq.com/press-release/immunocore-presents-clinical-data-further-characterizing-the-overall-survival-benefit
IMGN,"JUL 1, 2021",ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/immunogen-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-2021-07-01
IMMP,1 DAY AGO,Immutep Quarterly Activities Report,https://www.nasdaq.com/press-release/immutep-quarterly-activities-report-2021-07-13
IMNM,"JUL 6, 2021",Immunome to Present at the Ladenburg Thalmann 2021 Healthcare Conference,https://www.nasdaq.com/press-release/immunome-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference-2021-07-06
IMRA,14 HOURS AGO,Imara Announces Pricing of Public Offering,https://www.nasdaq.com/press-release/imara-announces-pricing-of-public-offering-2021-07-13
IMRN,"MAY 13, 2021",IMM124E – May offer a New modality for Inhibition of SARS-CoV-2,https://www.nasdaq.com/press-release/imm124e-may-offer-a-new-modality-for-inhibition-of-sars-cov-2-2021-05-13
IMRNW,,,
IMTX,"JUL 7, 2021",BioCopy AG and Immatics enter into a collaboration to characterize T cell receptor - peptide-HLA interactions,https://www.nasdaq.com/press-release/biocopy-ag-and-immatics-enter-into-a-collaboration-to-characterize-t-cell-receptor
IMTXW,"JUL 2, 2020",Immatics Announces Completion of Business Combination and Listing on NASDAQ,https://www.nasdaq.com/press-release/immatics-announces-completion-of-business-combination-and-listing-on-nasdaq-2020-07-0
IMUX,2 DAYS AGO,"Immunic, Inc. to Host Virtual R&D Day Today to Provide an Update on the Preclinical and Clinical Development of IMU-935, a Potentially Best-in-Class RORγt Inverse Agonist",https://www.nasdaq.com/press-release/immunic-inc.-to-host-virtual-rd-day-today-to-provide-an-update-on-the-preclinical-and
IMV,"JUN 18, 2021",IMV Announces Annual and Special Meeting of Shareholders Voting Results,https://www.nasdaq.com/press-release/imv-announces-annual-and-special-meeting-of-shareholders-voting-results-2021-06-18
IMVT,"JUN 1, 2021","Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter and Fiscal Year Ended March 31, 2021",https://www.nasdaq.com/press-release/immunovant-provides-corporate-updates-and-reports-financial-results-for-the-quarter
INBX,"JUN 21, 2021","Inhibrx Initiates a Potential Registration-Enabling Phase 2 Study of INBRX-109 in Conventional Chondrosarcoma Patients, Updates Data for Ongoing Phase 1 Study and Announces Amended Loan Agreement with Oxford",https://www.nasdaq.com/press-release/inhibrx-initiates-a-potential-registration-enabling-phase-2-study-of-inbrx-109-in
INCY,"JUN 25, 2021",Incyte and MorphoSys Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma,https://www.nasdaq.com/press-release/incyte-and-morphosys-announce-positive-chmp-opinion-for-tafasitamab-in-combination
INFI,"JUN 14, 2021",Infinity to Present at The Keystone Symposia Precision Oncology Meeting,https://www.nasdaq.com/press-release/infinity-to-present-at-the-keystone-symposia-precision-oncology-meeting-2021-06-14
INFU,"JUN 30, 2021",InfuSystem Announces $20 Million Stock Repurchase Program,https://www.nasdaq.com/press-release/infusystem-announces-%2420-million-stock-repurchase-program-2021-06-30
INGN,7 HOURS AGO,"Inogen to Announce Second Quarter 2021 Financial Results on August 4, 2021",https://www.nasdaq.com/press-release/inogen-to-announce-second-quarter-2021-financial-results-on-august-4-2021-2021-07-14
INM,"JUN 29, 2021",InMed Pharmaceuticals Announces $12 Million Private Placement Priced At-the-Market under Nasdaq Rules,https://www.nasdaq.com/press-release/inmed-pharmaceuticals-announces-%2412-million-private-placement-priced-at-the-market
INMB,4 HOURS AGO,"INMUNE BIO, INC. ANNOUNCES $40 MILLION REGISTERED DIRECT OFFERING",https://www.nasdaq.com/press-release/inmune-bio-inc.-announces-%2440-million-registered-direct-offering-2021-07-14
INMD,2 DAYS AGO,"InMode Expects Record Second Quarter 2021 Revenue Between $86.5M-$87.0M, Increasing Full Year 2021 Revenue Guidance to $305-$315M",https://www.nasdaq.com/press-release/inmode-expects-record-second-quarter-2021-revenue-between-%2486.5m-%2487.0m-increasing
INO,"JUN 8, 2021","INOVIO Expands Partnership with Advaccine to Conduct Global Phase 3 Efficacy Trial of COVID-19 DNA Vaccine Candidate, INO-4800",https://www.nasdaq.com/press-release/inovio-expands-partnership-with-advaccine-to-conduct-global-phase-3-efficacy-trial-of
INSM,6 DAYS AGO,Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/insmed-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2021-07-08
INSP,"JUL 6, 2021","Inspire Medical Systems, Inc. to Report Second Quarter 2021 Financial Results on August 3, 2021",https://www.nasdaq.com/press-release/inspire-medical-systems-inc.-to-report-second-quarter-2021-financial-results-on
INVA,"MAY 20, 2021",Innoviva Announces Strategic Repurchase of GSK’s Equity Stake,https://www.nasdaq.com/press-release/innoviva-announces-strategic-repurchase-of-gsks-equity-stake-2021-05-20
INVO,4 HOURS AGO,"INVO Bioscience Appoints Barbara Levy as Senior VP, Global Clinical Integration",https://www.nasdaq.com/press-release/invo-bioscience-appoints-barbara-levy-as-senior-vp-global-clinical-integration-2021
INZY,1 DAY AGO,"Inozyme Pharma Announces Appointment of Gayle Gironda as Senior Vice President, Human Resources",https://www.nasdaq.com/press-release/inozyme-pharma-announces-appointment-of-gayle-gironda-as-senior-vice-president-human
IONS,1 DAY AGO,Ionis enters exclusive licensing agreement with Bicycle Therapeutics aimed at further advancing LICA technology,https://www.nasdaq.com/press-release/ionis-enters-exclusive-licensing-agreement-with-bicycle-therapeutics-aimed-at-further
IOVA,"JUN 29, 2021","Iovance Biotherapeutics to Host Conference Call and Webcast to Discuss Clinical Data for LN-145 in Non-Small Cell Lung Cancer on June 29, 2021 at 4:30pm ET",https://www.nasdaq.com/press-release/iovance-biotherapeutics-to-host-conference-call-and-webcast-to-discuss-clinical-data
IPA,"JUN 22, 2021",Eurofins Discovery and ImmunoPrecise Announce Collaboration to Expand their Antibody Discovery Platform,https://www.nasdaq.com/press-release/eurofins-discovery-and-immunoprecise-announce-collaboration-to-expand-their-antibody
IPHA,2 DAYS AGO,"Number of Shares and Voting Rights of Innate Pharma as of July 1, 2021",https://www.nasdaq.com/press-release/number-of-shares-and-voting-rights-of-innate-pharma-as-of-july-1-2021-2021-07-12
IQV,20 HOURS AGO,"IQVIA to Announce Second-Quarter 2021 Results on July 27, 2021",https://www.nasdaq.com/press-release/iqvia-to-announce-second-quarter-2021-results-on-july-27-2021-2021-07-13
IRIX,"MAY 11, 2021",Iridex Announces First Quarter 2021 Financial Results,https://www.nasdaq.com/press-release/iridex-announces-first-quarter-2021-financial-results-2021-05-11
IRMD,"JUL 7, 2021",IRADIMED CORPORATION to Hold 2021 Second Quarter Financial Results Conference Call on July 30th,https://www.nasdaq.com/press-release/iradimed-corporation-to-hold-2021-second-quarter-financial-results-conference-call-on
IRTC,7 HOURS AGO,iRhythm® Technologies Comments on the Centers for Medicare and Medicaid Services 2022 Proposed Medicare Physician Fee Schedule,https://www.nasdaq.com/press-release/irhythmr-technologies-comments-on-the-centers-for-medicare-and-medicaid-services-2022
IRWD,"JUN 16, 2021",Ironwood Pharmaceuticals Announces That The American Journal of Gastroenterology Publishes Full Results from Positive LINZESS® (linaclotide) Phase IIIb Trial in Adults with Irritable Bowel Syndrome with Constipation (IBS-C),https://www.nasdaq.com/press-release/ironwood-pharmaceuticals-announces-that-the-american-journal-of-gastroenterology
ISEE,1 DAY AGO,"IVERIC bio, Inc. Announces Pricing of $100 Million Public Offering of Common Stock",https://www.nasdaq.com/press-release/iveric-bio-inc.-announces-pricing-of-%24100-million-public-offering-of-common-stock
ISR,"MAY 13, 2021",Isoray Announces Third Quarter Fiscal 2021 Financial Results,https://www.nasdaq.com/press-release/isoray-announces-third-quarter-fiscal-2021-financial-results-2021-05-13
ISRG,"APR 26, 2021",Intuitive Appoints Dr. Monica P. Reed to its Board of Directors,https://www.nasdaq.com/press-release/intuitive-appoints-dr.-monica-p.-reed-to-its-board-of-directors-2021-04-26
ITCI,"JUN 7, 2021","CAPLYTA® (lumateperone) Schizophrenia Safety and Tolerability Profile Published in the Journal, International Clinical Psychopharmacology",https://www.nasdaq.com/press-release/caplytar-lumateperone-schizophrenia-safety-and-tolerability-profile-published-in-the
ITMR,"JUN 30, 2021","Itamar Medical to Present at the Ladenburg Thalmann Annual Healthcare Conference on Wednesday, July 14, 2021",https://www.nasdaq.com/press-release/itamar-medical-to-present-at-the-ladenburg-thalmann-annual-healthcare-conference-on
ITOS,6 DAYS AGO,iTeos Therapeutics to Present at William Blair Biotech Focus Conference 2021,https://www.nasdaq.com/press-release/iteos-therapeutics-to-present-at-william-blair-biotech-focus-conference-2021-2021-07
ITRM,"JUL 1, 2021",Iterum Therapeutics Provides Regulatory Update,https://www.nasdaq.com/press-release/iterum-therapeutics-provides-regulatory-update-2021-07-01
IVA,,,
IVC,"JUN 28, 2021",Invacare Corporation to Participate in the 21st Annual CJS Securities New Ideas Summer Conference,https://www.nasdaq.com/press-release/invacare-corporation-to-participate-in-the-21st-annual-cjs-securities-new-ideas
JAGX,4 HOURS AGO,Jaguar Health Announces Completion of Investigator-Initiated Phase 2 HALT-D Study Evaluating Mytesi (Crofelemer) for Prevention and Prophylaxis of Diarrhea in Breast Cancer Patients,https://www.nasdaq.com/press-release/jaguar-health-announces-completion-of-investigator-initiated-phase-2-halt-d-study
JAZZ,20 HOURS AGO,"Jazz Pharmaceuticals Announces Rylaze™ (asparaginase erwinia chrysanthemi (recombinant)-rywn) Investor Webcast on July 20, 2021",https://www.nasdaq.com/press-release/jazz-pharmaceuticals-announces-rylazetm-asparaginase-erwinia-chrysanthemi-recombinant
JNCE,"JUL 7, 2021",Jounce Therapeutics to Participate in William Blair’s Biotech Focus Conference,https://www.nasdaq.com/press-release/jounce-therapeutics-to-participate-in-william-blairs-biotech-focus-conference-2021-07
JNJ,"JUL 1, 2021",Positive New Data for Johnson & Johnson Single-Shot COVID-19 Vaccine on Activity Against Delta Variant and Long-lasting Durability of Response,https://www.nasdaq.com/press-release/positive-new-data-for-johnson-johnson-single-shot-covid-19-vaccine-on-activity
JWS,"JUN 3, 2021",Cano Health Closes Business Combination with Jaws Acquisition Corp. and Will Begin Trading on the New York Stock Exchange,https://www.nasdaq.com/press-release/cano-health-closes-business-combination-with-jaws-acquisition-corp.-and-will-begin
KALA,"JUN 18, 2021",Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/kala-pharmaceuticals-reports-inducement-grant-under-nasdaq-listing-rule-5635c4-2021-3
KALV,1 DAY AGO,KalVista Pharmaceuticals Provides Operational Update and Fiscal Year Financial Results,https://www.nasdaq.com/press-release/kalvista-pharmaceuticals-provides-operational-update-and-fiscal-year-financial-0
KDMN,"MAY 25, 2021",Kadmon to Present at Upcoming Investor Conferences,https://www.nasdaq.com/press-release/kadmon-to-present-at-upcoming-investor-conferences-2021-05-25
KDNY,1 DAY AGO,Chinook Therapeutics to Present at the William Blair Biotech Focus Conference 2021,https://www.nasdaq.com/press-release/chinook-therapeutics-to-present-at-the-william-blair-biotech-focus-conference-2021
KIDS,"JUN 10, 2021",OrthoPediatrics Corp. Announces Launch of Next Generation Cannulated Screw System,https://www.nasdaq.com/press-release/orthopediatrics-corp.-announces-launch-of-next-generation-cannulated-screw-system
KIN,"JUN 16, 2021",Elanco Announces Agreement to Acquire Kindred Biosciences,https://www.nasdaq.com/press-release/elanco-announces-agreement-to-acquire-kindred-biosciences-2021-06-16
KLDO,"JUN 10, 2021",Kaleido Biosciences to Participate in the JMP Securities Life Sciences Conference,https://www.nasdaq.com/press-release/kaleido-biosciences-to-participate-in-the-jmp-securities-life-sciences-conference
KMDA,"JUN 2, 2021","Kedrion and Kamada Announce FDA Approval of KEDRAB® Label Update, Confirming Safety and Effectiveness in Children",https://www.nasdaq.com/press-release/kedrion-and-kamada-announce-fda-approval-of-kedrabr-label-update-confirming-safety
KMPH,"JUN 18, 2021",KemPharm Announces Exercise of Existing Warrants and Issuance of Warrants in Private Placement,https://www.nasdaq.com/press-release/kempharm-announces-exercise-of-existing-warrants-and-issuance-of-warrants-in-private
KNSA,"JUN 8, 2021",Kiniksa Announces Issuance of U.S. Patent for Treatment of Recurrent Pericarditis,https://www.nasdaq.com/press-release/kiniksa-announces-issuance-of-u.s.-patent-for-treatment-of-recurrent-pericarditis
KNTE,6 DAYS AGO,Kinnate Biopharma Inc. to Participate in the William Blair Biotech Focus Conference 2021,https://www.nasdaq.com/press-release/kinnate-biopharma-inc.-to-participate-in-the-william-blair-biotech-focus-conference
KOD,"MAY 20, 2021",Kodiak Sciences to Present at Upcoming Conferences,https://www.nasdaq.com/press-release/kodiak-sciences-to-present-at-upcoming-conferences-2021-05-20
KPTI,"JUL 1, 2021",Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/karyopharm-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-21
KRBP,"JUL 2, 2021","Kiromic BioPharma, Inc. Announces Closing of Public Offering",https://www.nasdaq.com/press-release/kiromic-biopharma-inc.-announces-closing-of-public-offering-2021-07-02
KRMD,"MAY 12, 2021",KORU Medical Systems Announces 2021 First Quarter Financial Results,https://www.nasdaq.com/press-release/koru-medical-systems-announces-2021-first-quarter-financial-results-2021-05-12
KRON,"MAY 26, 2021",Kronos Bio Announces Participation in Upcoming Investor Conferences,https://www.nasdaq.com/press-release/kronos-bio-announces-participation-in-upcoming-investor-conferences-2021-05-26
KROS,"JUN 22, 2021",Keros Therapeutics Announces Preliminary Results from its Phase 2 Clinical Trial Evaluating KER-050 in Patients with Myelodysplastic Syndromes,https://www.nasdaq.com/press-release/keros-therapeutics-announces-preliminary-results-from-its-phase-2-clinical-trial
KRTX,"JUN 23, 2021",PureTech Founded Entity Karuna Therapeutics Announces Results from Phase 1b Trial Evaluating the Safety and Tolerability of KarXT in Healthy Elderly Volunteers,https://www.nasdaq.com/press-release/puretech-founded-entity-karuna-therapeutics-announces-results-from-phase-1b-trial
KRYS,"JUL 1, 2021",Krystal Biotech Provides Update on the Clinical Trial Evaluating Topical KB105 for the Treatment of TGM-1 Associated Ichthyosis,https://www.nasdaq.com/press-release/krystal-biotech-provides-update-on-the-clinical-trial-evaluating-topical-kb105-for
KTRA,"JUL 1, 2021",Kintara Reports Topline Results From Phase 2 Clinical Trial of VAL-083 for Recurrent GBM,https://www.nasdaq.com/press-release/kintara-reports-topline-results-from-phase-2-clinical-trial-of-val-083-for-recurrent
KURA,"JUL 6, 2021",Kura Oncology Announces Clinical Collaboration to Evaluate Tipifarnib in Combination with Alpelisib in Head and Neck Squamous Cell Carcinoma,https://www.nasdaq.com/press-release/kura-oncology-announces-clinical-collaboration-to-evaluate-tipifarnib-in-combination
KYMR,2 DAYS AGO,Kymera Therapeutics Presents New Preclinical Data on STAT3 Degraders Showing Antitumor Activity in STAT3 Mutant and Wild-Type Peripheral T-Cell Lymphoma at 13th Annual T-Cell Lymphoma Forum,https://www.nasdaq.com/press-release/kymera-therapeutics-presents-new-preclinical-data-on-stat3-degraders-showing
KZIA,"JUN 30, 2021",Kazia Provides Progress Update on Paxalisib and EVT801 Clinical Programs,https://www.nasdaq.com/press-release/kazia-provides-progress-update-on-paxalisib-and-evt801-clinical-programs-2021-06-30
KZR,6 DAYS AGO,Kezar Life Sciences to Participate in the William Blair Biotech Focus Conference 2021,https://www.nasdaq.com/press-release/kezar-life-sciences-to-participate-in-the-william-blair-biotech-focus-conference-2021
LABP,"JUN 14, 2021",Landos Biopharma to Present at the Raymond James Virtual Human Health Innovation Conference,https://www.nasdaq.com/press-release/landos-biopharma-to-present-at-the-raymond-james-virtual-human-health-innovation
LAKE,"JUL 7, 2021",Lakeland Industries Announces New $5.0 Million Expansion to Stock Repurchase Program,https://www.nasdaq.com/press-release/lakeland-industries-announces-new-%245.0-million-expansion-to-stock-repurchase-program
LCI,2 DAYS AGO,Lannett Launches Fluvastatin Sodium ER Tablets,https://www.nasdaq.com/press-release/lannett-launches-fluvastatin-sodium-er-tablets-2021-07-12
LCTX,1 DAY AGO,"OpRegen® Data Update to Be Featured at 54th Annual Retina Society Meeting in Podium Presentation by Christopher D. Riemann, M.D.",https://www.nasdaq.com/press-release/opregenr-data-update-to-be-featured-at-54th-annual-retina-society-meeting-in-podium
LEGN,"JUN 22, 2021",Legend Biotech Announces Advancement of Global Manufacturing Infrastructure,https://www.nasdaq.com/press-release/legend-biotech-announces-advancement-of-global-manufacturing-infrastructure-2021-06
LEXX,1 DAY AGO,Lexaria Receives Patent Protection in Japan,https://www.nasdaq.com/press-release/lexaria-receives-patent-protection-in-japan-2021-07-13
LEXXW,,,
LFVN,"APR 29, 2021",LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2021,https://www.nasdaq.com/press-release/lifevantage-announces-financial-results-for-the-third-quarter-of-fiscal-2021-2021-04
LGND,"JUN 2, 2021",GenScript Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensing Agreement,https://www.nasdaq.com/press-release/genscript-biotech-and-ligand-pharmaceuticals-enter-into-global-omniabr-licensing
LGVW,"FEB 16, 2021","Butterfly Network, a Global Leader in Democratizing Medical Imaging, Closes Business Combination and Will Begin Trading on the New York Stock Exchange",https://www.nasdaq.com/press-release/butterfly-network-a-global-leader-in-democratizing-medical-imaging-closes-business
LH,"JUL 2, 2021","Labcorp to Announce Second Quarter Financial Results on July 29, 2021",https://www.nasdaq.com/press-release/labcorp-to-announce-second-quarter-financial-results-on-july-29-2021-2021-07-02
LHCG,"JUL 7, 2021",LHC Group and SCP Health Partner to Provide Advanced Clinical Care in the Home,https://www.nasdaq.com/press-release/lhc-group-and-scp-health-partner-to-provide-advanced-clinical-care-in-the-home-2021
LHDX,"MAY 28, 2021",LUCIRA™ HEALTH Hires Chief Revenue Officer Kevin Collins,https://www.nasdaq.com/press-release/luciratm-health-hires-chief-revenue-officer-kevin-collins-2021-05-28
LIFE,6 DAYS AGO,aTyr Pharma Announces Last Patient Visit in Phase 1b/2a Clinical Trial of ATYR1923 in Patients with Pulmonary Sarcoidosis,https://www.nasdaq.com/press-release/atyr-pharma-announces-last-patient-visit-in-phase-1b-2a-clinical-trial-of-atyr1923-in
LIVN,"JUN 28, 2021",LivaNova to Host Conference Call for Second Quarter 2021 Results,https://www.nasdaq.com/press-release/livanova-to-host-conference-call-for-second-quarter-2021-results-2021-06-28
LIXT,1 DAY AGO,Lixte Biotechnology Comments on Outside Research Citing LB-100’s PP2A Inhibition as a Potential Therapeutic Strategy for Triple-Negative Breast Cancer,https://www.nasdaq.com/press-release/lixte-biotechnology-comments-on-outside-research-citing-lb-100s-pp2a-inhibition-as-a
LIXTW,,,
LJPC,"MAY 7, 2021","La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2021 and Highlights Corporate Progress",https://www.nasdaq.com/press-release/la-jolla-pharmaceutical-company-announces-financial-results-for-the-three-months-0
LLY,6 HOURS AGO,Lilly Announces Acquisition of Protomer Technologies,https://www.nasdaq.com/press-release/lilly-announces-acquisition-of-protomer-technologies-2021-07-14
LMAT,14 HOURS AGO,LeMaitre Announces Pricing of Public Offering of Common Stock,https://www.nasdaq.com/press-release/lemaitre-announces-pricing-of-public-offering-of-common-stock-2021-07-13
LMNL,4 DAYS AGO,Liminal BioSciences Announces Closing of Sale of Plasma-Derived Therapeutics Manufacturing Facility,https://www.nasdaq.com/press-release/liminal-biosciences-announces-closing-of-sale-of-plasma-derived-therapeutics
LMNX,1 DAY AGO,Middlesex Water Set to Join S&P SmallCap 600,https://www.nasdaq.com/press-release/middlesex-water-set-to-join-sp-smallcap-600-2021-07-12
LNSR,"MAY 24, 2021","LENSAR to Present at the Oppenheimer MedTech, Tools, & Diagnostics Summit",https://www.nasdaq.com/press-release/lensar-to-present-at-the-oppenheimer-medtech-tools-diagnostics-summit-2021-05-24
LNTH,5 HOURS AGO,"Lantheus Holdings to Host Second Quarter 2021 Earnings Conference Call and Webcast on July 28, 2021 at 8:00 a.m. Eastern Time",https://www.nasdaq.com/press-release/lantheus-holdings-to-host-second-quarter-2021-earnings-conference-call-and-webcast-on
LOGC,6 DAYS AGO,LogicBio Therapeutics to Participate in William Blair Biotech Focus Conference 2021,https://www.nasdaq.com/press-release/logicbio-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021
LPCN,"JUL 6, 2021",Lipocine To Present At The Ladenburg Thalmann Healthcare Conference,https://www.nasdaq.com/press-release/lipocine-to-present-at-the-ladenburg-thalmann-healthcare-conference-2021-07-06
LPTX,"JUL 7, 2021",Leap Therapeutics to Present at Ladenburg Thalmann 2021 Virtual Healthcare Conference,https://www.nasdaq.com/press-release/leap-therapeutics-to-present-at-ladenburg-thalmann-2021-virtual-healthcare-conference
LQDA,"JUN 7, 2021",United Therapeutics Pursues New Claims For Trade Secret Misappropriation Against Liquidia,https://www.nasdaq.com/press-release/united-therapeutics-pursues-new-claims-for-trade-secret-misappropriation-against
LRMR,5 DAYS AGO,Larimar Therapeutics to Present at the William Blair Biotech Focus Conference 2021,https://www.nasdaq.com/press-release/larimar-therapeutics-to-present-at-the-william-blair-biotech-focus-conference-2021
LTRN,,,
LUMO,"JUN 28, 2021",Lumos Pharma Announces OraGrowtH212 Trial of LUM-201 in PGHD Is Open for Enrollment,https://www.nasdaq.com/press-release/lumos-pharma-announces-oragrowth212-trial-of-lum-201-in-pghd-is-open-for-enrollment
LUNA,"JUN 21, 2021",Luna Innovations Adds More Bench Strength,https://www.nasdaq.com/press-release/luna-innovations-adds-more-bench-strength-2021-06-21
LUNG,"MAY 17, 2021",Zephyr® Valve Treatment Provides Long-Term Quality of Life and Lung Function Improvements for Patients with Severe COPD/Emphysema,https://www.nasdaq.com/press-release/zephyrr-valve-treatment-provides-long-term-quality-of-life-and-lung-function
LXRX,"JUN 25, 2021",Lexicon Pharmaceuticals Announces Symposium at the American Diabetes Association 81st Scientific Sessions,https://www.nasdaq.com/press-release/lexicon-pharmaceuticals-announces-symposium-at-the-american-diabetes-association-81st
LYRA,2 DAYS AGO,Lyra Therapeutics to Present at Upcoming Virtual Healthcare Conference,https://www.nasdaq.com/press-release/lyra-therapeutics-to-present-at-upcoming-virtual-healthcare-conference-2021-07-12
MACK,"MAR 10, 2021",Merrimack Reports Full Year 2020 Financial Results,https://www.nasdaq.com/press-release/merrimack-reports-full-year-2020-financial-results-2021-03-10
MASI,21 HOURS AGO,"Masimo to Report Second Quarter 2021 Financial Results after Market Close on Tuesday, July 27",https://www.nasdaq.com/press-release/masimo-to-report-second-quarter-2021-financial-results-after-market-close-on-tuesday
MBIO,"JUN 17, 2021",Mustang Bio Awarded Massachusetts Life Sciences Center Tax Incentive,https://www.nasdaq.com/press-release/mustang-bio-awarded-massachusetts-life-sciences-center-tax-incentive-2021-06-17
MBOT,"JUN 29, 2021",Microbot Medical Secures Patent Allowance in China; Third Global Jurisdiction in 2021 to Recognize Novelty of ‘One & Done’ Technology,https://www.nasdaq.com/press-release/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021
MBRX,1 DAY AGO,Moleculin Receives Approval to Extend Dose Escalation in Phase 1/2 European Clinical Trial Evaluating Annamycin for the Treatment of Acute Myeloid Leukemia,https://www.nasdaq.com/press-release/moleculin-receives-approval-to-extend-dose-escalation-in-phase-1-2-european-clinical
MCK,6 DAYS AGO,McKesson Corporation Announces Offer to Purchase up to $500 Million Aggregate Principal Amount of Debt,https://www.nasdaq.com/press-release/mckesson-corporation-announces-offer-to-purchase-up-to-%24500-million-aggregate
MCRB,"JUL 1, 2021","Seres Therapeutics, Nestlé Health Science Announce SER-109 Co-Commercialization License Agreement",https://www.nasdaq.com/press-release/seres-therapeutics-nestle-health-science-announce-ser-109-co-commercialization
MD,"MAY 7, 2021",Mednax Reports First Quarter Results,https://www.nasdaq.com/press-release/mednax-reports-first-quarter-results-2021-05-07
MDGL,19 HOURS AGO,Madrigal Pharmaceuticals Offers Patients Resmetirom in a Planned Open Label Active Treatment Extension of the Phase 3 MAESTRO-NAFLD-1 Clinical Study,https://www.nasdaq.com/press-release/madrigal-pharmaceuticals-offers-patients-resmetirom-in-a-planned-open-label-active
MDGS,"JUL 7, 2021",Medigus: Increases Holdings in Gix to Approximately 36.7% on a Fully Diluted Basis,https://www.nasdaq.com/press-release/medigus%3A-increases-holdings-in-gix-to-approximately-36.7-on-a-fully-diluted-basis
MDGSW,,,
MDNA,4 HOURS AGO,Medicenna’s IL-2 Superkine Platform Featured in Peer-Reviewed Publication Demonstrating its Superiority and Ability to Reprogram the Tumor Microenvironment in Pancreatic Cancer,https://www.nasdaq.com/press-release/medicennas-il-2-superkine-platform-featured-in-peer-reviewed-publication
MDT,6 DAYS AGO,A Culture of Belonging That Drives Innovation,https://www.nasdaq.com/press-release/a-culture-of-belonging-that-drives-innovation-2021-07-07
MDVL,"JUN 28, 2021",MedAvail Added to Russell 2000® and 3000® Indexes,https://www.nasdaq.com/press-release/medavail-added-to-russell-2000r-and-3000r-indexes-2021-06-28
MDXG,4 HOURS AGO,"NAACP to Present Historic Spingarn Medal to Regenerative Engineering Pioneer Cato T. Laurencin, M.D., Ph.D., at 112th Annual Convention",https://www.nasdaq.com/press-release/naacp-to-present-historic-spingarn-medal-to-regenerative-engineering-pioneer-cato-t.
MEDP,"MAY 27, 2021","Medpace Holdings, Inc. to Report Second Quarter 2021 Financial Results on July 26, 2021",https://www.nasdaq.com/press-release/medpace-holdings-inc.-to-report-second-quarter-2021-financial-results-on-july-26-2021
MEDS,1 DAY AGO,"TRxADE HEALTH to Report Second Quarter 2021 Financial Results on Monday, July 26th at 4:30 p.m. Eastern Time",https://www.nasdaq.com/press-release/trxade-health-to-report-second-quarter-2021-financial-results-on-monday-july-26th-at
MEIP,"JUL 7, 2021","MEI Pharma Appoints Tina C. Beamon, J.D., as Chief Compliance Officer",https://www.nasdaq.com/press-release/mei-pharma-appoints-tina-c.-beamon-j.d.-as-chief-compliance-officer-2021-07-07
MESO,"JUN 30, 2021",Mesoblast Provides Update on Program for Chronic Low Back Pain Due to Degenerative Disc Disease,https://www.nasdaq.com/press-release/mesoblast-provides-update-on-program-for-chronic-low-back-pain-due-to-degenerative
MGLN,6 DAYS AGO,Magellan Rx Management and Heuro Health Collaborate to Offer Live Behavioral Health Support and Wellness Coaching,https://www.nasdaq.com/press-release/magellan-rx-management-and-heuro-health-collaborate-to-offer-live-behavioral-health
MGNX,"JUN 16, 2021",MacroGenics and Zai Lab Enter Into Broad Strategic Collaboration to Develop and Commercialize Preclinical Bispecific Antibodies in Oncology,https://www.nasdaq.com/press-release/macrogenics-and-zai-lab-enter-into-broad-strategic-collaboration-to-develop-and
MGTA,"JUL 7, 2021",Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors,https://www.nasdaq.com/press-release/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4
MGTX,"MAY 11, 2021",MeiraGTx Reports First Quarter 2021 Financial and Operational Results,https://www.nasdaq.com/press-release/meiragtx-reports-first-quarter-2021-financial-and-operational-results-2021-05-11
MIRM,1 DAY AGO,Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/mirum-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-12
MIST,"MAY 26, 2021",Milestone Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference,https://www.nasdaq.com/press-release/milestone-pharmaceuticals-to-present-at-the-jefferies-virtual-healthcare-conference
MITO,6 DAYS AGO,Stealth BioTherapeutics Joins the Rare Disease Company Coalition,https://www.nasdaq.com/press-release/stealth-biotherapeutics-joins-the-rare-disease-company-coalition-2021-07-07
MLND,,,
MLSS,"JUL 7, 2021",Milestone Scientific Commences Sales of CompuFlo® / CathCheck™ Disposables within the UTMB Health Clear Lake Campus Hospital,https://www.nasdaq.com/press-release/milestone-scientific-commences-sales-of-compuflor-cathchecktm-disposables-within-the
MMM,1 DAY AGO,3M Announces Upcoming Investor Event,https://www.nasdaq.com/press-release/3m-announces-upcoming-investor-event-2021-07-13
MMSI,4 DAYS AGO,"Merit Medical Systems to Announce Second Quarter Results on July 29, 2021",https://www.nasdaq.com/press-release/merit-medical-systems-to-announce-second-quarter-results-on-july-29-2021-2021-07-09
MNKD,"JUN 28, 2021",Policy Change Allows Approval For Medicare Patients Living With Diabetes To Use Both Afrezza® And Continuous Glucose Monitoring Devices Beginning July 18,https://www.nasdaq.com/press-release/policy-change-allows-approval-for-medicare-patients-living-with-diabetes-to-use-both
MNOV,"JUL 6, 2021",MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Ophthalmic Disease,https://www.nasdaq.com/press-release/medicinova-receives-notice-of-allowance-for-new-patent-covering-mn-166-ibudilast-1
MNPR,2 DAYS AGO,"Monopar Appoints Octávio Costa, MD, as Chief Medical Officer",https://www.nasdaq.com/press-release/monopar-appoints-octavio-costa-md-as-chief-medical-officer-2021-07-12
MOH,"JUN 10, 2021",Molina Healthcare Announces Second Quarter 2021 Earnings Release and Conference Call Dates,https://www.nasdaq.com/press-release/molina-healthcare-announces-second-quarter-2021-earnings-release-and-conference-call
MOR,"JUL 1, 2021",MorphoSys Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Constellation Pharmaceuticals,https://www.nasdaq.com/press-release/morphosys-announces-expiration-of-the-hart-scott-rodino-waiting-period-for
MORF,5 DAYS AGO,"Morphic Reports New Data from Positive Phase 1 Study of MORF-057, Oral Integrin Inhibitor Candidate for IBD",https://www.nasdaq.com/press-release/morphic-reports-new-data-from-positive-phase-1-study-of-morf-057-oral-integrin
MOTS,"JUN 29, 2021",Motus GI to Present at the Ladenburg Thalmann Healthcare Conference,https://www.nasdaq.com/press-release/motus-gi-to-present-at-the-ladenburg-thalmann-healthcare-conference-2021-06-29
MREO,"JUN 2, 2021",Mereo BioPharma Announces Positive Desmosine Biomarker Data from an Interim Analysis of an Investigator Initiated Study of alvelestat in Bronchiolitis Obliterans Syndrome (BOS),https://www.nasdaq.com/press-release/mereo-biopharma-announces-positive-desmosine-biomarker-data-from-an-interim-analysis
MRK,2 DAYS AGO,Merck Announces Presentation of New Data from Broad HIV Program at IAS 2021,https://www.nasdaq.com/press-release/merck-announces-presentation-of-new-data-from-broad-hiv-program-at-ias-2021-2021-07
MRKR,"JUL 6, 2021",Marker Therapeutics Announces Completion of Safety Lead-In Portion of Phase 2 Study in Post-Transplant AML,https://www.nasdaq.com/press-release/marker-therapeutics-announces-completion-of-safety-lead-in-portion-of-phase-2-study
MRNA,2 DAYS AGO,Moderna Announces Supply Agreement with Argentina for 20 Million Doses of its COVID-19 Vaccine,https://www.nasdaq.com/press-release/moderna-announces-supply-agreement-with-argentina-for-20-million-doses-of-its-covid
MRNS,"JUL 1, 2021","Marinus Pharmaceuticals Further Strengthens Board of Directors with Appointment of Santiago Arroyo, M.D., Ph.D.",https://www.nasdaq.com/press-release/marinus-pharmaceuticals-further-strengthens-board-of-directors-with-appointment-of
MRSN,"MAY 26, 2021",Mersana Therapeutics to Present at Jefferies Virtual Healthcare Conference,https://www.nasdaq.com/press-release/mersana-therapeutics-to-present-at-jefferies-virtual-healthcare-conference-2021-05-26
MRTX,"JUN 24, 2021",Mirati Therapeutics' Adagrasib Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Patients with Advanced Non-Small Cell Lung Cancer Harboring the KRAS G12C Mutation,https://www.nasdaq.com/press-release/mirati-therapeutics-adagrasib-receives-breakthrough-therapy-designation-from-u.s.
MRUS,6 DAYS AGO,Merus to Participate in William Blair's Biotech Focus Conference 2021,https://www.nasdaq.com/press-release/merus-to-participate-in-william-blairs-biotech-focus-conference-2021-2021-07-07
MRVI,"MAY 26, 2021",Maravai LifeSciences Announces June 2021 Investor Conference Schedule,https://www.nasdaq.com/press-release/maravai-lifesciences-announces-june-2021-investor-conference-schedule-2021-05-26
MSA,"JUL 1, 2021","MSA Safety Completes Acquisition of Bacharach, Inc.; A Leader in Heating, Ventilation, Air Conditioning and Refrigeration (HVAC-R) Leak Detection",https://www.nasdaq.com/press-release/msa-safety-completes-acquisition-of-bacharach-inc.-a-leader-in-heating-ventilation
MTCR,"JUL 6, 2021",Metacrine to Present New Preclinical Data in Inflammatory Bowel Disease (IBD) at European Crohn’s and Colitis Organisation (ECCO) 2021 Virtual Congress ,https://www.nasdaq.com/press-release/metacrine-to-present-new-preclinical-data-in-inflammatory-bowel-disease-ibd-at
MTEM,5 DAYS AGO,"Molecular Templates, Inc. Announces Dosing of First Subject in Phase 1 Study of MT-6402 in PD-L1-Positive Solid Tumors",https://www.nasdaq.com/press-release/molecular-templates-inc.-announces-dosing-of-first-subject-in-phase-1-study-of-mt
MTNB,"MAY 20, 2021","Matinas BioPharma to Hold Virtual R&D Day on June 17, 2021",https://www.nasdaq.com/press-release/matinas-biopharma-to-hold-virtual-rd-day-on-june-17-2021-2021-05-20
MTP,2 DAYS AGO,Midatech Pharma PLC Announces Appointment of Chief Scientific Officer,https://www.nasdaq.com/press-release/midatech-pharma-plc-announces-appointment-of-chief-scientific-officer-2021-07-12
MYGN,"JUL 1, 2021",Myriad Genetics Completes Sale of Myriad RBM to IQVIA’s Q2 Solutions,https://www.nasdaq.com/press-release/myriad-genetics-completes-sale-of-myriad-rbm-to-iqvias-q2-solutions-2021-07-01
MYO,"JUN 28, 2021","Myomo, Inc. Stock Added to Russell Microcap® Index",https://www.nasdaq.com/press-release/myomo-inc.-stock-added-to-russell-microcapr-index-2021-06-28
MYOV,4 HOURS AGO,"Myovant Sciences to Host First Fiscal Quarter 2021 Earnings Conference Call at 8:30 a.m. Eastern Time on July 28, 2021",https://www.nasdaq.com/press-release/myovant-sciences-to-host-first-fiscal-quarter-2021-earnings-conference-call-at-8%3A30-a
NAOV,"JUN 3, 2021",NanoVibronix Provides Business Update,https://www.nasdaq.com/press-release/nanovibronix-provides-business-update-2021-06-03
NARI,"JUN 22, 2021",Inari Medical Appoints Outset Medical Executive Rebecca Chambers to Board of Directors,https://www.nasdaq.com/press-release/inari-medical-appoints-outset-medical-executive-rebecca-chambers-to-board-of
NATR,6 DAYS AGO,Nature's Sunshine Appoints Tariq H. Hassan to Board of Directors,https://www.nasdaq.com/press-release/natures-sunshine-appoints-tariq-h.-hassan-to-board-of-directors-2021-07-07
NAVB,"JUN 24, 2021","Macrophage Therapeutics, Inc. Wins Delaware Case Against Michael Goldberg for Breach of Fiduciary Duty",https://www.nasdaq.com/press-release/macrophage-therapeutics-inc.-wins-delaware-case-against-michael-goldberg-for-breach
NBIX,5 DAYS AGO,Neurocrine Biosciences to Participate at the William Blair Biotech Focus Conference,https://www.nasdaq.com/press-release/neurocrine-biosciences-to-participate-at-the-william-blair-biotech-focus-conference-0
NBRV,4 DAYS AGO,Nabriva Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/nabriva-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-5
NBSE,"JUN 8, 2021",NeuBase Therapeutics Demonstrates Functional Rescue in Myotonic Dystrophy Type 1 Model and Allele-Selective Inhibition of KRAS Mutations to Inhibit Tumor Growth,https://www.nasdaq.com/press-release/neubase-therapeutics-demonstrates-functional-rescue-in-myotonic-dystrophy-type-1
NBTX,"JUN 30, 2021",NANOBIOTIX Announces Initiation of New Clinical Study Evaluating NBTXR3 in Lung Cancer,https://www.nasdaq.com/press-release/nanobiotix-announces-initiation-of-new-clinical-study-evaluating-nbtxr3-in-lung
NBY,6 DAYS AGO,NovaBay Pharmaceuticals to Participate in Two July Investment Conferences,https://www.nasdaq.com/press-release/novabay-pharmaceuticals-to-participate-in-two-july-investment-conferences-2021-07-08
NCNA,"MAY 25, 2021",NuCana to Present at the Jefferies Virtual Healthcare Conference,https://www.nasdaq.com/press-release/nucana-to-present-at-the-jefferies-virtual-healthcare-conference-2021-05-25
NDRA,"JUL 7, 2021",ENDRA Life Sciences Strengthens TAEUS(R) System Intellectual Property Protection with the Issuance of Three U.S. Patents,https://www.nasdaq.com/press-release/endra-life-sciences-strengthens-taeusr-system-intellectual-property-protection-with
NDRAW,,,
NEO,"JUN 18, 2021",NeoGenomics Completes Inivata Acquisition - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology Platform,https://www.nasdaq.com/press-release/neogenomics-completes-inivata-acquisition-combining-best-in-class-liquid-biopsy
NEOG,"JUN 28, 2021","NEOGEN, Gencove Extend Animal Genomics Partnership",https://www.nasdaq.com/press-release/neogen-gencove-extend-animal-genomics-partnership-2021-06-28
NEOS,"MAR 12, 2021","Glass Lewis, a Leading Independent Proxy Advisory Firm, Recommends Neos Therapeutics Stockholders Vote “FOR” the Pending Merger With Aytu BioScience",https://www.nasdaq.com/press-release/glass-lewis-a-leading-independent-proxy-advisory-firm-recommends-neos-therapeutics
NEPH,2 DAYS AGO,"Nephros Announces Acquisition of GenArraytion, Inc.",https://www.nasdaq.com/press-release/nephros-announces-acquisition-of-genarraytion-inc.-2021-07-12
NEPT,21 HOURS AGO,"Neptune to Report Fiscal Fourth Quarter and Full Year 2021 - Financial Results on July 15, 2021",https://www.nasdaq.com/press-release/neptune-to-report-fiscal-fourth-quarter-and-full-year-2021-financial-results-on-july
NERV,"JUN 10, 2021",Minerva Neurosciences to Present at JMP Securities Life Sciences Conference,https://www.nasdaq.com/press-release/minerva-neurosciences-to-present-at-jmp-securities-life-sciences-conference-2021-06
NFH,"MAY 25, 2021",New Frontier Health Corporation Receives NYSE Notice Regarding Late Form 20-F Filing,https://www.nasdaq.com/press-release/new-frontier-health-corporation-receives-nyse-notice-regarding-late-form-20-f-filing
NGM,"JUL 7, 2021",NGM Bio Announces Initiation of Phase 1/2 Clinical Study of NGM707 for the Treatment of Advanced Solid Tumors,https://www.nasdaq.com/press-release/ngm-bio-announces-initiation-of-phase-1-2-clinical-study-of-ngm707-for-the-treatment
NHC,"JUN 18, 2021",NHC Acquires Outstanding Interest in Caris Healthcare,https://www.nasdaq.com/press-release/nhc-acquires-outstanding-interest-in-caris-healthcare-2021-06-18
NK,,,
NKTR,"JUN 7, 2021",Nektar Therapeutics to Participate in Fireside Chat at the Goldman Sachs 42nd Annual Global Healthcare Conference,https://www.nasdaq.com/press-release/nektar-therapeutics-to-participate-in-fireside-chat-at-the-goldman-sachs-42nd-annual
NKTX,6 HOURS AGO,Nkarta Establishes New Combined NK Cell Therapy Manufacturing Facility / Company Headquarters,https://www.nasdaq.com/press-release/nkarta-establishes-new-combined-nk-cell-therapy-manufacturing-facility-company
NLSP,5 DAYS AGO,NLS Pharmaceutics to Present at the Access to Giving Virtual Investor Conference on July 15th,https://www.nasdaq.com/press-release/nls-pharmaceutics-to-present-at-the-access-to-giving-virtual-investor-conference-on
NLSPW,,,
NLTX,"MAY 26, 2021",Neoleukin Therapeutics to Participate in Jefferies Virtual Healthcare Conference,https://www.nasdaq.com/press-release/neoleukin-therapeutics-to-participate-in-jefferies-virtual-healthcare-conference-2021
NMRD,2 DAYS AGO,"Nemaura Medical to Present at the Access to Giving Virtual Investor Conference on July 13, 2021",https://www.nasdaq.com/press-release/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on
NMTR,6 DAYS AGO,"9 Meters Biopharma, Inc. To Present at the William Blair Biotech Focus Conference",https://www.nasdaq.com/press-release/9-meters-biopharma-inc.-to-present-at-the-william-blair-biotech-focus-conference-2021
NNOX,2 DAYS AGO,"Nanox Signs MSaaS Agreement for the Deployment of 1,000 Nanox Systems in Nigeria",https://www.nasdaq.com/press-release/nanox-signs-msaas-agreement-for-the-deployment-of-1000-nanox-systems-in-nigeria-2021
NNVC,"MAY 17, 2021","NanoViricides Has Filed Quarterly Report for Period Ending March 31, 2021 - Has Sufficient Cash, Coronavirus Drug Candidate Moving Towards IND",https://www.nasdaq.com/press-release/nanoviricides-has-filed-quarterly-report-for-period-ending-march-31-2021-has
NOVN,"JUN 24, 2021",Novan Announces Inclusion in Russell Microcap® Index,https://www.nasdaq.com/press-release/novan-announces-inclusion-in-russell-microcapr-index-2021-06-24
NRBO,2 DAYS AGO,NeuroBo Pharmaceuticals' Shareholders Elect Hyung Heon Kim and Andrew I. Koven to NeuroBo's Board of Directors,https://www.nasdaq.com/press-release/neurobo-pharmaceuticals-shareholders-elect-hyung-heon-kim-and-andrew-i.-koven-to
NRC,5 DAYS AGO,NRC Health’s Chief Security and Privacy Officer Recognized as One of the Top 100 CISOs in the Country,https://www.nasdaq.com/press-release/nrc-healths-chief-security-and-privacy-officer-recognized-as-one-of-the-top-100-cisos
NRIX,21 HOURS AGO,Nurix Therapeutics Reports Second Quarter Fiscal 2021 Financial Results and Provides a Corporate Update,https://www.nasdaq.com/press-release/nurix-therapeutics-reports-second-quarter-fiscal-2021-financial-results-and-provides
NSPR,"JUN 2, 2021","InspireMD to Present at the LD Micro Virtual Invitational Conference on June 9, 2021",https://www.nasdaq.com/press-release/inspiremd-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-9-2021
NSTG,6 DAYS AGO,"NanoString to Release Second Quarter 2021 Operating Results and Host Conference Call on Wednesday, August 4, 2021",https://www.nasdaq.com/press-release/nanostring-to-release-second-quarter-2021-operating-results-and-host-conference-call
NTEC,"MAR 16, 2021",Intec Pharma Announces Filing of 2020 Annual Report on Form 10-K,https://www.nasdaq.com/press-release/intec-pharma-announces-filing-of-2020-annual-report-on-form-10-k-2021-03-16
NTLA,"JUL 2, 2021",Intellia Therapeutics Announces Closing of $690 Million Public Offering of Common Stock,https://www.nasdaq.com/press-release/intellia-therapeutics-announces-closing-of-%24690-million-public-offering-of-common
NTN,"MAR 23, 2021",NTN Buzztime Announces Proposed Reverse Stock Split Ratio and Anticipated Closing of Merger,https://www.nasdaq.com/press-release/ntn-buzztime-announces-proposed-reverse-stock-split-ratio-and-anticipated-closing-of
NTRA,"JUL 2, 2021",New Results From the Landmark Prospective CIRCULATE Trial Expand Clinical Utility of the Signatera® MRD Test in Colorectal Cancer,https://www.nasdaq.com/press-release/new-results-from-the-landmark-prospective-circulate-trial-expand-clinical-utility-of
NTUS,"JUL 1, 2021",Natus Medical to Hold 2021 Second Quarter Financial Results Conference Call on August 6th,https://www.nasdaq.com/press-release/natus-medical-to-hold-2021-second-quarter-financial-results-conference-call-on-august
NURO,"JUN 15, 2021",NeuroMetrix Reports that Quell® Technology is to be Evaluated for Neuromyelitis Optica Spectrum Disorder (NMOSD) in a Randomized Controlled Trial,https://www.nasdaq.com/press-release/neurometrix-reports-that-quellr-technology-is-to-be-evaluated-for-neuromyelitis
NUS,2 DAYS AGO,Grōv Technologies Signs Definitive Agreement with Superior Farms to Bring Sustainability to Ground-breaking U.S. Lamb Production,https://www.nasdaq.com/press-release/grov-technologies-signs-definitive-agreement-with-superior-farms-to-bring
NUVA,"JUN 30, 2021",NuVasive Receives Latest CE Mark Approval for Pulse Platform and Starts Global Clinical Evaluations,https://www.nasdaq.com/press-release/nuvasive-receives-latest-ce-mark-approval-for-pulse-platform-and-starts-global
NVAX,"JUL 6, 2021","Novavax to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights on August 5, 2021",https://www.nasdaq.com/press-release/novavax-to-host-conference-call-to-discuss-second-quarter-financial-results-and
NVCN,1 DAY AGO,Neovasc Announces New Appointments in Regulatory and Clinical Leadership,https://www.nasdaq.com/press-release/neovasc-announces-new-appointments-in-regulatory-and-clinical-leadership-2021-07-13
NVCR,6 DAYS AGO,Novocure to Report Second Quarter 2021 Financial Results,https://www.nasdaq.com/press-release/novocure-to-report-second-quarter-2021-financial-results-2021-07-08
NVIV,1 DAY AGO,InVivo Therapeutics Announces FDA Acceptance of Preclinical Module in Support of Company’s Complete HDE Submission,https://www.nasdaq.com/press-release/invivo-therapeutics-announces-fda-acceptance-of-preclinical-module-in-support-of
NVO,2 DAYS AGO,Prothena and Novo Nordisk Announce Acquisition Agreement for Prothena’s ATTR Amyloidosis Programme,https://www.nasdaq.com/press-release/prothena-and-novo-nordisk-announce-acquisition-agreement-for-prothenas-attr
NVRO,"JUL 7, 2021",Nevro to Report Second Quarter 2021 Financial Results,https://www.nasdaq.com/press-release/nevro-to-report-second-quarter-2021-financial-results-2021-07-07
NVS,"JUN 23, 2021",Novartis and Hewlett Packard Enterprise Join Forces to Advance Novartis Global Health Efforts,https://www.nasdaq.com/press-release/novartis-and-hewlett-packard-enterprise-join-forces-to-advance-novartis-global-health
NVST,1 DAY AGO,Envista Schedules Second Quarter 2021 Earnings Call,https://www.nasdaq.com/press-release/envista-schedules-second-quarter-2021-earnings-call-2021-07-12
NVTA,"JUN 22, 2021",OPKO Health Appoints Katherine Stueland as President and CEO of GeneDx,https://www.nasdaq.com/press-release/opko-health-appoints-katherine-stueland-as-president-and-ceo-of-genedx-2021-06-22
NXTC,"JUL 6, 2021",NextCure Initiates Phase 1/2 Clinical Trial of NC762 for Solid Tumors,https://www.nasdaq.com/press-release/nextcure-initiates-phase-1-2-clinical-trial-of-nc762-for-solid-tumors-2021-07-06
NYMX,"MAY 6, 2021",Nymox Announces Date for Fexapotide Filing,https://www.nasdaq.com/press-release/nymox-announces-date-for-fexapotide-filing-2021-05-06
OBLN,,,
OBSV,"JUL 2, 2021",ObsEva to Present Ebopiprant (OBE022) Data at the Society for Reproductive Investigation 68th Annual Meeting,https://www.nasdaq.com/press-release/obseva-to-present-ebopiprant-obe022-data-at-the-society-for-reproductive
OCDX,4 DAYS AGO,Ortho Clinical Diagnostics' Quantitative COVID-19 IgG Antibody Test First to Receive FDA Emergency Use Authorization,https://www.nasdaq.com/press-release/ortho-clinical-diagnostics-quantitative-covid-19-igg-antibody-test-first-to-receive
OCGN,"JUL 2, 2021","Ocugen’s COVID-19 Vaccine Co-Development Partner, Bharat Biotech, Shares Phase 3 Results Demonstrating 77.8% Protection against Overall Disease",https://www.nasdaq.com/press-release/ocugens-covid-19-vaccine-co-development-partner-bharat-biotech-shares-phase-3-results
OCUL,"JUN 29, 2021",Ocular Therapeutix™ and Mosaic Biosciences Enter into Strategic Discovery Collaboration Targeting the Treatment of Dry Age-Related Macular Degeneration,https://www.nasdaq.com/press-release/ocular-therapeutixtm-and-mosaic-biosciences-enter-into-strategic-discovery
OCUP,1 DAY AGO,Ocuphire Selected to Present at Multiple Ophthalmic Conferences in July,https://www.nasdaq.com/press-release/ocuphire-selected-to-present-at-multiple-ophthalmic-conferences-in-july-2021-07-13
OCX,"JUN 22, 2021",Oncocyte Celebrates Women Thoracic Surgeons in #ShesMySurgeon Campaign,https://www.nasdaq.com/press-release/oncocyte-celebrates-women-thoracic-surgeons-in-shesmysurgeon-campaign-2021-06-22
ODT,"MAY 14, 2021","Odonate Therapeutics Announces Financial Results for the Three Months Ended March 31, 2021",https://www.nasdaq.com/press-release/odonate-therapeutics-announces-financial-results-for-the-three-months-ended-march-0
OFIX,2 DAYS AGO,Publication of Data Shows High Fusion Rate in Patients Treated with PEMF Therapy Using the Orthofix SpinalStim Device,https://www.nasdaq.com/press-release/publication-of-data-shows-high-fusion-rate-in-patients-treated-with-pemf-therapy
OGEN,"JUL 1, 2021",Oragenics Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum,https://www.nasdaq.com/press-release/oragenics-announces-adjournment-of-annual-meeting-of-shareholders-due-to-lack-of
OGI,1 DAY AGO,Organigram Reports Third Quarter Fiscal 2021 Results,https://www.nasdaq.com/press-release/organigram-reports-third-quarter-fiscal-2021-results-2021-07-13
OLMA,"MAY 18, 2021",Olema Oncology to Participate at the Jefferies 2021 Virtual Healthcare Conference,https://www.nasdaq.com/press-release/olema-oncology-to-participate-at-the-jefferies-2021-virtual-healthcare-conference
OM,"JUL 1, 2021",Outset Medical Announces Departure of CFO and Appointment of Nabeel Ahmed as Interim CFO,https://www.nasdaq.com/press-release/outset-medical-announces-departure-of-cfo-and-appointment-of-nabeel-ahmed-as-interim
OMER,"JUN 14, 2021",Omeros’ Narsoplimab Pivotal Trial Data Shared in Oral Presentation at 2021 Annual Congress of the European Hematology Association,https://www.nasdaq.com/press-release/omeros-narsoplimab-pivotal-trial-data-shared-in-oral-presentation-at-2021-annual
OMI,"JUN 30, 2021",Owens & Minor Pursues Sustainable Solutions for Healthcare Through Electric Truck Pilot,https://www.nasdaq.com/press-release/owens-minor-pursues-sustainable-solutions-for-healthcare-through-electric-truck-pilot
ONCR,"JUN 17, 2021","Oncorus Appoints Eric Rubin, M.D. to its Board of Directors",https://www.nasdaq.com/press-release/oncorus-appoints-eric-rubin-m.d.-to-its-board-of-directors-2021-06-17
ONCS,"JUL 6, 2021","OncoSec Enters into a Collaboration Agreement with Merck for a Pivotal Global Phase 3 Study, KEYNOTE-C87, of TAVO™ Combined with KEYTRUDA® for Late-Stage Metastatic Melanoma",https://www.nasdaq.com/press-release/oncosec-enters-into-a-collaboration-agreement-with-merck-for-a-pivotal-global-phase-3
ONCT,"JUL 1, 2021","Oncternal Therapeutics Appoints Pablo Urbaneja as Sr. Vice President, Corporate Development",https://www.nasdaq.com/press-release/oncternal-therapeutics-appoints-pablo-urbaneja-as-sr.-vice-president-corporate
ONCY,"JUN 30, 2021",Oncolytics Biotech® to Present at the Ladenburg Thalmann Healthcare Conference,https://www.nasdaq.com/press-release/oncolytics-biotechr-to-present-at-the-ladenburg-thalmann-healthcare-conference-2021
ONEM,"JUN 8, 2021",One Medical Appoints Scott C. Taylor to Board of Directors,https://www.nasdaq.com/press-release/one-medical-appoints-scott-c.-taylor-to-board-of-directors-2021-06-08
ONTX,"JUN 28, 2021",Onconova Therapeutics Provides an Update on the Phase 1/2a Trial of Rigosertib-Nivolumab Combination in KRAS+ Non-Small Cell Lung Cancer,https://www.nasdaq.com/press-release/onconova-therapeutics-provides-an-update-on-the-phase-1-2a-trial-of-rigosertib
ONTXW,,,
ONVO,"MAR 2, 2021",Organovo Announces Participation at the H.C. Wainwright Global Life Sciences Conference March 9-10 2021 (VIRTUAL CONFERENCE),https://www.nasdaq.com/press-release/organovo-announces-participation-at-the-h.c.-wainwright-global-life-sciences
OPCH,21 HOURS AGO,Option Care Health to Announce Second Quarter 2021 Financial Results and Host Conference Call,https://www.nasdaq.com/press-release/option-care-health-to-announce-second-quarter-2021-financial-results-and-host
OPGN,,,
OPK,2 DAYS AGO,OPKO Health Licenses Oligonucleotide Therapeutics Platform to CAMP4 Therapeutics,https://www.nasdaq.com/press-release/opko-health-licenses-oligonucleotide-therapeutics-platform-to-camp4-therapeutics-2021
OPNT,2 DAYS AGO,Opiant Pharmaceuticals Announces Appointment of Matthew Ruth as Chief Commercial Officer,https://www.nasdaq.com/press-release/opiant-pharmaceuticals-announces-appointment-of-matthew-ruth-as-chief-commercial
OPTN,"JUN 24, 2021",Optinose Technology Inventor Per Djupesland Named Winner of European Inventor Award 2021 for Industry,https://www.nasdaq.com/press-release/optinose-technology-inventor-per-djupesland-named-winner-of-european-inventor-award
ORGO,"JUL 2, 2021","Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2021 Financial Results on August 9, 2021",https://www.nasdaq.com/press-release/organogenesis-holdings-inc.-to-report-second-quarter-of-fiscal-year-2021-financial
ORGS,"JUL 6, 2021",Orgenesis Achieves Multiple Ranpirnase Development Milestones,https://www.nasdaq.com/press-release/orgenesis-achieves-multiple-ranpirnase-development-milestones-2021-07-06
ORIC,"JUN 28, 2021","ORIC Pharmaceuticals Announces FDA Clearance of IND Application for ORIC-533, a Highly Potent, Orally Bioavailable Small Molecule CD73 Inhibitor",https://www.nasdaq.com/press-release/oric-pharmaceuticals-announces-fda-clearance-of-ind-application-for-oric-533-a-highly
ORMP,"JUN 22, 2021",Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® Indexes,https://www.nasdaq.com/press-release/oramed-pharmaceuticals-to-join-russell-2000r-and-russell-3000r-indexes-2021-06-22
ORPH,"JUN 30, 2021",CytRx Comments on Orphazyme’s Promising 24-Month Interim Trial Results of Arimoclomol for Niemann-Pick Disease Type C,https://www.nasdaq.com/press-release/cytrx-comments-on-orphazymes-promising-24-month-interim-trial-results-of-arimoclomol
ORTX,"JUL 1, 2021",Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo autologous HSC Gene Therapy for Hereditary Angioedema,https://www.nasdaq.com/press-release/orchard-therapeutics-and-pharming-group-announce-collaboration-to-develop-and
OSH,"JUN 7, 2021","Oak Street Health Announces Plans to Enter 20th State, Arizona Centers to Open in 2022",https://www.nasdaq.com/press-release/oak-street-health-announces-plans-to-enter-20th-state-arizona-centers-to-open-in-2022
OSMT,"JUN 30, 2021","Osmotica Subsidiary RVL Pharmaceuticals, Focused on Eye Care and Ocular Aesthetics, Strengthens and Expands Leadership Team",https://www.nasdaq.com/press-release/osmotica-subsidiary-rvl-pharmaceuticals-focused-on-eye-care-and-ocular-aesthetics
OSUR,"JUN 17, 2021",OraSure Technologies to Present at the Raymond James 2021 Human Health and Innovation Conference,https://www.nasdaq.com/press-release/orasure-technologies-to-present-at-the-raymond-james-2021-human-health-and-innovation
OTIC,"JUN 15, 2021",Otonomy Initiates Expansion of Phase 1/2 Clinical Trial for OTO-413 in Hearing Loss,https://www.nasdaq.com/press-release/otonomy-initiates-expansion-of-phase-1-2-clinical-trial-for-oto-413-in-hearing-loss
OTLK,"JUL 7, 2021",Outlook Therapeutics Appoints C. Russell Trenary III as President and Chief Executive Officer,https://www.nasdaq.com/press-release/outlook-therapeutics-appoints-c.-russell-trenary-iii-as-president-and-chief-executive
OTLKW,,,
OTRK,"JUL 7, 2021",Landmark Behavioral Health Study Presented at AHIP Event,https://www.nasdaq.com/press-release/landmark-behavioral-health-study-presented-at-ahip-event-2021-07-07
OTRKP,"MAY 5, 2021",Ontrak Declares Quarterly Dividend on 9.50% Non-Convertible Series A Preferred Stock,https://www.nasdaq.com/press-release/ontrak-declares-quarterly-dividend-on-9.50-non-convertible-series-a-preferred-stock-0
OVID,5 DAYS AGO,Ovid Therapeutics Strengthens Board & Leadership Team to Focus Efforts on Expanding Its Neurosciences Capabilities,https://www.nasdaq.com/press-release/ovid-therapeutics-strengthens-board-leadership-team-to-focus-efforts-on-expanding-its
OXFD,"MAR 4, 2021","Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection",https://www.nasdaq.com/press-release/oxford-immunotec-submits-emergency-use-authorization-request-to-the-fda-and-ce-marks
OYST,"JUL 1, 2021",Oyster Point Pharma Announces Preclinical Data Highlighting Potent Activity of OC-01 (varenicline) and OC-02 (simpinicline) Against SARS-CoV-2 Virus and Variants,https://www.nasdaq.com/press-release/oyster-point-pharma-announces-preclinical-data-highlighting-potent-activity-of-oc-01
PAHC,"MAY 6, 2021",Phibro Animal Health Corporation Reports Third Quarter and Year-to-Date Results,https://www.nasdaq.com/press-release/phibro-animal-health-corporation-reports-third-quarter-and-year-to-date-results-2021
PANA,"FEB 10, 2021","Nuvation Bio Closes Transaction with Panacea, Debuts as Publicly Traded Oncology Company",https://www.nasdaq.com/press-release/nuvation-bio-closes-transaction-with-panacea-debuts-as-publicly-traded-oncology
PAND,"APR 1, 2021",Merck Completes Acquisition of Pandion Therapeutics,https://www.nasdaq.com/press-release/merck-completes-acquisition-of-pandion-therapeutics-2021-04-01
PASG,"JUN 1, 2021","Derrell D. Porter, M.D., Elected to Board of Directors of Passage Bio",https://www.nasdaq.com/press-release/derrell-d.-porter-m.d.-elected-to-board-of-directors-of-passage-bio-2021-06-01
PAVM,"JUN 14, 2021","Tim Baxter, Former CEO of Samsung Electronics North America and Global Technology Industry Leader, Joins PAVmed Board of Directors",https://www.nasdaq.com/press-release/tim-baxter-former-ceo-of-samsung-electronics-north-america-and-global-technology
PAVMW,,,
PAVMZ,,,
PBH,"JUL 1, 2021","Prestige Consumer Healthcare Completes Acquisition of TheraTears, Announces First Quarter Fiscal 2022 Earnings Results Date",https://www.nasdaq.com/press-release/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first
PBLA,6 DAYS AGO,"50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021",https://www.nasdaq.com/press-release/50-companies-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-0
PBYI,"JUL 2, 2021",Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/puma-biotechnology-reports-inducement-awards-under-nasdaq-listing-rule-5635c4-2021-07
PCRX,1 DAY AGO,Pacira BioSciences Reports Record Revenue of $135.6 Million for the Second Quarter of 2021,https://www.nasdaq.com/press-release/pacira-biosciences-reports-record-revenue-of-%24135.6-million-for-the-second-quarter-of
PCSA,6 DAYS AGO,"50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021",https://www.nasdaq.com/press-release/50-companies-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-0
PCVX,"MAY 27, 2021",Vaxcyte to Present at the Jefferies Virtual Healthcare Conference,https://www.nasdaq.com/press-release/vaxcyte-to-present-at-the-jefferies-virtual-healthcare-conference-2021-05-27
PDCO,1 DAY AGO,Patterson Announces Dental Leadership Changes,https://www.nasdaq.com/press-release/patterson-announces-dental-leadership-changes-2021-07-13
PDEX,"JUN 3, 2021","Pro-Dex, Inc. Discusses Record Third Quarter Sales and Aggressive Growth Strategy with The Stock Day Podcast",https://www.nasdaq.com/press-release/pro-dex-inc.-discusses-record-third-quarter-sales-and-aggressive-growth-strategy-with
PDSB,"JUL 1, 2021",PDS Biotechnology Joins Russell Microcap® Index,https://www.nasdaq.com/press-release/pds-biotechnology-joins-russell-microcapr-index-2021-07-01
PEN,1 DAY AGO,"Penumbra, Inc. Schedules Second Quarter 2021 Earnings Release and Conference Call for August 9, 2021",https://www.nasdaq.com/press-release/penumbra-inc.-schedules-second-quarter-2021-earnings-release-and-conference-call-for
PETQ,"MAY 26, 2021","PetIQ, Inc. to Participate in Two Upcoming Virtual Investor Conferences",https://www.nasdaq.com/press-release/petiq-inc.-to-participate-in-two-upcoming-virtual-investor-conferences-2021-05-26
PETS,"MAY 3, 2021","PetMed Express, Inc. d/b/a 1-800-PetMeds Announces Its Fourth Quarter and Fiscal Year End Financial Results and Increases Its Quarterly Dividend to $0.30 per Share",https://www.nasdaq.com/press-release/petmed-express-inc.-d-b-a-1-800-petmeds-announces-its-fourth-quarter-and-fiscal-0
PFE,5 DAYS AGO,"Collaboration Between AbbVie, Biogen and Pfizer Creates World’s Largest Browsable Resource Linking Rare Protein-Coding Genetic Variants to Human Health and Disease",https://www.nasdaq.com/press-release/collaboration-between-abbvie-biogen-and-pfizer-creates-worlds-largest-browsable-0
PGEN,"JUN 10, 2021","Precigen ActoBio Announces Positive Topline Results from Phase 1b/2a Study of AG019 ActoBiotics™, A Novel Therapy Designed to Address the Underlying Cause of Type 1 Diabetes",https://www.nasdaq.com/press-release/precigen-actobio-announces-positive-topline-results-from-phase-1b-2a-study-of-ag019
PGNY,"JUN 4, 2021","Progyny, Inc. to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference",https://www.nasdaq.com/press-release/progyny-inc.-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference
PHAR,"JUL 1, 2021",Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo autologous HSC Gene Therapy for Hereditary Angioedema,https://www.nasdaq.com/press-release/orchard-therapeutics-and-pharming-group-announce-collaboration-to-develop-and
PHAS,"JUN 30, 2021",PhaseBio Pharmaceuticals to Present at the William Blair Biotech Focus Conference 2021 on July 15,https://www.nasdaq.com/press-release/phasebio-pharmaceuticals-to-present-at-the-william-blair-biotech-focus-conference
PHAT,"MAY 25, 2021",Phathom Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference,https://www.nasdaq.com/press-release/phathom-pharmaceuticals-to-present-at-the-jefferies-virtual-healthcare-conference
PHG,6 DAYS AGO,"Philips and Cognizant collaborate to introduce digital health solutions to providers, researchers, and patients",https://www.nasdaq.com/press-release/philips-and-cognizant-collaborate-to-introduce-digital-health-solutions-to-providers
PHGE,"JUN 14, 2021",BiomX Presents Preclinical Results With BX005 for Atopic Dermatitis at the Revolutionizing Atopic Dermatitis 2021 Virtual Conference and the International Conference on Phage Therapy and Bacteriophages,https://www.nasdaq.com/press-release/biomx-presents-preclinical-results-with-bx005-for-atopic-dermatitis-at-the
PHIO,6 DAYS AGO,Phio Pharmaceuticals Scheduled to Participate in a Fireside Chat with H.C. Wainwright on July 12th,https://www.nasdaq.com/press-release/phio-pharmaceuticals-scheduled-to-participate-in-a-fireside-chat-with-h.c.-wainwright
PHIOW,,,
PHVS,4 DAYS AGO,Pharvaris Presents Clinical Data on Oral PHA121 Supporting the Prophylactic Treatment of Hereditary Angioedema at the EAACI Annual Congress 2021,https://www.nasdaq.com/press-release/pharvaris-presents-clinical-data-on-oral-pha121-supporting-the-prophylactic-treatment
PIRS,"JUN 25, 2021",Pieris Pharmaceuticals Announces Inhaled CTGF Inhibitor PRS-220 for Idiopathic Pulmonary Fibrosis and 17 Million Dollar Grant From Bavarian Government To Accelerate Program Development for Post-COVID-19 Pulmonary Fibrosis,https://www.nasdaq.com/press-release/pieris-pharmaceuticals-announces-inhaled-ctgf-inhibitor-prs-220-for-idiopathic
PLRX,"MAY 10, 2021",Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2021 Financial Results,https://www.nasdaq.com/press-release/pliant-therapeutics-provides-corporate-update-and-reports-first-quarter-2021
PLSE,"JUL 1, 2021",Pulse Biosciences Announces $50 Million Private Placement,https://www.nasdaq.com/press-release/pulse-biosciences-announces-%2450-million-private-placement-2021-07-01
PLX,"JUN 2, 2021",Protalix Biotherapeutics and Chiesi Global Rare Diseases Provide Update Regarding Clinical Development of PRX-102 for Treatment of Fabry Disease,https://www.nasdaq.com/press-release/protalix-biotherapeutics-and-chiesi-global-rare-diseases-provide-update-regarding
PLXP,1 DAY AGO,"PLx Pharma Inc.’s VAZALORE to Launch in over 4,500 Walmart Stores Nationwide in August",https://www.nasdaq.com/press-release/plx-pharma-inc.s-vazalore-to-launch-in-over-4500-walmart-stores-nationwide-in-august
PMD,"JUN 1, 2021",Montana Advisors Writes Open Letter to Psychemedics,https://www.nasdaq.com/press-release/montana-advisors-writes-open-letter-to-psychemedics-2021-06-01
PMVP,"JUN 9, 2021",PMV Pharmaceuticals Announces Participation at the Bank of America Securities 2021 Napa Biopharma Virtual Conference,https://www.nasdaq.com/press-release/pmv-pharmaceuticals-announces-participation-at-the-bank-of-america-securities-2021
PNTG,"JUN 17, 2021",The Pennant Group Acquires California Hospice Provider,https://www.nasdaq.com/press-release/the-pennant-group-acquires-california-hospice-provider-2021-06-17
POAI,"JUN 22, 2021",Predictive Oncology Inc.’s Subsidiaries Soluble Biotech Inc. and TumorGenesis Inc. are both constructing new GMP labs,https://www.nasdaq.com/press-release/predictive-oncology-inc.s-subsidiaries-soluble-biotech-inc.-and-tumorgenesis-inc.-are
PODD,"JUL 1, 2021","Insulet to Announce Second Quarter 2021 Financial Results on August 5, 2021",https://www.nasdaq.com/press-release/insulet-to-announce-second-quarter-2021-financial-results-on-august-5-2021-2021-07-01
PPBT,"JUN 4, 2021",Purple Biotech Presents New Clinical Data from NT219 at the 2021 ASCO Annual Meeting,https://www.nasdaq.com/press-release/purple-biotech-presents-new-clinical-data-from-nt219-at-the-2021-asco-annual-meeting
PPD,,,
PRAH,"JUN 28, 2021",DT Midstream Set to Join S&P MidCap 400,https://www.nasdaq.com/press-release/dt-midstream-set-to-join-sp-midcap-400-2021-06-28
PRAX,"JUL 6, 2021",Praxis Precision Medicines to Present at Upcoming Investor Conferences,https://www.nasdaq.com/press-release/praxis-precision-medicines-to-present-at-upcoming-investor-conferences-2021-07-06
PRFX,"MAY 13, 2021",PainReform Provides Business Update for the First Quarter of 2021,https://www.nasdaq.com/press-release/painreform-provides-business-update-for-the-first-quarter-of-2021-2021-05-13
PRGO,"JUL 6, 2021",Perrigo Completes Divestiture Of Generic Rx Business For $1.55 Billion,https://www.nasdaq.com/press-release/perrigo-completes-divestiture-of-generic-rx-business-for-%241.55-billion-2021-07-06
PRLD,"JUN 2, 2021",Prelude Therapeutics Announces Participation at Two Upcoming Virtual Investor Conferences,https://www.nasdaq.com/press-release/prelude-therapeutics-announces-participation-at-two-upcoming-virtual-investor
PROF,"MAY 25, 2021",Profound Medical to Participate in June Investor Conferences,https://www.nasdaq.com/press-release/profound-medical-to-participate-in-june-investor-conferences-2021-05-25
PROG,"JUN 30, 2021",Progenity Announces Appointment of Surbhi Sarna to its Board of Directors,https://www.nasdaq.com/press-release/progenity-announces-appointment-of-surbhi-sarna-to-its-board-of-directors-2021-06-30
PRPH,2 DAYS AGO,"ProPhase Labs to Present at the Access to Giving Virtual Investor Conference on July 15, 2021",https://www.nasdaq.com/press-release/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july
PRQR,"JUN 10, 2021",ProQR to Present at Upcoming JMP Securities Life Sciences Conference,https://www.nasdaq.com/press-release/proqr-to-present-at-upcoming-jmp-securities-life-sciences-conference-2021-06-10
PRTA,2 DAYS AGO,Prothena and Novo Nordisk Announce Acquisition Agreement for Prothena’s ATTR Amyloidosis Programme,https://www.nasdaq.com/press-release/prothena-and-novo-nordisk-announce-acquisition-agreement-for-prothenas-attr
PRTC,5 DAYS AGO,PureTech Founded Entity Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined with a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML),https://www.nasdaq.com/press-release/puretech-founded-entity-vor-biopharma-announces-collaboration-with-janssen-to-develop
PRTK,"JUN 29, 2021",Paratek Pharmaceuticals Announces First BARDA Project BioShield Procurement of NUZYRA® (omadacycline) Valued at ~$38 Million,https://www.nasdaq.com/press-release/paratek-pharmaceuticals-announces-first-barda-project-bioshield-procurement-of
PRVB,2 DAYS AGO,Teplizumab Awarded Innovation Passport in the United Kingdom (UK) for the Delay of Onset of Clinical Type 1 Diabetes in At-risk Individuals,https://www.nasdaq.com/press-release/teplizumab-awarded-innovation-passport-in-the-united-kingdom-uk-for-the-delay-of
PSNL,"JUN 22, 2021",Personalis Announces NeXT Level Biomarkers Symposium,https://www.nasdaq.com/press-release/personalis-announces-next-level-biomarkers-symposium-2021-06-22
PSTI,6 DAYS AGO,Pluristem Brings ARDS Associated with COVID-19 Phase II Studies to Clinical Readout,https://www.nasdaq.com/press-release/pluristem-brings-ards-associated-with-covid-19-phase-ii-studies-to-clinical-readout
PSTV,"JUN 16, 2021",Plus Therapeutics Announces DSMB Approval to Proceed into Eighth Cohort in ReSPECT™ Glioblastoma Trial,https://www.nasdaq.com/press-release/plus-therapeutics-announces-dsmb-approval-to-proceed-into-eighth-cohort-in-respecttm
PSTX,"JUN 2, 2021",Poseida Therapeutics Announces Virtual 2021 Annual Meeting of Stockholders,https://www.nasdaq.com/press-release/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders-2021-06-02
PTCT,"JUN 24, 2021",Results Add to Body of Evidence Confirming EMFLAZA®'s Benefit Over Prednisone,https://www.nasdaq.com/press-release/results-add-to-body-of-evidence-confirming-emflazars-benefit-over-prednisone-2021-06
PTE,2 DAYS AGO,PolarityTE Receives Notice of Allowance for Chinese Patent,https://www.nasdaq.com/press-release/polarityte-receives-notice-of-allowance-for-chinese-patent-2021-07-12
PTGX,"JUN 30, 2021",Protagonist Therapeutics Reports Granting of Inducement Award,https://www.nasdaq.com/press-release/protagonist-therapeutics-reports-granting-of-inducement-award-2021-06-30
PTN,5 DAYS AGO,Palatin Announces Adjournment of Annual Meeting of Stockholders,https://www.nasdaq.com/press-release/palatin-announces-adjournment-of-annual-meeting-of-stockholders-2021-07-08
PTPI,1 DAY AGO,Petros Pharmaceuticals Completes Pilot Label Comprehension Study to Initiate Process for Stendra® Prescription Erectile Dysfunction Medication to Achieve Designation as an Over-the-Counter Treatment,https://www.nasdaq.com/press-release/petros-pharmaceuticals-completes-pilot-label-comprehension-study-to-initiate-process
PULM,"MAY 11, 2021",Pulmatrix Reports First Quarter 2021 Financial Results and Provides Business Update,https://www.nasdaq.com/press-release/pulmatrix-reports-first-quarter-2021-financial-results-and-provides-business-update
PYPD,2 DAYS AGO,"PolyPid Strengthens Executive Team, Appointing Dr. Anthony Senagore as Senior Medical Director",https://www.nasdaq.com/press-release/polypid-strengthens-executive-team-appointing-dr.-anthony-senagore-as-senior-medical
QDEL,2 DAYS AGO,Quidel Receives CE Mark for Savanna® Multiplex Molecular Analyzer and Respiratory Viral Panel,https://www.nasdaq.com/press-release/quidel-receives-ce-mark-for-savannar-multiplex-molecular-analyzer-and-respiratory
QGEN,2 DAYS AGO,QIAGEN N.V. Conference Call on July 13 to Discuss Preliminary Q2 2021 Results,https://www.nasdaq.com/press-release/qiagen-n.v.-conference-call-on-july-13-to-discuss-preliminary-q2-2021-results-2021-07
QLGN,5 HOURS AGO,"Qualigen Therapeutics, Inc. Announces Submission of Investigational New Drug (IND) Application for QN-165, for the Treatment of COVID-19",https://www.nasdaq.com/press-release/qualigen-therapeutics-inc.-announces-submission-of-investigational-new-drug-ind
QLI,5 DAYS AGO,Qilian International Holding Group Limited Enters into Investment Agreement for Pig By-product Processing Project in Chongqing,https://www.nasdaq.com/press-release/qilian-international-holding-group-limited-enters-into-investment-agreement-for-pig
QTNT,"JUL 2, 2021","Quotient Limited Announces Departure of Chief Financial Officer, Peter Buhler",https://www.nasdaq.com/press-release/quotient-limited-announces-departure-of-chief-financial-officer-peter-buhler-2021-07
QURE,"JUL 2, 2021",uniQure Announces Presentations at Upcoming International Society on Thrombosis and Haemostasis (ISTH) Virtual Congress,https://www.nasdaq.com/press-release/uniqure-announces-presentations-at-upcoming-international-society-on-thrombosis-and
RAD,"JUN 24, 2021",Rite Aid Releases Third Annual Corporate Sustainability Report,https://www.nasdaq.com/press-release/rite-aid-releases-third-annual-corporate-sustainability-report-2021-06-24
RAPT,"JUN 18, 2021",RAPT Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares,https://www.nasdaq.com/press-release/rapt-therapeutics-announces-closing-of-public-offering-of-common-stock-and-full
RARE,1 DAY AGO,MEDIA ADVISORY: Ultragenyx Announces Mepsevii® (vestronidase alfa) Receives Reimbursement Approval for Treatment of Mucopolysaccharidosis VII in Spain,https://www.nasdaq.com/press-release/media-advisory%3A-ultragenyx-announces-mepseviir-vestronidase-alfa-receives
RCEL,"JUN 29, 2021",AVITA Medical Announces Inclusion in the Russell 3000 Index,https://www.nasdaq.com/press-release/avita-medical-announces-inclusion-in-the-russell-3000-index-2021-06-29
RCKT,"MAY 13, 2021","Rocket Pharmaceuticals Presents Positive Clinical Data from Fanconi Anemia, Leukocyte Adhesion Deficiency-I, and Pyruvate Kinase Deficiency Programs at 24th Annual Meeting of the American Society of Gene and Cell Therapy",https://www.nasdaq.com/press-release/rocket-pharmaceuticals-presents-positive-clinical-data-from-fanconi-anemia-leukocyte
RCUS,1 DAY AGO,Arcus Biosciences Announces New Employment Inducement Grants,https://www.nasdaq.com/press-release/arcus-biosciences-announces-new-employment-inducement-grants-2021-07-12
RDHL,1 DAY AGO,RedHill Biopharma's Movantik® Added as Unrestricted Preferred Brand To A Major National Commercial Formulary Serving over 30 Million Americans,https://www.nasdaq.com/press-release/redhill-biopharmas-movantikr-added-as-unrestricted-preferred-brand-to-a-major
RDNT,"JUN 28, 2021","RadNet, Inc. and Jefferies to Host a Teach-In on Artificial Intelligence within Diagnostic Imaging",https://www.nasdaq.com/press-release/radnet-inc.-and-jefferies-to-host-a-teach-in-on-artificial-intelligence-within
RDUS,"JUN 2, 2021",Radius Health Business Update,https://www.nasdaq.com/press-release/radius-health-business-update-2021-06-02
RDY,"JUN 30, 2021",Dr. Reddy's Laboratories Announces Filing of Annual Report on Form 20-F,https://www.nasdaq.com/press-release/dr.-reddys-laboratories-announces-filing-of-annual-report-on-form-20-f-2021-07-01
REGN,6 DAYS AGO,"Regeneron to Report Second Quarter 2021 Financial and Operating Results and Host Conference Call and Webcast on August 5, 2021",https://www.nasdaq.com/press-release/regeneron-to-report-second-quarter-2021-financial-and-operating-results-and-host
REPH,1 DAY AGO,Recro Enters Development and Manufacturing Agreement With New Client,https://www.nasdaq.com/press-release/recro-enters-development-and-manufacturing-agreement-with-new-client-2021-07-13
REPL,"JUL 7, 2021",Replimune to Present at the William Blair Biotech Focus Conference 2021,https://www.nasdaq.com/press-release/replimune-to-present-at-the-william-blair-biotech-focus-conference-2021-2021-07-07
RETA,"JUN 7, 2021",Reata Pharmaceuticals Announces Participation in The Goldman Sachs 42nd Annual Global Healthcare Conference,https://www.nasdaq.com/press-release/reata-pharmaceuticals-announces-participation-in-the-goldman-sachs-42nd-annual-global
RGEN,1 DAY AGO,Repligen to Report Second Quarter 2021 Financial Results,https://www.nasdaq.com/press-release/repligen-to-report-second-quarter-2021-financial-results-2021-07-13
RGLS,"JUN 25, 2021",Regulus Therapeutics Presents Additional Data from its Autosomal Dominant Polycystic Kidney Disease (ADPKD) Program at PKD Connect 2021,https://www.nasdaq.com/press-release/regulus-therapeutics-presents-additional-data-from-its-autosomal-dominant-polycystic
RGNX,"JUN 9, 2021",REGENXBIO to Participate in Upcoming Investor Conferences,https://www.nasdaq.com/press-release/regenxbio-to-participate-in-upcoming-investor-conferences-2021-06-09
RIGL,5 HOURS AGO,New TAVALISSE® Data Analyses To Be Presented at International Society on Thrombosis and Haemostasis (ISTH) 2021 Congress,https://www.nasdaq.com/press-release/new-tavalisser-data-analyses-to-be-presented-at-international-society-on-thrombosis
RLAY,,,
RLMD,"JUN 15, 2021",Relmada Therapeutics to Present Data at the College on Problems of Drug Dependence 83rd Annual Scientific Meeting,https://www.nasdaq.com/press-release/relmada-therapeutics-to-present-data-at-the-college-on-problems-of-drug-dependence
RMD,"JUN 2, 2021",ResMed Announces Participation in the Goldman Sachs 42nd Annual Global Healthcare Conference,https://www.nasdaq.com/press-release/resmed-announces-participation-in-the-goldman-sachs-42nd-annual-global-healthcare
RMED,"JUN 29, 2021",Ra Medical Systems Announces Progress with Guidewire-Compatible Catheter Design and Provides Update on Atherectomy Trial Enrollment,https://www.nasdaq.com/press-release/ra-medical-systems-announces-progress-with-guidewire-compatible-catheter-design-and
RMTI,"JUN 28, 2021","Rockwell Medical, Inc. Files Pre-IND Meeting Request with FDA for its Proposed Clinical Trial of FPC as a Treatment for Iron Deficiency Anemia in Patients Receiving Home Infusion",https://www.nasdaq.com/press-release/rockwell-medical-inc.-files-pre-ind-meeting-request-with-fda-for-its-proposed
RNA,"MAY 19, 2021",Avidity Biosciences Announces Updates on the Pipeline and Platform at Virtual Investor and Analyst Event,https://www.nasdaq.com/press-release/avidity-biosciences-announces-updates-on-the-pipeline-and-platform-at-virtual
RNLX,,,
RPRX,"JUN 7, 2021",Royalty Pharma to Present at Upcoming Investor Conferences,https://www.nasdaq.com/press-release/royalty-pharma-to-present-at-upcoming-investor-conferences-2021-06-07
RPTX,"JUN 2, 2021",Repare Therapeutics to Participate at the 42nd Annual Goldman Sachs Virtual Global Healthcare Conference,https://www.nasdaq.com/press-release/repare-therapeutics-to-participate-at-the-42nd-annual-goldman-sachs-virtual-global
RUBY,"JUN 23, 2021",Rubius Therapeutics Announces First Patient Dosed with RTX-240 in Combination with KEYTRUDA® (pembrolizumab) in Ongoing Phase 1/2 Clinical Trial for the Treatment of Advanced Solid Tumors,https://www.nasdaq.com/press-release/rubius-therapeutics-announces-first-patient-dosed-with-rtx-240-in-combination-with
RVMD,"JUN 24, 2021",Revolution Medicines Announces Publication of Scientific Paper Describing Novel Class of Anti-Tumor Compounds Targeting mTORC1,https://www.nasdaq.com/press-release/revolution-medicines-announces-publication-of-scientific-paper-describing-novel-class
RVNC,"MAY 26, 2021",Revance to Participate in Upcoming Virtual Healthcare Conferences,https://www.nasdaq.com/press-release/revance-to-participate-in-upcoming-virtual-healthcare-conferences-2021-05-26
RVP,"JUN 7, 2021","Retractable Technologies, Inc. Announces Buyback Plan and Payment of All Dividends",https://www.nasdaq.com/press-release/retractable-technologies-inc.-announces-buyback-plan-and-payment-of-all-dividends
RVPH,"JUN 28, 2021",Reviva Added to Russell Microcap® Index,https://www.nasdaq.com/press-release/reviva-added-to-russell-microcapr-index-2021-06-28
RVPHW,,,
RWLK,"MAY 11, 2021",ReWalk Robotics Reports First Quarter 2021 Financial Results,https://www.nasdaq.com/press-release/rewalk-robotics-reports-first-quarter-2021-financial-results-2021-05-11
RYTM,"MAY 27, 2021",Rhythm Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference,https://www.nasdaq.com/press-release/rhythm-pharmaceuticals-to-present-at-jefferies-virtual-healthcare-conference-2021-05
RZLT,"JUN 28, 2021",Rezolute Added to Russell Microcap® Index,https://www.nasdaq.com/press-release/rezolute-added-to-russell-microcapr-index-2021-06-28
SAGE,6 DAYS AGO,Sage Therapeutics to Participate in Cowen’s Psychedelics & Novel Mechanisms in Neuropsychiatry Summit,https://www.nasdaq.com/press-release/sage-therapeutics-to-participate-in-cowens-psychedelics-novel-mechanisms-in
SANA,"JUN 26, 2021",Sana Biotechnology Presents Data at ISSCR 2021 Virtual Annual Meeting Showing Survival of Transplanted Hypoimmune Stem Cells Without Immunosuppression in Non-Human Primates,https://www.nasdaq.com/press-release/sana-biotechnology-presents-data-at-isscr-2021-virtual-annual-meeting-showing
SAVA,"JUN 21, 2021",Cassava Sciences Selects Clinical Research Organization for Phase 3 Clinical Program in Alzheimer’s Disease,https://www.nasdaq.com/press-release/cassava-sciences-selects-clinical-research-organization-for-phase-3-clinical-program
SBBP,1 DAY AGO,Strongbridge Biopharma plc Announces Publication of Long-term Efficacy and Safety Results for KEVEYIS® (dichlorphenamide) for the Treatment of Primary Periodic Paralysis in Muscle & Nerve,https://www.nasdaq.com/press-release/strongbridge-biopharma-plc-announces-publication-of-long-term-efficacy-and-safety
SBTX,"JUL 7, 2021","Silverback Therapeutics Announces Clinical Supply Agreement with Regeneron to Evaluate SBT6050 in Combination with Libtayo® (cemiplimab), initially in HER2-expressing Non-Small Cell Lung and Gastric Cancers",https://www.nasdaq.com/press-release/silverback-therapeutics-announces-clinical-supply-agreement-with-regeneron-to
SCPH,21 HOURS AGO,scPharmaceuticals Inc. Announces Positive Top-Line Results from FREEDOM-HF Study,https://www.nasdaq.com/press-release/scpharmaceuticals-inc.-announces-positive-top-line-results-from-freedom-hf-study-2021
SCPS,2 DAYS AGO,Scopus BioPharma Announces New Management Appointment Following Acquisition of Leading Immunotherapy Company,https://www.nasdaq.com/press-release/scopus-biopharma-announces-new-management-appointment-following-acquisition-of
SCYX,2 DAYS AGO,SCYNEXIS Announces Three Oral Presentations of Ibrexafungerp Demonstrating Clinical and In Vitro Activity Against Candida Species at the 31st ECCMID,https://www.nasdaq.com/press-release/scynexis-announces-three-oral-presentations-of-ibrexafungerp-demonstrating-clinical
SDC,"MAY 27, 2021",SmileDirectClub Partners With NAACP For New Scholarship,https://www.nasdaq.com/press-release/smiledirectclub-partners-with-naacp-for-new-scholarship-2021-05-27
SDGR,,,
SEEL,5 HOURS AGO,Seelos Therapeutics to Participate in Two Investor Conferences in August,https://www.nasdaq.com/press-release/seelos-therapeutics-to-participate-in-two-investor-conferences-in-august-2021-07-14
SELB,6 DAYS AGO,Selecta Biosciences to Participate at the William Blair Biotech Focus Conference 2021,https://www.nasdaq.com/press-release/selecta-biosciences-to-participate-at-the-william-blair-biotech-focus-conference-2021
SEM,5 DAYS AGO,Centers for Disease Control and Prevention (CDC) Releases Study on Physical Health and Functional Status Among Patients Referred to Outpatient Rehabilitation Clinics After COVID-19 Diagnosis,https://www.nasdaq.com/press-release/centers-for-disease-control-and-prevention-cdc-releases-study-on-physical-health-and
SESN,5 HOURS AGO,Sesen Bio Announces Productive Late-Cycle Meeting with the FDA for Vicineum™,https://www.nasdaq.com/press-release/sesen-bio-announces-productive-late-cycle-meeting-with-the-fda-for-vicineumtm-2021-07
SGEN,4 DAYS AGO,U.S. FDA Grants Regular Approval and Expands Indication for PADCEV® (enfortumab vedotin-ejfv) for Patients with Locally Advanced or Metastatic Urothelial Cancer,https://www.nasdaq.com/press-release/u.s.-fda-grants-regular-approval-and-expands-indication-for-padcevr-enfortumab
SGMO,"MAY 24, 2021","Sangamo Therapeutics Appoints Prathyusha Duraibabu, CPA, MBA, to Chief Financial Officer",https://www.nasdaq.com/press-release/sangamo-therapeutics-appoints-prathyusha-duraibabu-cpa-mba-to-chief-financial-officer
SGRY,5 DAYS AGO,"Surgery Partners, Inc. Announces Second Quarter 2021 Earnings Release Date and Conference Call Details",https://www.nasdaq.com/press-release/surgery-partners-inc.-announces-second-quarter-2021-earnings-release-date-and
SGTX,5 DAYS AGO,Sigilon Therapeutics Announces Clinical Hold on SIG-001 Phase 1/2 Study in Hemophilia A,https://www.nasdaq.com/press-release/sigilon-therapeutics-announces-clinical-hold-on-sig-001-phase-1-2-study-in-hemophilia
SHC,2 DAYS AGO,Sotera Health Announces Q2 2021 Earnings Release Date,https://www.nasdaq.com/press-release/sotera-health-announces-q2-2021-earnings-release-date-2021-07-12
SIBN,6 HOURS AGO,"SI-BONE, Inc. Announces Centene Establishes Positive Coverage for MIS SI Joint Fusion including the Triangular iFuse Implant System",https://www.nasdaq.com/press-release/si-bone-inc.-announces-centene-establishes-positive-coverage-for-mis-si-joint-fusion
SIEN,2 DAYS AGO,Sientra Announces Appointment of Chief Financial Officer,https://www.nasdaq.com/press-release/sientra-announces-appointment-of-chief-financial-officer-2021-07-12
SIGA,"JUN 30, 2021",SIGA Supplies TPOXX® (Tecovirimat) as Compassionate Treatment for Monkeypox Case in the United Kingdom,https://www.nasdaq.com/press-release/siga-supplies-tpoxxr-tecovirimat-as-compassionate-treatment-for-monkeypox-case-in-the
SILK,"JUL 6, 2021",First Ever Standard Surgical Risk Patient TCAR Data to be Presented at the Society for Vascular Surgery 2021 Vascular Annual Meeting,https://www.nasdaq.com/press-release/first-ever-standard-surgical-risk-patient-tcar-data-to-be-presented-at-the-society
SINT,,,
SIOX,"JUN 9, 2021",Sio Gene Therapies Announces Fiscal Year 2020 Year-End Financial Results and Expected Fiscal Year 2021 Key Milestones,https://www.nasdaq.com/press-release/sio-gene-therapies-announces-fiscal-year-2020-year-end-financial-results-and-expected
SLDB,"JUL 2, 2021","Solid Biosciences Reports Inducement Grant to New Senior Vice President, Clinical Development",https://www.nasdaq.com/press-release/solid-biosciences-reports-inducement-grant-to-new-senior-vice-president-clinical
SLGL,"JUN 28, 2021",Sol-Gel Announces Pipeline Update and Future Development Plans,https://www.nasdaq.com/press-release/sol-gel-announces-pipeline-update-and-future-development-plans-2021-06-28
SLN,"MAY 25, 2021",Silence Therapeutics Receives Remaining $40 Million from AstraZeneca as Part of Upfront Investment for Ongoing siRNA Collaboration,https://www.nasdaq.com/press-release/silence-therapeutics-receives-remaining-%2440-million-from-astrazeneca-as-part-of
SLNO,"JUL 6, 2021",Soleno Therapeutics Provides Regulatory Update on DCCR for the Treatment of Prader-Willi Syndrome,https://www.nasdaq.com/press-release/soleno-therapeutics-provides-regulatory-update-on-dccr-for-the-treatment-of-prader-1
SLRX,5 HOURS AGO,"Salarius Pharmaceuticals Announces Aundrietta Duncan, Ph.D., To Present During Virtual Epigenetic Therapeutic Targets Summit",https://www.nasdaq.com/press-release/salarius-pharmaceuticals-announces-aundrietta-duncan-ph.d.-to-present-during-virtual
SLS,"JUN 30, 2021",SELLAS Reports Promising Updated Clinical Data and Initial Immune Response Profiles from Ongoing Phase 1/2 Study of Galinpepimut-S (GPS) Combined with Keytruda for Treating WT1+ Advanced Ovarian Cancer,https://www.nasdaq.com/press-release/sellas-reports-promising-updated-clinical-data-and-initial-immune-response-profiles
SMMT,2 DAYS AGO,"Summit Therapeutics Presents Breakthrough Research Data from Phase II Studies, including Evidence Validating Microbiome Preservation, for its Investigational Drug Ridinilazole",https://www.nasdaq.com/press-release/summit-therapeutics-presents-breakthrough-research-data-from-phase-ii-studies
SMTI,"JUN 4, 2021",Sanara MedTech Inc. Announces Exclusive Partnership with Pixalere Healthcare Inc. to Advance its Comprehensive Wound and Skin Care Strategy,https://www.nasdaq.com/press-release/sanara-medtech-inc.-announces-exclusive-partnership-with-pixalere-healthcare-inc.-to
SNCA,,,
SNDX,"JUN 28, 2021",SNDX-5613 Granted FDA Fast Track Designation for the Treatment of Relapsed/Refractory Acute Leukemias,https://www.nasdaq.com/press-release/sndx-5613-granted-fda-fast-track-designation-for-the-treatment-of-relapsed-refractory
SNGX,6 DAYS AGO,"50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021",https://www.nasdaq.com/press-release/50-companies-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-0
SNGXW,,,
SNN,"JUL 7, 2021",Smith+Nephew launches the FAST-FIX™ FLEX Meniscal Repair System; extends all-inside repair possibilities with greater access across all zones of the meniscus*,https://www.nasdaq.com/press-release/smithnephew-launches-the-fast-fixtm-flex-meniscal-repair-system-extends-all-inside
SNOA,"MAR 31, 2021",Sonoma Pharmaceuticals and EMC Pharma Announce an Exclusive Partnership to Expand Commercial Channels of the Microcyn®-based Rx Dermatology and Eye Care Products Nationwide,https://www.nasdaq.com/press-release/sonoma-pharmaceuticals-and-emc-pharma-announce-an-exclusive-partnership-to-expand
SNSE,"JUN 28, 2021","Sensei Biotherapeutics Announces Prioritization of Next-Generation Multi-Antigenic ImmunoPhage Platform, Monoclonal Antibody and Nanobody Programs",https://www.nasdaq.com/press-release/sensei-biotherapeutics-announces-prioritization-of-next-generation-multi-antigenic
SNSS,,,
SNY,1 DAY AGO,Sanofi announces Paris 2024 Premium partnership for the Olympic and Paralympic Games in Paris,https://www.nasdaq.com/press-release/sanofi-announces-paris-2024-premium-partnership-for-the-olympic-and-paralympic-games
SOLY,"MAY 12, 2021",Soliton Reports First Quarter 2021 Results,https://www.nasdaq.com/press-release/soliton-reports-first-quarter-2021-results-2021-05-12
SONN,"JUN 14, 2021",Sonnet BioTherapeutics Announces Change in Date of Annual Meeting,https://www.nasdaq.com/press-release/sonnet-biotherapeutics-announces-change-in-date-of-annual-meeting-2021-06-14
SPNE,6 DAYS AGO,SeaSpine Announces FDA 510(k) Clearance of 7D Surgical Percutaneous Spine Module for Minimally Invasive Surgery,https://www.nasdaq.com/press-release/seaspine-announces-fda-510k-clearance-of-7d-surgical-percutaneous-spine-module-for
SPPI,"JUN 4, 2021",Spectrum Pharmaceuticals Presents Poziotinib Data in Patients with Brain Metastases from the ZENITH20 Clinical Trial at 2021 ASCO Annual Meeting,https://www.nasdaq.com/press-release/spectrum-pharmaceuticals-presents-poziotinib-data-in-patients-with-brain-metastases
SPRB,"JUN 24, 2021","Spruce Biosciences Appoints Renowned Drug Developer Kirk Ways, M.D., Ph.D. to Board of Directors",https://www.nasdaq.com/press-release/spruce-biosciences-appoints-renowned-drug-developer-kirk-ways-m.d.-ph.d.-to-board-of
SPRO,6 DAYS AGO,Spero Therapeutics to Present at the Ladenburg Thalmann Healthcare Conference,https://www.nasdaq.com/press-release/spero-therapeutics-to-present-at-the-ladenburg-thalmann-healthcare-conference-2021-07
SQZ,"JUL 1, 2021",SQZ Biotechnologies Strengthens Board with Global Commercial and Clinical Development Experience,https://www.nasdaq.com/press-release/sqz-biotechnologies-strengthens-board-with-global-commercial-and-clinical-development
SRDX,"JUL 6, 2021",Surmodics Builds Thrombectomy Portfolio with Acquisition of Vetex Medical Limited,https://www.nasdaq.com/press-release/surmodics-builds-thrombectomy-portfolio-with-acquisition-of-vetex-medical-limited
SRGA,"JUL 6, 2021","Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)",https://www.nasdaq.com/press-release/surgalign-holdings-inc.-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-1
SRNE,"JUL 6, 2021",FDA Clears Sorrento Phase 2 Trial Of Non-Opioid Product Candidate Resiniferatoxin (RTX) For Treatment of the Knee Pain in Osteoarthritis (OA) Patients,https://www.nasdaq.com/press-release/fda-clears-sorrento-phase-2-trial-of-non-opioid-product-candidate-resiniferatoxin-rtx
SRPT,"JUN 30, 2021",Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/sarepta-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-22
SRRA,"JUL 7, 2021",Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/sierra-oncology-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-2021-07
SRRK,"JUN 18, 2021",Scholar Rock to Present Apitegromab TOPAZ Phase 2 Trial Results Highlighting Pharmacokinetic (PK) and Pharmacodynamic (PD) Data at the 2021 European Academy of Neurology Congress,https://www.nasdaq.com/press-release/scholar-rock-to-present-apitegromab-topaz-phase-2-trial-results-highlighting
SRTS,"MAY 6, 2021",Sensus Healthcare Reports First Quarter 2021 Financial Results,https://www.nasdaq.com/press-release/sensus-healthcare-reports-first-quarter-2021-financial-results-2021-05-06
SSKN,"MAY 18, 2021","STRATA Skin Sciences to Participate in the Oppenheimer MedTech, Tools & Diagnostics Summit",https://www.nasdaq.com/press-release/strata-skin-sciences-to-participate-in-the-oppenheimer-medtech-tools-diagnostics
SSY,"MAY 14, 2021","SunLink Health Systems, Inc. Announces Fiscal 2021 Third Quarter Results and COVID-19 Update",https://www.nasdaq.com/press-release/sunlink-health-systems-inc.-announces-fiscal-2021-third-quarter-results-and-covid-19
STAA,"MAY 5, 2021",STAAR Surgical Reports Record First Quarter 2021 Net Sales of $50.8 Million Up 44% Y/Y,https://www.nasdaq.com/press-release/staar-surgical-reports-record-first-quarter-2021-net-sales-of-%2450.8-million-up-44-y-y
STE,"JUN 2, 2021",STERIS Completes the Acquisition of Cantel Medical,https://www.nasdaq.com/press-release/steris-completes-the-acquisition-of-cantel-medical-2021-06-02
STIM,5 HOURS AGO,Neuronetics Launches Enhanced Digital Resource Center for NeuroStar Providers,https://www.nasdaq.com/press-release/neuronetics-launches-enhanced-digital-resource-center-for-neurostar-providers-2021-07
STOK,"MAY 18, 2021",Stoke Therapeutics to Present at the UBS Global Healthcare Virtual Conference,https://www.nasdaq.com/press-release/stoke-therapeutics-to-present-at-the-ubs-global-healthcare-virtual-conference-2021-05
STRO,"JUN 15, 2021",Sutro Biopharma to Participate in Two Virtual Investor Conferences in June,https://www.nasdaq.com/press-release/sutro-biopharma-to-participate-in-two-virtual-investor-conferences-in-june-2021-06-15
STRR,5 DAYS AGO,"Star Equity Holdings, Inc. to Present at the Access to Giving Virtual Conference on July 15",https://www.nasdaq.com/press-release/star-equity-holdings-inc.-to-present-at-the-access-to-giving-virtual-conference-on
STRRP,5 DAYS AGO,"Star Equity Holdings, Inc. to Present at the Access to Giving Virtual Conference on July 15",https://www.nasdaq.com/press-release/star-equity-holdings-inc.-to-present-at-the-access-to-giving-virtual-conference-on
STSA,"JUN 22, 2021",Satsuma Pharmaceuticals to Present at SVB Leerink’s CNS Forum,https://www.nasdaq.com/press-release/satsuma-pharmaceuticals-to-present-at-svb-leerinks-cns-forum-2021-06-22
STTK,,,
STXS,"MAY 10, 2021",Stereotaxis Reports 2021 First Quarter Financial Results,https://www.nasdaq.com/press-release/stereotaxis-reports-2021-first-quarter-financial-results-2021-05-10
SUPN,"MAY 25, 2021",Supernus to Present at Jefferies Virtual Healthcare Conference,https://www.nasdaq.com/press-release/supernus-to-present-at-jefferies-virtual-healthcare-conference-2021-05-25
SURF,6 DAYS AGO,Surface Oncology Appoints Denice Torres to Board of Directors,https://www.nasdaq.com/press-release/surface-oncology-appoints-denice-torres-to-board-of-directors-2021-07-08
SVRA,"JUN 30, 2021",Savara Announces First Patient Dosed in Pivotal Phase 3 Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Trial,https://www.nasdaq.com/press-release/savara-announces-first-patient-dosed-in-pivotal-phase-3-autoimmune-pulmonary-alveolar
SWAV,"JUN 28, 2021",Publications Validate Clinical Safety and Efficacy of Shockwave Intravascular Lithotripsy,https://www.nasdaq.com/press-release/publications-validate-clinical-safety-and-efficacy-of-shockwave-intravascular
SWTX,"JUN 28, 2021",Precision BioSciences and SpringWorks Therapeutics Dose First Patient in Expanded Phase 1/2a Clinical Trial Evaluating PBCAR269A with Nirogacestat in Patients with Relapsed/Refractory Multiple Myeloma,https://www.nasdaq.com/press-release/precision-biosciences-and-springworks-therapeutics-dose-first-patient-in-expanded
SXTC,"FEB 19, 2021","China SXT Pharmaceuticals, Inc. Announces 1 for 4 Reverse Share Split",https://www.nasdaq.com/press-release/china-sxt-pharmaceuticals-inc.-announces-1-for-4-reverse-share-split-2021-02-19
SYBX,"JUN 17, 2021",Synlogic Enters Research Collaboration with Roche for Development of Novel Therapy to Treat Inflammatory Bowel Disease,https://www.nasdaq.com/press-release/synlogic-enters-research-collaboration-with-roche-for-development-of-novel-therapy-to
SYK,"JUN 24, 2021","Stryker to host conference call on July 27, 2021",https://www.nasdaq.com/press-release/stryker-to-host-conference-call-on-july-27-2021-2021-06-24
SYN,"JUN 29, 2021",Synthetic Biologics Provides Update on SYN-020 Intestinal Alkaline Phosphatase Phase 1 Single-Ascending Dose Clinical Trial,https://www.nasdaq.com/press-release/synthetic-biologics-provides-update-on-syn-020-intestinal-alkaline-phosphatase-phase
SYNH,5 HOURS AGO,Syneos Health Names Michael Brooks Chief Development Officer,https://www.nasdaq.com/press-release/syneos-health-names-michael-brooks-chief-development-officer-2021-07-14
SYRS,"JUN 9, 2021",Syros Pharmaceuticals to Present at JMP Securities 2021 Life Sciences Conference,https://www.nasdaq.com/press-release/syros-pharmaceuticals-to-present-at-jmp-securities-2021-life-sciences-conference-2021
TAK,4 DAYS AGO,New Data from the Phase 3 HELP Study™ Open-Label Extension Evaluating Safety and Efficacy of TAKHZYRO® (lanadelumab) for Hereditary Angioedema Patients to be Presented at European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress,https://www.nasdaq.com/press-release/new-data-from-the-phase-3-help-studytm-open-label-extension-evaluating-safety-and
TARA,"JUL 7, 2021",Protara Therapeutics to Present at the Ladenburg Thalmann Healthcare Conference,https://www.nasdaq.com/press-release/protara-therapeutics-to-present-at-the-ladenburg-thalmann-healthcare-conference-2021
TARO,"JUN 18, 2021","Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2021",https://www.nasdaq.com/press-release/taro-annual-report-on-form-20-f-available-for-fiscal-year-ended-march-31-2021-2021-06
TARS,6 DAYS AGO,"Tarsus Pharmaceuticals, Inc. to Participate in the Ladenburg Thalmann 2021 Virtual Healthcare Conference",https://www.nasdaq.com/press-release/tarsus-pharmaceuticals-inc.-to-participate-in-the-ladenburg-thalmann-2021-virtual
TBIO,6 DAYS AGO,Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/translate-bio-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2021-07-07
TBPH,"JUN 24, 2021","Theravance Biopharma, Inc. Announces Pricing of Public Offering of Ordinary Shares",https://www.nasdaq.com/press-release/theravance-biopharma-inc.-announces-pricing-of-public-offering-of-ordinary-shares
TCDA,"JUN 2, 2021",Tricida to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference,https://www.nasdaq.com/press-release/tricida-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference-2021
TCMD,"JUN 29, 2021","Tactile Medical to Release Second Quarter of Fiscal Year 2021 Financial Results on August 2, 2021",https://www.nasdaq.com/press-release/tactile-medical-to-release-second-quarter-of-fiscal-year-2021-financial-results-on
TCON,"JUN 30, 2021",TRACON Pharmaceuticals Announces Appointment of Ya Huang as Executive Director of Statistical Programming and Granting of Inducement Award,https://www.nasdaq.com/press-release/tracon-pharmaceuticals-announces-appointment-of-ya-huang-as-executive-director-of
TCRR,"MAY 26, 2021",TCR² Therapeutics to Participate in Two Upcoming Conferences in June,https://www.nasdaq.com/press-release/tcr2-therapeutics-to-participate-in-two-upcoming-conferences-in-june-2021-05-26
TDOC,5 HOURS AGO,Teladoc Health and Microsoft Collaborate to Create a Unified Practice Experience for Clinicians,https://www.nasdaq.com/press-release/teladoc-health-and-microsoft-collaborate-to-create-a-unified-practice-experience-for
TECH,1 DAY AGO,"Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results",https://www.nasdaq.com/press-release/bio-techne-to-host-conference-call-on-august-5-2021-to-announce-fourth-quarter-2021
TELA,"JUN 14, 2021",TELA Bio to Participate in Upcoming JMP Securities Life Sciences Conference,https://www.nasdaq.com/press-release/tela-bio-to-participate-in-upcoming-jmp-securities-life-sciences-conference-2021-06
TENX,"JUL 7, 2021",Tenax Therapeutics Announces CEO Transition and $10 Million PIPE Offering Priced At-the-Market under Nasdaq Rules,https://www.nasdaq.com/press-release/tenax-therapeutics-announces-ceo-transition-and-%2410-million-pipe-offering-priced-at
TERN,"JUN 24, 2021",Terns Announces Initiation of Patient Dosing in AVIATION Phase 1b NASH Clinical Trial of VAP-1 Inhibitor TERN-201,https://www.nasdaq.com/press-release/terns-announces-initiation-of-patient-dosing-in-aviation-phase-1b-nash-clinical-trial
TEVA,"JUL 1, 2021","Teva to Host Conference Call to Discuss Second Quarter 2021 Financial Results at 8 a.m. ET on July 28, 2021",https://www.nasdaq.com/press-release/teva-to-host-conference-call-to-discuss-second-quarter-2021-financial-results-at-8-a
TFFP,1 DAY AGO,TFF Pharmaceuticals Announces Completion of Enrollment and Preliminary Data from its Phase 1 Clinical Trial of Tacrolimus Inhalation Powder,https://www.nasdaq.com/press-release/tff-pharmaceuticals-announces-completion-of-enrollment-and-preliminary-data-from-its
TFX,5 DAYS AGO,Largest U.S. Healthcare Claims and Utilization Analysis for BPH Procedures Reveals Lowest Overall Complication Rates and Consistent Durability after Treatment with Minimally Invasive UroLift System,https://www.nasdaq.com/press-release/largest-u.s.-healthcare-claims-and-utilization-analysis-for-bph-procedures-reveals
TGTX,5 DAYS AGO,TG Therapeutics to Participate in the Ladenburg Thalmann 2021 Healthcare Conference,https://www.nasdaq.com/press-release/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference
THC,"JUN 22, 2021",Tenet to Report its Second Quarter 2021 Results on July 21,https://www.nasdaq.com/press-release/tenet-to-report-its-second-quarter-2021-results-on-july-21-2021-06-22
THTX,"JUN 30, 2021",Theratechnologies to Announce Financial Results for Its Second Quarter Fiscal 2021,https://www.nasdaq.com/press-release/theratechnologies-to-announce-financial-results-for-its-second-quarter-fiscal-2021
TLC,"JUL 5, 2021",TLC Announces Details of Stock Swap Transactions,https://www.nasdaq.com/press-release/tlc-announces-details-of-stock-swap-transactions-2021-07-05
TLGT,"JUN 30, 2021","Teligent, Inc. Announces Adjournment of Annual Meeting of Stockholders",https://www.nasdaq.com/press-release/teligent-inc.-announces-adjournment-of-annual-meeting-of-stockholders-2021-06-30
TLMD,"MAY 26, 2021",SOC Telemed Announces Pricing of Public Offering of Class A Common Stock,https://www.nasdaq.com/press-release/soc-telemed-announces-pricing-of-public-offering-of-class-a-common-stock-2021-05-26
TLMDW,,,
TLSA,6 DAYS AGO,"Tiziana Life Sciences plc - ADS Ex-Dividend Date Scheduled for July 09, 2021",https://www.nasdaq.com/press-release/tiziana-life-sciences-plc-ads-ex-dividend-date-scheduled-for-july-09-2021-2021-07-08
TMBR,"JUN 3, 2021",Timber Pharmaceuticals Announces Adjournment of Annual Meeting,https://www.nasdaq.com/press-release/timber-pharmaceuticals-announces-adjournment-of-annual-meeting-2021-06-03
TMDI,2 DAYS AGO,Titan Medical Announces Appointment of New Chief Financial Officer,https://www.nasdaq.com/press-release/titan-medical-announces-appointment-of-new-chief-financial-officer-2021-07-12
TMDX,6 HOURS AGO,TransMedics Stock Trading Halted Today; FDA Advisory Committee to Review Premarket Approval Application for the OCS Liver System,https://www.nasdaq.com/press-release/transmedics-stock-trading-halted-today-fda-advisory-committee-to-review-premarket-0
TNDM,1 DAY AGO,"Tandem Diabetes Care to Announce Second Quarter 2021 Financial Results on August 4, 2021",https://www.nasdaq.com/press-release/tandem-diabetes-care-to-announce-second-quarter-2021-financial-results-on-august-4
TNXP,"JUN 28, 2021",Tonix Pharmaceuticals Added to Russell 2000® and Russell 3000® Indexes,https://www.nasdaq.com/press-release/tonix-pharmaceuticals-added-to-russell-2000r-and-russell-3000r-indexes-2021-06-28
TPTX,"JUN 29, 2021",Turning Point Therapeutics Appoints Paolo Tombesi as Executive Vice President and Chief Financial Officer,https://www.nasdaq.com/press-release/turning-point-therapeutics-appoints-paolo-tombesi-as-executive-vice-president-and
TRIB,"MAY 25, 2021","Trinity Biotech Announces Results for Q1, 2021",https://www.nasdaq.com/press-release/trinity-biotech-announces-results-for-q1-2021-2021-05-25
TRIL,"JUL 6, 2021",Trillium Therapeutics Announces Dosing of First Patient in Phase 1b/2 Study of TTI-622 in Combination With Azacitidine and Venetoclax in TP53-Wild Type Acute Myeloid Leukemia,https://www.nasdaq.com/press-release/trillium-therapeutics-announces-dosing-of-first-patient-in-phase-1b-2-study-of-tti-0
TRUP,6 DAYS AGO,Trupanion Partnership with We Rate Dogs Shines Light on Mental Health Challenges Faced by Veterinary Professionals,https://www.nasdaq.com/press-release/trupanion-partnership-with-we-rate-dogs-shines-light-on-mental-health-challenges
TRVI,"JUN 9, 2021",Trevi Therapeutics to Present at 2021 BIO Digital Conference,https://www.nasdaq.com/press-release/trevi-therapeutics-to-present-at-2021-bio-digital-conference-2021-06-09
TRVN,2 DAYS AGO,Trevena Announces Publication of OLINVYK® Health Economic Model in Journal of Comparative Effectiveness Research,https://www.nasdaq.com/press-release/trevena-announces-publication-of-olinvykr-health-economic-model-in-journal-of
TRXC,"MAR 5, 2021",Asensus Surgical Announces Finalization of Name and Ticker Symbol Change,https://www.nasdaq.com/press-release/asensus-surgical-announces-finalization-of-name-and-ticker-symbol-change-2021-03-05
TSHA,6 DAYS AGO,Taysha Gene Therapies to Participate in Upcoming July Investor Healthcare Conference,https://www.nasdaq.com/press-release/taysha-gene-therapies-to-participate-in-upcoming-july-investor-healthcare-conference
TTNP,"JUN 23, 2021",Titan Announces Positive Results from the First Studies of TP-2021 Implant in an Established Animal Model of Chronic Pruritus,https://www.nasdaq.com/press-release/titan-announces-positive-results-from-the-first-studies-of-tp-2021-implant-in-an
TTOO,"JUN 21, 2021",T2 Biosystems to Participate at Clinical Conferences in June and July 2021,https://www.nasdaq.com/press-release/t2-biosystems-to-participate-at-clinical-conferences-in-june-and-july-2021-2021-06-21
TVTX,"JUN 4, 2021",Travere Therapeutics Announces Presentation of Abstracts at ERA-EDTA Congress 2021,https://www.nasdaq.com/press-release/travere-therapeutics-announces-presentation-of-abstracts-at-era-edta-congress-2021
TVTY,2 DAYS AGO,SilverSneakers Opens Nominations for 2021 Member of the Year Awards,https://www.nasdaq.com/press-release/silversneakers-opens-nominations-for-2021-member-of-the-year-awards-2021-07-12
TWST,"JUN 30, 2021",Twist Bioscience Acquires NGS Library Preparation Maker iGenomX,https://www.nasdaq.com/press-release/twist-bioscience-acquires-ngs-library-preparation-maker-igenomx-2021-06-30
TXMD,"MAY 25, 2021",TherapeuticsMD Announces Submission of Low Dose BIJUVA® 0.5 mg/100 mg Supplemental New Drug Application to FDA,https://www.nasdaq.com/press-release/therapeuticsmd-announces-submission-of-low-dose-bijuvar-0.5-mg-100-mg-supplemental
TYME,"JUN 10, 2021","Tyme Technologies, Inc. Completes Strategic Review, Announces OASIS Breast Trial With Georgetown University, and Reports Fiscal Year 2021 Financial Results",https://www.nasdaq.com/press-release/tyme-technologies-inc.-completes-strategic-review-announces-oasis-breast-trial-with
UBX,"JUL 6, 2021",UNITY Biotechnology Announces Positive Data from Phase 1 Clinical Trial of UBX1325 in Patients with Advanced Vascular Eye Disease,https://www.nasdaq.com/press-release/unity-biotechnology-announces-positive-data-from-phase-1-clinical-trial-of-ubx1325-in
UFPT,"JUN 15, 2021",UFP Technologies to Present Virtually and Host 1x1 Investor Meetings at the 11th Annual East Coast Ideas Investor Conference on June 16 & 17,https://www.nasdaq.com/press-release/ufp-technologies-to-present-virtually-and-host-1x1-investor-meetings-at-the-11th
UHS,"JUL 6, 2021","Universal Health Services, Inc. Announces Date For Second Quarter 2021 Earnings Release And Conference Call",https://www.nasdaq.com/press-release/universal-health-services-inc.-announces-date-for-second-quarter-2021-earnings
UNH,6 DAYS AGO,UnitedHealthcare Introduces the Use of Predictive Analytics to Expand its Capabilities to Address Social Determinants of Health,https://www.nasdaq.com/press-release/unitedhealthcare-introduces-the-use-of-predictive-analytics-to-expand-its
URGN,5 HOURS AGO,UroGen Pharma Reports Strong Preliminary Jelmyto® Sales for Second Quarter 2021,https://www.nasdaq.com/press-release/urogen-pharma-reports-strong-preliminary-jelmytor-sales-for-second-quarter-2021-2021
UROV,"FEB 12, 2021",Urovant Sciences Provides Merger Update and Reports Third Quarter Fiscal Year 2020 Results,https://www.nasdaq.com/press-release/urovant-sciences-provides-merger-update-and-reports-third-quarter-fiscal-year-2020
USPH,,,
UTHR,"JUN 30, 2021",United Therapeutics Announces The Lancet Respiratory Medicine Publication Of Post-Hoc Analysis Of FVC Change From The Tyvaso® INCREASE Study,https://www.nasdaq.com/press-release/united-therapeutics-announces-the-lancet-respiratory-medicine-publication-of-post-hoc
UTMD,"MAY 11, 2021","Utah Medical Products, Inc. Announces Quarterly Dividend",https://www.nasdaq.com/press-release/utah-medical-products-inc.-announces-quarterly-dividend-2021-05-12
VAPO,"JUN 9, 2021",Vapotherm to Host First Investor Day,https://www.nasdaq.com/press-release/vapotherm-to-host-first-investor-day-2021-06-09
VAR,"APR 15, 2021",PTC Set to Join S&P 500; Lattice Semiconductor & Progyny to Join S&P MidCap 400; Domtar to Join S&P SmallCap 600,https://www.nasdaq.com/press-release/ptc-set-to-join-sp-500-lattice-semiconductor-progyny-to-join-sp-midcap-400-domtar-to
VBIV,"JUL 7, 2021",VBI Vaccines Appoints Linda Bain to Board of Directors,https://www.nasdaq.com/press-release/vbi-vaccines-appoints-linda-bain-to-board-of-directors-2021-07-07
VBLT,6 DAYS AGO,VBL Therapeutics Appoints Alison Finger and Michael Rice to its Board of Directors,https://www.nasdaq.com/press-release/vbl-therapeutics-appoints-alison-finger-and-michael-rice-to-its-board-of-directors
VCEL,"JUL 7, 2021","Vericel to Present at the Ladenburg Thalmann Healthcare Conference on Tuesday, July 13, 2021",https://www.nasdaq.com/press-release/vericel-to-present-at-the-ladenburg-thalmann-healthcare-conference-on-tuesday-july-13
VCNX,"JUN 30, 2021",Vaccinex to Chair Panel Q&A Session and Present Poster at the XV European Meeting on Glial Cells in Health and Disease,https://www.nasdaq.com/press-release/vaccinex-to-chair-panel-qa-session-and-present-poster-at-the-xv-european-meeting-on
VCYT,2 DAYS AGO,"Veracyte Appoints Rebecca Chambers as Executive Vice President and Chief Financial Officer, Further Positioning Company for Global Growth",https://www.nasdaq.com/press-release/veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial
VERO,2 DAYS AGO,Venus Concept Inc. to Participate in the Ladenburg Thalmann Healthcare Conference on July 13th,https://www.nasdaq.com/press-release/venus-concept-inc.-to-participate-in-the-ladenburg-thalmann-healthcare-conference-on
VERU,"JUN 28, 2021",Veru Announces the Presentation of a Phase 1b/2 Clinical Study Update for Sabizabulin (VERU-111) in Men with Metastatic Castration Resistant Prostate Cancer at the 2021 European Association of Urology Annual Congress,https://www.nasdaq.com/press-release/veru-announces-the-presentation-of-a-phase-1b-2-clinical-study-update-for-sabizabulin
VIE,"MAR 15, 2021","Horizon Therapeutics plc Completes Acquisition of Viela Bio, Inc.",https://www.nasdaq.com/press-release/horizon-therapeutics-plc-completes-acquisition-of-viela-bio-inc.-2021-03-15
VINC,"JUN 28, 2021",Vincerx Pharma Announces Inclusion in Russell 3000® and Microcap® Indexes,https://www.nasdaq.com/press-release/vincerx-pharma-announces-inclusion-in-russell-3000r-and-microcapr-indexes-2021-06-28
VINCU,,,
VINCW,,,
VIR,"JUN 25, 2021",Vir Biotechnology Presents New Clinical Data from Ongoing Trials of VIR-2218 and VIR-3434 in Patients with Chronic Hepatitis B Virus Infection at the International Liver Congress 2021,https://www.nasdaq.com/press-release/vir-biotechnology-presents-new-clinical-data-from-ongoing-trials-of-vir-2218-and-vir
VIRI,"JUN 9, 2021",Virios Therapeutics Highlights Safety Data from Phase 2a Fibromyalgia Trial at the International Association for the Study of Pain (IASP) World Congress,https://www.nasdaq.com/press-release/virios-therapeutics-highlights-safety-data-from-phase-2a-fibromyalgia-trial-at-the
VIVE,"JUL 7, 2021",Viveve Announces New Category III CPT Code for its Stress Urinary Incontinence Procedure,https://www.nasdaq.com/press-release/viveve-announces-new-category-iii-cpt-code-for-its-stress-urinary-incontinence
VIVO,4 HOURS AGO,"Meridian Bioscience to Hold Third Quarter Fiscal 2021 Financial Results Conference Call on August 6, 2021",https://www.nasdaq.com/press-release/meridian-bioscience-to-hold-third-quarter-fiscal-2021-financial-results-conference
VKTX,"JUN 24, 2021",Viking Therapeutics Announces Initiation of Phase 1b Clinical Trial of VK0214 in Patients with X-ALD,https://www.nasdaq.com/press-release/viking-therapeutics-announces-initiation-of-phase-1b-clinical-trial-of-vk0214-in
VKTXW,,,
VMD,"JUN 10, 2021",Viemed Healthcare Announces Voting Results From Its Annual & Special Meeting of Shareholders,https://www.nasdaq.com/press-release/viemed-healthcare-announces-voting-results-from-its-annual-special-meeting-of
VNDA,"MAY 12, 2021",Vanda Pharmaceuticals Announces Participation at Upcoming 2021 Investor Conferences,https://www.nasdaq.com/press-release/vanda-pharmaceuticals-announces-participation-at-upcoming-2021-investor-conferences
VNRX,"JUN 22, 2021",Sidoti Summer Virtual Small-Cap Conference,https://www.nasdaq.com/press-release/sidoti-summer-virtual-small-cap-conference-2021-06-22
VOR,5 DAYS AGO,PureTech Founded Entity Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined with a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML),https://www.nasdaq.com/press-release/puretech-founded-entity-vor-biopharma-announces-collaboration-with-janssen-to-develop
VRAY,"JUL 7, 2021",Miami Cancer Institute Enrolls First Patients in Single-Fraction Stereotactic MRI-Guided Adaptive Radiation Therapy for Inoperable Primary or Metastatic Cancer Trial,https://www.nasdaq.com/press-release/miami-cancer-institute-enrolls-first-patients-in-single-fraction-stereotactic-mri
VRCA,5 DAYS AGO,Verrica Pharmaceuticals Announces Appointment of Terry Kohler as Chief Financial Officer,https://www.nasdaq.com/press-release/verrica-pharmaceuticals-announces-appointment-of-terry-kohler-as-chief-financial
VRDN,5 HOURS AGO,Viridian Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/viridian-therapeutics-announces-inducement-grant-under-nasdaq-listing-rule-5635c4
VRNA,"JUN 10, 2021",Verona Pharma and Nuance Pharma Announce $219 Million Strategic Collaboration to Develop and Commercialize Ensifentrine in Greater China,https://www.nasdaq.com/press-release/verona-pharma-and-nuance-pharma-announce-%24219-million-strategic-collaboration-to
VRTX,"JUN 28, 2021",Vertex Announces National Reimbursement Agreement in France for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) and SYMKEVI® (tezacaftor/ivacaftor) for Eligible Cystic Fibrosis Patients,https://www.nasdaq.com/press-release/vertex-announces-national-reimbursement-agreement-in-france-for-kaftrior-ivacaftor
VSTM,"JUL 6, 2021",Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/verastem-oncology-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-2021-0
VTGN,5 DAYS AGO,VistaGen Therapeutics to Participate in William Blair Biotech Focus Conference 2021,https://www.nasdaq.com/press-release/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021
VTRS,5 DAYS AGO,"Viatris Inc. to Release Second Quarter 2021 Financial Results on Aug. 9, 2021",https://www.nasdaq.com/press-release/viatris-inc.-to-release-second-quarter-2021-financial-results-on-aug.-9-2021-2021-07
VTVT,"JUN 29, 2021",vTv Therapeutics to Participate at the 6th World Psoriasis & Psoriatic Arthritis Conference with Poster Presentation on HPP737,https://www.nasdaq.com/press-release/vtv-therapeutics-to-participate-at-the-6th-world-psoriasis-psoriatic-arthritis
VVOS,1 DAY AGO,One in Four Patients in Latest Clinical Study Show No Symptoms of Obstructive Sleep Apnea After Vivos Treatment,https://www.nasdaq.com/press-release/one-in-four-patients-in-latest-clinical-study-show-no-symptoms-of-obstructive-sleep
VXRT,"JUL 7, 2021",Vaxart Announces Exclusive Worldwide License Agreement with Altesa Biosciences for its Vapendavir Antiviral Asset,https://www.nasdaq.com/press-release/vaxart-announces-exclusive-worldwide-license-agreement-with-altesa-biosciences-for
VYGR,"MAY 19, 2021",Voyager Therapeutics Announces Strategic Shift and Leadership Transitions,https://www.nasdaq.com/press-release/voyager-therapeutics-announces-strategic-shift-and-leadership-transitions-2021-05-19
VYNE,"JUN 29, 2021",VYNE Therapeutics to Participate in the 2nd Annual JAK Inhibitors Drug Development Digital Event,https://www.nasdaq.com/press-release/vyne-therapeutics-to-participate-in-the-2nd-annual-jak-inhibitors-drug-development
WBA,6 DAYS AGO,Walgreens and VillageMD to Open 29 Full-Service Primary Care Practices in Texas This Year,https://www.nasdaq.com/press-release/walgreens-and-villagemd-to-open-29-full-service-primary-care-practices-in-texas-this
WINT,6 DAYS AGO,"50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021",https://www.nasdaq.com/press-release/50-companies-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-0
WVE,"JUN 2, 2021",Wave Life Sciences Announces Proof-of-Concept Preclinical Data for ADAR Editing Program in Alpha-1 Antitrypsin Deficiency,https://www.nasdaq.com/press-release/wave-life-sciences-announces-proof-of-concept-preclinical-data-for-adar-editing
XAIR,5 DAYS AGO,Beyond Air® Announces Participation at Upcoming Virtual Investor Conferences in July 2021,https://www.nasdaq.com/press-release/beyond-airr-announces-participation-at-upcoming-virtual-investor-conferences-in-july
XBIO,"MAY 12, 2021","Xenetic Biosciences, Inc. Reports First Quarter 2021 Financial Results",https://www.nasdaq.com/press-release/xenetic-biosciences-inc.-reports-first-quarter-2021-financial-results-2021-05-12
XBIOW,,,
XBIT,"JUL 6, 2021",XBiotech Announces Dividend to Holders of Common Stock,https://www.nasdaq.com/press-release/xbiotech-announces-dividend-to-holders-of-common-stock-2021-07-06
XCUR,6 DAYS AGO,Exicure Announces Upcoming Neuroscience Pipeline Update at Virtual R&D Day,https://www.nasdaq.com/press-release/exicure-announces-upcoming-neuroscience-pipeline-update-at-virtual-rd-day-2021-07-08
XENE,1 DAY AGO,Xenon Pharmaceuticals to Participate at the William Blair Biotech Focus Conference 2021,https://www.nasdaq.com/press-release/xenon-pharmaceuticals-to-participate-at-the-william-blair-biotech-focus-conference
XENT,"MAY 20, 2021",Intersect ENT Receives CE Mark Approval for PROPEL® Contour for Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery,https://www.nasdaq.com/press-release/intersect-ent-receives-ce-mark-approval-for-propelr-contour-for-patients-with-chronic
XERS,"JUL 7, 2021",Invesco ltd: Form 8.3 - Xeris Pharmaceuticals Plc.,https://www.nasdaq.com/press-release/invesco-ltd%3A-form-8.3-xeris-pharmaceuticals-plc.-2021-07-07
XFOR,"JUL 1, 2021",X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/x4-pharmaceuticals-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-13
XGN,21 HOURS AGO,AVISE® Lupus Test Demonstrates Statistically Significant Clinical Utility in Achieving a Definitive SLE Diagnosis and Positively Impacts Treatment Decisions,https://www.nasdaq.com/press-release/aviser-lupus-test-demonstrates-statistically-significant-clinical-utility-in
XLRN,"JUN 11, 2021",Bristol Myers Squibb and Acceleron Present First Results from Phase 2 BEYOND Study of Reblozyl® (luspatercept-aamt) in Adults with Non-Transfusion Dependent (NTD) Beta Thalassemia,https://www.nasdaq.com/press-release/bristol-myers-squibb-and-acceleron-present-first-results-from-phase-2-beyond-study-of
XNCR,"MAY 27, 2021",Xencor to Present at the Jefferies Virtual Healthcare Conference,https://www.nasdaq.com/press-release/xencor-to-present-at-the-jefferies-virtual-healthcare-conference-2021-05-27
XOMA,"JUN 21, 2021",XOMA Declares Quarterly Preferred Stock Dividends,https://www.nasdaq.com/press-release/xoma-declares-quarterly-preferred-stock-dividends-2021-06-21
XOMAP,,,
XRAY,"JUL 6, 2021",DENTSPLY SIRONA to Host Second Quarter 2021 Conference Call on August 5th,https://www.nasdaq.com/press-release/dentsply-sirona-to-host-second-quarter-2021-conference-call-on-august-5th-2021-07-06
XTLB,,,
XTNT,"MAY 13, 2021",Xtant Medical to Present at the Canaccord Musculoskeletal Conference,https://www.nasdaq.com/press-release/xtant-medical-to-present-at-the-canaccord-musculoskeletal-conference-2021-05-13
YI,"MAY 19, 2021","111, Inc. Announces First Quarter 2021 Unaudited Financial Results",https://www.nasdaq.com/press-release/111-inc.-announces-first-quarter-2021-unaudited-financial-results-2021-05-19
YMAB,"JUL 6, 2021",Y-mAbs Announces NMPA Submission of BLA for DANYELZA® (naxitamab-gqgk) in China,https://www.nasdaq.com/press-release/y-mabs-announces-nmpa-submission-of-bla-for-danyelzar-naxitamab-gqgk-in-china-2021-07
YMTX,"JUN 14, 2021",Yumanity Therapeutics Appoints Devin W. Smith as General Counsel,https://www.nasdaq.com/press-release/yumanity-therapeutics-appoints-devin-w.-smith-as-general-counsel-2021-06-14
ZBH,"JUL 6, 2021",Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2021 Financial Results,https://www.nasdaq.com/press-release/zimmer-biomet-announces-webcast-and-conference-call-of-second-quarter-2021-financial
ZEAL,21 HOURS AGO,Zealand Pharma A/S – Transaction Under Share Repurchase Program,https://www.nasdaq.com/press-release/zealand-pharma-a-s-transaction-under-share-repurchase-program-2021-07-13
ZGNX,"JUN 21, 2021",Zogenix to Participate in Two Upcoming Investor Conferences,https://www.nasdaq.com/press-release/zogenix-to-participate-in-two-upcoming-investor-conferences-2021-06-21
ZIOP,"MAY 24, 2021",Ziopharm Oncology to Participate in Upcoming Conferences,https://www.nasdaq.com/press-release/ziopharm-oncology-to-participate-in-upcoming-conferences-2021-05-24
ZLAB,"JUN 16, 2021",Zai Lab and MacroGenics Enter Into Broad Strategic Collaboration to Develop and Commercialize Preclinical Bispecific Antibodies in Oncology,https://www.nasdaq.com/press-release/zai-lab-and-macrogenics-enter-into-broad-strategic-collaboration-to-develop-and
ZNTL,"JUL 1, 2021",Zentalis Pharmaceuticals Announces Closing of Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares,https://www.nasdaq.com/press-release/zentalis-pharmaceuticals-announces-closing-of-offering-of-common-stock-and-full
ZOM,"JUL 6, 2021",Zomedica Provides Corporate Update,https://www.nasdaq.com/press-release/zomedica-provides-corporate-update-2021-07-06
ZSAN,"MAY 26, 2021",Zosano Pharma Announces Publication of Clinical Data Regarding the Long-term use of Qtrypta™ for the Treatment of Acute Migraine in The Journal of Headache and Pain,https://www.nasdaq.com/press-release/zosano-pharma-announces-publication-of-clinical-data-regarding-the-long-term-use-of
ZTS,"JUL 2, 2021",Zoetis Donates COVID-19 Vaccines to Help Support the Health of Zoo Animals,https://www.nasdaq.com/press-release/zoetis-donates-covid-19-vaccines-to-help-support-the-health-of-zoo-animals-2021-07-02
ZYME,6 DAYS AGO,Zymeworks to Present at Ladenburg Thalmann Healthcare Conference,https://www.nasdaq.com/press-release/zymeworks-to-present-at-ladenburg-thalmann-healthcare-conference-2021-07-08
ZYNE,"JUL 7, 2021",Zynerba Pharmaceuticals to Present at the Ladenburg Thalmann Virtual Healthcare Conference,https://www.nasdaq.com/press-release/zynerba-pharmaceuticals-to-present-at-the-ladenburg-thalmann-virtual-healthcare
ZYXI,1 DAY AGO,Zynex Announces Uplisting to the Nasdaq Global Select Market®,https://www.nasdaq.com/press-release/zynex-announces-uplisting-to-the-nasdaq-global-select-marketr-2021-07-13
